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ABSTRACT OF THE DISSERTATION
Regulation of Mycobacterial Transcription Initiation
by
Jayan Rammohan
Doctor of Philosophy in Biology and Biomedical Sciences
Computational and Molecular Biophysics
Washington University in St. Louis, 2016
Professor Eric A. Galburt, Chair

Cellular life relies on gene expression, in which DNA is first transcribed into RNA, which is then
translated into protein. Transcription is performed by the protein RNA polymerase (RNAP),
which interacts with DNA in three sequential events known as initiation, elongation and
termination. Mycobacterium tuberculosis (Mtb) represents a global burden to public health, and
the transcription factors CarD and RbpA are both essential to Mtb. I have studied the effect of
CarD and RbpA on transcription initiation in vitro at the Mtb rrnAP3 promoter. I have shown
that CarD stabilizes unwinding of promoter DNA by RNAP using a two-tiered kinetic
mechanism. I have also shown that RbpA stabilizes mycobacterial open complexes using a
mechanism distinct from that of CarD. Furthermore, RbpA and CarD cooperatively stabilize
mycobacterial open complexes, leading to increased transcription. Taken together, these findings
lay the groundwork for a mechanistic understanding of gene regulation by essential transcription
factors in a bacterium that kills millions of people each year.

xiii

Chapter 1

Introduction

1

1.1 Cells regulate transcription initiation to turn genes
on and off
Cellular organisms respond to changes in their environment. They do this by choosing
which RNA and protein molecules to manufacture based on environmental conditions.
This process involves the transcription of DNA into RNA, which can then be translated
into protein.

This flow, or expression, of genetic information between different

molecular classes is commonly known as the Central Dogma of Biology.

Gene

expression can be regulated at any of the steps of transcription and translation, and these
regulatory mechanisms enable a cell to manufacture molecules as needed (1).

Transcription represents the beginning of gene expression, and consists of initiation,
elongation, and termination (Figure 1). One of the most important opportunities for
regulating gene expression is the beginning of the beginning: Transcription initiation.
Transcription initiation consists of several reversible steps. RNA polymerase holoenzyme
(RNAP) binds promoter DNA, unwinds the DNA, and begins transcription by
incorporating nucleotides on the template strand. Transcription initiation is followed by
an irreversible transition into transcription elongation, during which RNAP moves
downstream along the gene and continues transcribing RNA. Transcription ends with
termination, during which RNAP and the completed RNA transcript dissociate from each
other and the template DNA. While all steps leading to the formation of a complete RNA
transcript can in principle be used to regulate gene expression, regulation is most often
observed at the step of transcription initiation.

2

R = RNA Polymerase, the enzyme that transcribes RNA from DNA
P = Promoter DNA sequence, where transcription starts at the beginning of a gene
|----------------------------Initiation--------------------------- Elongation
R+P ↔

RP c

↔

RP o

↔

RP itc

→

RP e

→

Termination
R + P + RNA

Figure 1: General kinetic mechanism of bacterial transcription. Transcription begins
with initiation, during which RNA Polymerase (R) binds Promoter DNA (P) to form the
closed complex (RP c ), RNAP unwinds the DNA to form the open complex (RP o ), and
RNA Polymerase incorporates the initial nucleotides of the RNA transcript onto the
template strand to form the initial-transcribing complex (RP itc ). RNA Polymerase then
transitions into an elongation complex (RP e ) in which the RNA transcript is extended.
The end of transcription is known as termination, during which RNA polymerase and the
RNA transcript dissociate from the DNA.

Transcription factors can be used to turn genes on and off depending on what stimuli the
cell is experiencing. In a classic example from the model bacterial organism Escherichia
coli (E.coli, or Eco), the lactose operon is regulated by the lac repressor such that the
proteins for digesting lactose are not made unless lactose is present (1). The lac repressor
binds to specific sequence of DNA at the beginning of the gene for beta-galactosidase,
which is an enzyme that bacteria make for metabolizing lactose. By inhibiting the ability
of RNAP to initiate transcription, the lac repressor acts to turn off the operon for lactosemetabolizing proteins when lactose is not present.

When a sufficiently high

concentration of lactose is present in the environment, lactose is able to bind the
repressor, which leads to a reduction in the affinity of the repressor for promoter DNA.
The reduction in the occupancy of the promoter by repressor allows the RNAP access to
the gene and stimulates transcription. This removal of lac repressor by lactose turns the
gene from “off” to “on”, which results in transcription of RNA and subsequent translation

3

of the protein beta-galactosidase.

Thus, in response to an environmental stimulus

(lactose), the cell regulates transcription initiation in order to turn this particular gene on.

The precise kinetic mechanism of lac repression has been a subject of study for decades
(1-4). Initial studies posited that lac repressor functioned by blocking transcription
initiation. Other studies suggested that lac repressor and RNAP could be bound to the
DNA at the same time, and that lac repressor had an inhibitory effect on the activity of
bound RNAP. Kinetic schemes to describe this process were hypothesized, and
experiments were conducted to provide constraints and distinguish between models. This
process was repeated iteratively over decades, and a minimal kinetic mechanism for lac
repression has emerged (3). This model describes how lac repressor works by describing
each of the most important states and the rates of conversion between them. Such a
kinetic model quantitatively describes the thermodynamics and kinetics by which lac
repressor competitively binds to the promoter DNA to block transcription. Complete
kinetic characterization of a system represents a gold standard of understanding in
biophysical mechanism since such a model can be used to quantitatively predict the
pathways of equilibration and timing of relaxation when the system is subject to
perturbation. Lac repressor continues to be the subject of mechanistic study – very recent
work (published over 50 years after the system was first described) has shown how lac
repressor bindings modes are linked to sequence properties such as spacer length (4).
This serves to illustrate that kinetic mechanisms are never fully solved, and new
investigations can always be performed to illuminate new mechanistic details.
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1.2 Regulation
initiation

of

mycobacterial

transcription

One of the most perplexing mysteries of how an organism regulates transcription in
response to its environment is Mycobacterium tuberculosis (Mtb), the obligate pathogenic
bacteria responsible for the disease Tuberculosis. The disease was first described in 1882
by Robert Koch as the “tubercle bacillus” since the bacteria were rod-like in shape
(bacilli), approximately 2-4 microns in length and 0.2-0.4 microns in width. In 1905,
Koch received the Nobel Prize in Physiology and Medicine for his work describing
Tuberculosis. Over a century later, we have learned much about Tuberculosis; however,
in spite of these great advancements in our knowledge of this organism, Tuberculosis
remains a highly successful pathogen. Mtb is typically transmitted by aerosol and infects
the lungs of humans, where it is subject to acute and chronic attack by the immune
system. Mtb is initially encapsulated by immune cells that form a granuloma where Mtb
is subject to an onslaught of environmental stresses including attacks on the
mycobacterial cell surface, acidification of phagosomes, reactive nitrogen intermediates,
reactive oxygen species, hypoxia, nutrient starvation, phosphate deprivation and DNA
damage (5). Amazingly, Mtb has adapted strategies to survive these stresses including
prevention of fusion of the phagolysosome and the transition into a dormant (latent) state.
Latent tuberculosis infects at least one-third of the world’s population, and in many cases
it reactivates resulting in over 1 million deaths per year (World Health Organization).
Mycobacterium tuberculosis has evolved within humans for over 50,000 years, and Mtb
continues to evolve resulting in an alarming emergence of multidrug resistant strains. As
such, Mtb poses a major global burden to public health.
5

One of the primary reasons that Mtb is able to respond to these stresses is that it has
evolved sophisticated methods for regulating transcription initiation (6). The genome of
the paradigm strain of Mtb known as H37Rv has over 4 million base pairs and 3959
known genes.

The expression of these genes are carefully tuned by hundreds of

transcription factors which form a regulatory network that is just now starting to be
mapped using computational methods from systems biology (6). However, there have
been relatively few mechanistic studies on how individual transcription factors from Mtb
affect the kinetics of transcription initiation.

In fact, transcription by the basal system of mycobacterial RNAP alone is not yet
understood. Our understanding of bacterial transcription initiation has been largely
shaped by decades of studies of E.coli, which has served as a useful model system. There
are many similarities between Eco and Mtb transcription systems. For instance, RNAP
from both bacteria consist of the same homologous subunits α2 ββ’ω, and the promoter
architecture is generally the same (-35 hexamer, spacer region, -10 hexamer,
discriminator sequence, transcription start site) (7).

However, there are differences

between the two systems that could have important ramifications with regard to their
respective mechanisms of transcription initiation. For example, mycobacterial promoters
do not have a strong consensus -35 region, and they have a more well-defined “extended
-10” motif (7). So far, the limited kinetic studies of mycobacterial RNAP have been
performed using low-resolution studies and have been interpreted assuming that initiation
proceeds through the same kinetic mechanism as EcoRNAP (8). Mycobacterial
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promoters exhibit significantly reduced activity in E.coli, suggesting that EcoRNAP
cannot initiate efficiently from mycobacterial promoters (9, 10). However, direct
comparisons of in vitro transcription initiation kinetics between EcoRNAP and
mycobacterial RNAP have not been performed. Such studies would provide valuable
information on how transcription systems in the two organisms can be compared.
Understanding the mechanisms of transcription initiation in Mtb and how this process is
regulated by essential transcription factors represents an urgent biomedical research
challenge, so that we can develop new strategies to treat tuberculosis.

Formation of the transcription “open complex” (RP o ) has been recognized as a ratelimiting step in transcription initiation in several bacterial systems including the model
system of E.coli (11-13) This is especially true at ribosomal promoters, which are known
to have unstable open complexes in E.coli and Mtb (14, 8). Transcription of ribosomal
RNA (rRNA) is tightly linked to the growth rate of bacteria, and under certain conditions
represents the majority of all transcription within the cell (15). Open-complex stability of
rRNA promoters in E.coli is determined by a number of factors including GC content,
interactions with sigma factor, initial nucleotide concentration, (p)ppGpp, DksA and Fis
(16, 17). However, DksA is not conserved across all bacteria, and mycobacteria have
evolved different transcription factors to regulate transcription of rRNA (18). Thus, the
unique mechanisms by which Mtb regulate open-complex formation at rRNA promoters
represents an important research challenge not only for understanding the ability of Mtb
to grow and survive in a range of environmental conditions, but also for understanding
bacterial transcription in non-model organisms.

7

1.2.1 CarD
CarD is a recently discovered transcription factor that is essential to survival and
pathogenesis of Mycobacterium tuberculosis (11). CarD is named for its similarity to a
protein in Myxococcus xanthus that helps produce carotenoid pigments in response to
blue light (Car+ phenotype, D locus) (19). CarD is highly conserved among the
Mycobacteriacea family as well as the larger Actinobacteria phylum. The phylogenetic
distribution of CarD also includes but is not limited to Proteobacteria, Spirochaetes,
Deinococcus-Thermus, and Firmicutes (20). Importantly, CarD is not found in E.coli, nor
is it found in humans (11, 13). Although structurally and evolutionarily unrelated, CarD’s
role in transcription initiation has been functionally compared to TFIIE in eukaryotes and
TFE in archaea (21). CarD is required for Mtb to survive under a range of stresses
including reactive oxygen species, nutrient starvation, and DNA damage (5).

CarD consists of 162 amino acids that fold into two distinct structural domains. The Nterminal domain is known as the RNAP-Interacting Domain (RID), since it binds the β1
lobe of the β subunit of RNAP as shown by a bacterial two-hybrid assay (22). The Cterminal Domain (CTD) binds DNA non-specifically, and includes a tryptophan residue
that is essential for functionality (22, 23). Interestingly, CarD has been directly linked to
treatment of Tuberculosis because weakening CarD’s RID domain results in an increase
in the efficacy of Rifampicin, an antibiotic that is used in the first line-of-defense (22).
This underscores the possibility of using our understanding of CarD to improve clinical
therapies.
8

In ChIP experiments, CarD is found at promoters throughout the mycobacterial genome,
suggesting that CarD is a global regulator of transcription initiation (20). Furthermore,
CarD has been shown to be important for regulating transcription of ribosomal RNA
(rRNA), and is found at both promoters of the Mtb rRNA operon (20, 24, 11). CarD
activates transcription from Mtb rrnAP3 in vitro, however the mechanism of this
activation is unknown (20). It is possible that CarD could affect any of the steps of
transcription including initiation, elongation and termination.

Depletion of CarD leads to increased rRNA, which led to the initial hypothesis that CarD
represses rRNA transcription in a manner that is functionally similar but structurally
distinct from that of EcoDksA (11). However, CarD mutants with weakened interactions
with RNAP and DNA result in decreased levels of 16S rRNA (20), indicating that CarD
may activate transcription. This in vivo evidence that CarD activates transcription of
rRNA is consistent with in vitro studies in which CarD increases transcription from the
Mtb rrnAP3 promoter (20). Importantly, CarD’s activation of in vitro transcription was
observed in the presence of competitor DNA, demonstrating that CarD stabilizes
promoter-bound transcription competent complexes (20).

CarD activation of

transcription depends not only on residues in its RID domain known to interact with
RNAP, but also on interactions between CarD’s CTD and DNA, including a highly
conserved solvent-exposed tryptophan (TthCarD W86, MtbCarD W85) (23, 20).
Structural modeling of CarD with the transcription initiation open complex predicts that
this tryptophan interacts with the upstream edge of the transcription bubble, leading to the

9

natural hypothesis that CarD stabilizes the mycobacterial transcription open-complex
(20).

In my thesis work, I have studied the mechanism of CarD’s effect on transcription
initiation at the Mtb rrnAP3 promoter. Possible kinetic mechanisms by which CarD could
activate transcription initiation include but are not limited to stabilization of bound
complex, acceleration of promoter opening, and deceleration of promoter closing, and
acceleration of promoter escape. The relative values of these rates ultimately give rise to
transcriptional flux by RNAP from a promoter. As such, one of the primary goals of my
doctoral work was to measure the effect of CarD on the energetics of promoter opening,
in order to quantify thermodynamic and kinetic properties of CarD-regulated
transcription initiation.

1.2.2 RbpA
RbpA (RNAP-binding protein A) is a small (14 kDa) RNAP-binding protein that was
originally discovered in Streptomyces coelicolor (Sco), and identified as an important
regulator of growth and Rifampicin resistance (25, 26).

RbpA is confined to and

widespread within the Actinobacteria phylum, and it is essential for survival of Mtb (27,
28). One important role of RbpA that has been the subject of several recent studies is its
ability to regulate the assembly of a subset of mycobacterial sigma factors with core
RNAP. RbpA binds group 1 (SigA) and certain group 2 (SigB) mycobacterial sigma
factors, and increases their affinity for core RNAP (27, 29, 30, 28). In this manner, RbpA
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can selectively drive transcription from a subset of promoters in the mycobacterial
genome by tuning the assembly of core RNAP with different sigma factors.
RbpA has also been linked to Rifampicin activity, although the nature of this relationship
is unclear.

Initial studies indicated that MsmRbpA could rescue SigA-dependent

transcription from the rel promoter in the presence of 100 µM Rifampicin (27, 31).
Combined with cross-linking studies that localized RbpA to a location in the active cleft
of RNAP (TthRNAP beta-subunit R381), these results led to a hypothesis that RbpA
competes with Rifampicin for binding within the active site of the transcription complex
(the so-called “exclusion model”) (32). This model is consistent with in vitro
transcription assays performed by a different laboratory in which RbpA’s presence
increases Rifampicin tolerance (27). However, the exclusion model is not consistent with
the fact that RbpA does not affect the IC50 of Rifampicin (27). Furthermore, RbpA
binding core RNAP was alternately mapped to the beta-subunit Sandwich-Barrel Hybrid
Motif, which does not overlap with the Rifampicin binding site (33, 27). As a result, a
different model has emerged in which RbpA and Rifampicin do not compete for binding,
and any relationship between the two is indirect. Possible reasons for the apparent
discrepancy in these reported results include the promoter being studied, the species of
the reagents being used, and the conditions under which the assays were performed.
Further studies are needed to elucidate the precise nature of RbpA’s interactions with
core RNAP and how these may be related to linkage between RbpA and Rifampicin.
Although RbpA binds to RNAP holoenzyme in the absence of DNA, RbpA’s activity is
promoter-dependent (30).
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Regulation of rRNA is hypothesized to be the driving force behind its link to growth
rate(26). Similarly to CarD, in vitro transcription assays have demonstrated that RbpA
activates transcription from the Mtb rrnAP3 promoter (27). Initial studies indicated that
RbpA is important for stabilizing promoter-bound RNAP at the Mtb rrnAP3 promoter
(27). Furthermore, using KMnO 4 footprinting, RbpA was required for the formation of
open-complex by SigB-holoenzyme at the sigAP promoter (30). However, the effect of
RbpA on promoter-opening at the Mtb rrnAP3 promoter has yet to be studied.

Intriguingly, the fact that CarD and RbpA both activate transcription from the Mtb
rrnAP3 promoter introduces the possibility that the two factors could potentially interact
with the transcription initiation complex simultaneously. This possibility has been
hypothesized, but never directly studied (27, 33). The interplay between CarD and RbpA
could lead to a range of outcomes, not only with regard to open complex stability at the
Mtb rrnAP3 promoter, but also on the overall flux of transcription from promoters
throughout the mycobacterial genome.
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Figure 2: Structure of CarD from Thermus thermophilus (20, 34). Top: Schematic
of CarD showing the N-terminal RNAP-interacting domain (RID, pink) and the DNAbinding C-terminal Domain (CTD, green). Bottom: The N-terminal domain is almost
entirely beta-sheet in structure, and the C-terminal domain is entirely alpha-helical.
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Figure 3: Structure of RbpA (28, 33, 34). Top: Schematic of RbpA shows that is
consists of an N-terminal “core” domain (white), connected by a basic linker (BL) to the
C-terminal sigma-interacting domain (SID, blue). Bottom, left: An NMR structure of the
N-terminal core domain indicates that it primarily consists of 4 anti-parallel beta strands.
Bottom, right: A co-crystal structure of the alpha-helical RbpA-SID (purple) with
subdomains of sigma-factor (orange and magenta).
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Figure 4: How do the essential transcription factors CarD and RbpA affect the
mechanism of mycobacterial transcription initiation?
Top: A general scheme for bacterial transcription initiation is shown on the top row,
where RNA Polymerase (R) binds Promoter DNA (P) to form the closed comples (RP c )
which isomerizes into the open complex (RP o ), incorporates initial nucleotides to form
the initial transcribing complex (RP itc ), and then irreversibly transitions into an
elongation complex (RP e ). Transcription factors such as CarD and RbpA (represented by
X) could potentially bind to any of these states (represented by the box enclosed by the
dashed line), affect their stabilities, and affect the rates of conversion between states.
Bottom: A free energy diagram aligned with the kinetic scheme (Top) in which states
(numbered 1-5) and transition states (1* through 4*) are depicted as local minima and
maxima along a reaction coordinate. A lower ∆G indicates a more stable state, and a
lower activation barrier (difference between a state and a transition state) results in a
faster rate of conversion between states. The dashed line represents the effect of a
hypothetical transcription factor that stabilizes states 2 and 5, and stabilizes the transition
states 3* and 4*. All of these effects change the kinetics of transcription initiation.
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1.3 Biophysical methods: experimental and theoretical
considerations

1.3.1 Ensemble and single-molecule approaches
Fluorescence spectroscopy using modified promoters has been used to study opencomplex formation in many transcription systems including E.coli (35-38), T7 RNAP
(39, 40), and mitochondrial RNAP (41). Fluorescence offers a distinct advantage over
alternate approaches such as potassium-permanganate footprinting because the readout
provides a real-time signal for the equilibration of the system, and therefore includes
information on the kinetics of open-complex formation and promoter escape (37). One
common challenge of interpreting fluorescence data arises from assigning structural
states to different phases of fluorescence enhancement. For example, Cy3 is an organic
dye that is frequently used in protein-induced fluorescence enhancement (PIFE)
experiments. The quantum yield of Cy3 can dramatically increase or decrease depending
on its microenvironment.

A real-time fluorescence assay for measuring RP o formation and promoter escape was
developed for the E.coli transcription system that utilizes a Cy3 fluorophore attached to
the +2 non-template dT (37). The signal largely reports on open complex formation in
real-time, allowing for one to measure observed rates of open complex equilibration. The
signal-over-background far exceeds that of other fluorophores (i.e. 2-aminopurine),
which allows for assays to be performed at low concentrations of Cy3-promoter (i.e. 10
nM). I have used this approach to study how transcription factors essential to Mtb affect
16

transcription initiation at the major promoter of the ribosomal operon in Mtb (Figure 5)
(24, 37, 42, 34).
Single molecule approaches to biology offer complementary strengths to ensemble
approaches, since they are able to provide information on sample heterogeneity that may
be lost in ensemble averaging (43). Single molecule technique can leverage many types
of spectroscopic signals. Perhaps the first earliest published single molecule measurement
used electric current to detect discrete steps in “Excitability Inducing Materials”, which
later turned out to be single channel recordings of ion channels (44). Fluorescence is
commonly used for a range of single molecule techniques including but not limited to
total-internal reflection fluorescence spectroscopy (TIRF), fluorescence correlation
spectroscopy (FCS), and many super-resolution imaging techniques (45, 46). Force
spectroscopy can be performed by many instruments including atomic force microscopes,
optical tweezers, and magnetic tweezers (47-50). Notably, of all of the techniques
mentioned here, magnetic tweezers uniquely allow for the study of promoter unwinding
in real-time on supercoiled DNA tethers, and they have been used to study all phases of
transcription initiation in the presence and absence of transcription factors (51-54).
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Figure 5. Schematic of the Mtb rrnAP3 promoter used in this study. Nontemplate and
template strand sequences for the Mtb rrnAP3 promoter are shown along with the
predicted region of strand separation upon open-complex formation with RNAP.
Promoter elements are shown including the -35 hexamer and -10 hexamer (both shown in
red), 18 base pair spacer region, extended -10 (Ext -10, blue), +1 transcription start site
(TSS, green), and the location of the Cy3 fluorophore which is covalently attached to the
+2 nontemplate dT.
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1.3.2 Energetic considerations of biophysical mechanism
Thermodynamic measurements of binding and linkage
State functions in thermodynamics describe path-independent properties of a closed
system at equilibrium that do not depend on how the system arrived at that state. The
Gibbs free energy is such a state function that describes the overall stability of a given
state and for binding reactions, the Gibbs free energy is related to the binding affinity of
the two reactants by ∆G = -RTlnK eq , where K eq = k on /k off .

In this manner, binding

affinities provide information about the concentration dependencies of molecular
interactions and inform as to the relative stabilities of different states. At the time I began
my doctoral research, there were no quantitative measurements of the binding affinities
of CarD or RbpA to RNAP and DNA. Therefore, quantitative measurements of binding
affinities represented an important goal towards characterizing the thermodynamic
properties of these transcription factors.

Chemical linkage describes the notion that the presence or absence of a chemical
component of the system directly affects the binding affinity between two molecules.
Linkage is also known as cooperativity, and it can be negative (resulting in weaker
affinity), positive (resulting in higher affinity), or zero (no effect on affinity). In its
simplest case, linkage can be quantitatively described by a single quantity α, which
represents the ratio of affinities in the presence and absence of the third component. In
the case of ternary complex formation, α represents the ratio of affinities of a ligand to
receptor in the presence or absence of the third component.
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Kinetic signatures for inferring mechanism
When attempting to dissect mechanisms of binding and conformational exchange, one
must perform kinetic experiments to measure observed rates, and study how these
observed rates depend on concentrations of the reactants. The dependence of observed
rate on concentration produces a “kinetic signature” for a given reactant, which can be
used to infer quantitative details about the underlying kinetic mechanism. Perhaps the
most readily interpretable kinetic signature is for that of binding, which is a linear
dependence of observed rate on reactant concentration. The slope of this line gives the
on-rate (bimolecular rate of association, units M-1s-1), while the y-intercept gives the offrate (unimolecular rate of dissociation, units s-1).

When considering kinetic signatures that are the manifestation of bimolecular binding
coupled to unimolecular isomerization, two limiting models are often considered.
“Conformational selection” describes conformational exchange that occurs prior to ligand
binding, whereas “induced fit” describes the case where ligand binding occurs prior to
conformational exchange. Typically, the kinetic signature of induced fit mechanisms
manifest as a hyperbolically increasing observed rate with ligand concentration.
Conformational selection mechanisms can produce hyperbolically increasing or
decreasing observed rates with ligand concentration, depending on the relative values of
the rate-constants in the system (55).
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The co-existence of conformational-selection and induced-fit in series is frequently used
to explain the kinetic signatures of molecular interactions (38). Interestingly, recent
analyses of thermodynamic cycles have demonstrated that they can also co-exist in
parallel (39). However, kinetic signatures for the parallel coexistence of conformational
selection and induced fit are rarely observed and have yet to be theoretically explored in a
general sense. A thermodynamic cycle describes a closed loop of states, which can be
connected by binding or conformational exchange. Several thermodynamic cycles can be
found in the general mechanism of transcription initiation linked to transcription factor
binding as shown in Figure 4. For example, the four states comprising RP c , RP o , X-RP c
and X-RP o form a cycle that is connected by binding (+/- X) and conformational
exchange (closed to open). Since free energy is a state function and therefore pathindependent, the sum of free energy change around the cycle must equal zero. This
property can be used to constrain possible combinations of kinetic rate constants that can
be used to describe a thermodynamic cycle. For example, the product of the forward rates
must be equal to the product of the reverse rates (56). As such, a thermodynamic cycle
can be used to constrain kinetic parameters when exploring different models.
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1.4 Scope of dissertation
Prior studies of the transcription factors CarD and RbpA have demonstrated that they are
both essential in the deadly pathogen Mycobacterium tuberculosis (Mtb), and that they
can activate transcription from promoters for ribosomal RNA. Therefore, the mechanisms
by which CarD and RbpA affect the kinetics of mycobacterial transcription initiation
have profound implications with respect to our ability to understand and treat this disease.
I have studied the effect of CarD and RbpA on transcription initiation the Mtb rrnAP3
promoter and my results are reported in the following chapters. In Chapter 2, I describe
binding assays to characterize the concentration dependencies of transcription complex
assembly. In Chapters 3 and 4, I detail my use of a real-time ensemble fluorescence
assay to characterize the effect of CarD and RbpA on Mtb rrnAP3 promoter opencomplex formation in vitro. In Chapter 5, I detail my evaluation of multiple kinetic
models that may be consistent with the data. In addition to pre-initiation studies, I have
performed ensemble fluorescence studies in the presence of competitors and NTP’s to
study both dissociation and promoter escape which are described in Chapter 6.

In

Chapter 7, experiments performed using glutamate instead of chloride as the primary
anion are discussed which highlight the potentially dramatic effects of solution conditions
on the mechanisms by which transcription initiation is regulated. Lastly, in Chapter 8, I
describe magnetic-tweezers assays in which I observe promoter opening in real-time at
the single-molecule level for the first time with the transcription initiation system from
mycobacteria.
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Taken together, this dissertation describes the energetics of CarD and RbpA interacting
with the mycobacterial transcription initiation machinery, and poses mechanistic models
that could explain how CarD and RbpA affect mycobacterial transcription open-complex
stability. These models utilize fundamental thermodynamic and kinetic principles to
explain measurements of binding, linkage, and observed rates. This work provides a
quantitative framework for understanding the regulation of transcription initiation in Mtb,
not only at the operon for ribosomal RNA but also genome-wide.
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Chapter 2
Binding studies of DNA, RNAP, and
CarD
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Introduction
Regulation of the housekeeping mycobacterial transcription initiation system depends on
binding interactions between multiple protein and DNA components – Sigma factor A
(SigA), core RNAP, promoter DNA, and transcription factors such as CarD and RbpA.
Binding affinities provide information regarding the concentration-dependence of
molecular interactions, and can be used to inform experimental design by providing
predictable conditions for macromolecular assembly. Therefore, I sought to measure
binding affinities between Mycobacterium bovis (Mbo) RNAP, CarD, and the
Mycobacterium tuberculosis (Mtb) rrnAP3 promoter. The experiments performed in this
chapter are largely exploratory in nature. The trends presented here were reproducible
across multiple experiments. However, since exact concentrations of DNA, RNAP and
CarD were not consistently used across experiments, error estimates are not included, and
estimates of affinities are based on individual data sets.

The specific DNA substrate I chose to study was a 150 bp promoter fragment containing
the Mtb rrnAP3 promoter fragment with an internal Cy3 label, since I was planning to use
this substrate for measuring promoter opening and escape in real-time (1). To probe the
assembly of the mycobacterial transcription initiation machinery on this promoter DNA
template, I measured binding interactions between CarD, RNAP, and DNA using an
electrophoretic mobility shift assay (EMSA) and a double-filter binding assay. CarDDNA interactions have been previously studied. It has been shown that CarD prefers to
shift longer pieces of DNA (Christina Stallings, personal communication). Therefore, it is
possible that CarD’s binding affinity to a 150 bp promoter fragment represents a lower
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bound on its affinity to genomic DNA. I measured the concentration dependence of
CarD-binding to this specific promoter fragment in order to inform the design of
ensemble fluorescence experiments that use this exact promoter template (2, 3).

To test how the affinity of mycobacterial RNAP holoenzyme for promoter DNA might be
affected by residues in SigA important for open-complex formation, I wanted to test
holoenzyme formed with a mutant SigA that could recognize promoter DNA but with
reduced ability to open the DNA. In Escherichia coli (E. coli or Eco), residues in
Sigma70 region 2.3 are thought to play a role in promoter opening by stabilizing
unstacked bases in the transcription bubble. For example, tyrosine 430 is thought to
stabilize the open conformation of the -11 non-template adenosine, where promoter
opening is nucleated (4-6). The development of a mycobacterial holoenzyme capable of
promoter-recognition and binding but deficient in promoter-opening will provide a
unique ability to probe properties of the closed-complex. To this end, I conducted
experiments using a holoenzyme formed with a mutant of SigA called “SigA-FYWW”,
in which 4 highly conserved aromatic residues in SigA were mutated to alanines. Our
working hypothesis is that holoenzyme formed with SigA-FYWW (MboRNAP-FYWW)
is capable of promoter-specific binding, but is deficient in promoter opening.

Methods
Preparation of Cy3-labeled promoter fragments
Promoter fragments were made as previously described (see Appendix A for detailed
protocol) (7).
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Preparation of proteins
Preparation of Mbo core RNAP, Mtb SigA, were prepared as described (7). Preparation
of Mycobacterium smegmatis (Msm) CarD and Mtb CarD were prepared as described (7).
Cloning of Mtb SigA-FYWW was performed by Ashley Garner, and purification was
performed by Ana Ruiz-Manzano.

Electrophoretic Mobility Shift Assays (EMSA)
Native Tris-Borate-EDTA (TBE) gels were used to test protein-nucleic acid binding
interactions as previously described, with minimal modifications as follows (8). Precast 4
- 20% gradient non-denaturing TBE-PAGE gels (Invitrogen) were pre-run in 0.38x TBE
buffer (100V / 90 min) to equilibrate the gel. The 0.38x TBE buffer was chosen in order
to minimize the potentially destabilizing effect of salt on the binding-reaction while
preserving the ability of the buffer to carry current. Promoter DNA (150 bp, containing
Mtb rrnAP3 promoter with Cy3 label) was mixed with MboRNAP, CarD, or both in 15 μl
reactions, which were allowed to equilibrate for 1 hr at 25 C. The reactions were mixed
with loading dye, each reaction was loaded into individual wells, and the gel was run at
100 V for 100 min.

Analysis of EMSA assays for estimating binding affinities were limited to those reactions
performed in the absence of competing nucleic acid, which can affect measurements of
CarD-DNA binding affinity and obscure the potential presence of nuclease contaminants
in the reaction (see Appendix B). EMSA experiments with promoter DNA, MboRNAP

32

holoenzyme, and CarD were performed multiple times. However since each individual
experiment did not necessarily use the exact same concentrations of reagents, these data
sets were not combined and used to estimate error. Importantly, the trends from all of
these experiments were consistent are sufficiently captured in the experimental data
shown in Figures 1-3. There was significant difficulty in quantifying the data by
densitometry due to material stuck in the wells of the gel and streaking of the gel. For this
reason, estimates of apparent binding affinities are approximate.

Double-filter binding assays
Double-filter binding assays were performed as previously described with the minimal
modifications as described below (9, 10). Nitrocellulose membranes were pre-treated by
soaking for 10 min in 0.4 M KOH. After rinsing the nitrocellulose filters with water,
both nitrocellulose and nylon filters were soaked in reaction buffer without bovine serum
albumin (BSA) for 1 hr at 4 C.
Reaction buffer:
60% MQ H2O
10% 10x Mycobacterial transcription buffer +DTT/+BSA (“MTB +/+”)
…also make MTB +/- (no BSA) for filter soaking and wash steps
20% RNAP Storage Buffer (10 mM Tris pH 8, 200 mM NaCl, 25% glycerol)
10% CarD Storage Buffer (20 mM Tris pH 8, 150 mM NaCl)
Final glycerol = 5% (v/v)

Reaction volume: 30 ul

33

Reaction mix:
6 ul RNAP Storage Buffer (up to 400 nM [RNAP]final )
3 ul CarD Storage Buffer (up to 11 uM [CarD]final )
3 ul 10x MTB +/+
18 ul MQ H2O/DNA for up to ~ 10nM [DNA]final, can use as low as 1nM

The concentration of DNA was chosen based on the minimal concentration that provided
sufficient signal-to-noise for binding (Appendix B, Figure 2). Nitrocellulose and nylon
membranes were loaded into a dot-blot apparatus and subjected to a 200 μl wash with
reaction buffer without BSA (4x with 50 μl multichannel pipette). House vacuum was
applied for ~10 s per load. Next, the 30 μl reaction was loaded into each well (1 x 30 μl
multichannel pipette), followed by application of the vacuum for ~10 s until the reaction
was pulled through the membranes. Next, each well was subject to another 200 μl wash
with reaction buffer (4 x 50 μl, 10 s vacuum/load). The membranes were then removed
from the dot-blot apparatus and placed in a glass tray. The filters were each gently dried
with a hair drier, taking caution to hold the filters at their edges with a pair of tweezers.
The filters were then dried for 1 hr in an oven set to 150 C. The dried filters were imaged
using Typhoon Imager, operated with the Cy3 settings (Ex 532 nm / Em 560-600 nm).
Densitometry was performed using ImageQuant, and the dot-blot grid feature was used to
manually select spots. Plotting was performed in Matlab.

Interestingly, end-labeled DNA constructs stuck to the nitrocellulose, while internally
labeled DNA did not. In addition, I found that pre-treatment of the nitrocellulose with 0.4
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M KOH was required to observe higher signal on nylon than nitrocellulose (see
Appendix B). For these reasons, analysis of double-filter binding assays for estimates of
binding affinities were limited to experiments performed with internally-labeled DNA
tested with nitrocellulose pre-treated with 0.4 M KOH. Filter-binding experiments with
MboRNAP-FYWW were only done once. Filter-binding experiments with promoter
DNA, core RNAP, MboRNAP holoenzyme, and CarD were performed multiple times.
However since each individual experiment did not necessarily use the exact same
concentrations of reagents, these data sets were not combined and used to estimate error.
Importantly, the trends from all of these experiments were consistent are sufficiently
captured in the single set of experimental data shown in Figure 4.

Results and Conclusions
The apparent K d of MboRNAP for promoter DNA is at least 120 nM
Titrations of MboRNAP holoenzyme were performed over promoter DNA in order to
measure binding affinity. EMSA measurements qualitatively indicated that [MboRNAP]
~ 120 nM corresponded to ~50% bound (Figure 1, bottom).

Densitometry of this

experiment (Figure 1, top) was difficult to fit to a binding isotherm due to poor signal-tonoise. Contributing factors include material stuck in the well and streaking within the
gel.

Double-filter binding experiments indicated that even higher concentrations of

MboRNAP were required to reach ~50% fraction bound, and the apparent K d of
MboRNAP holoenzyme to promoter DNA estimated from these experiments is at least
~400 nM (Figure 4 column 1, Figure 5 blue). The large differences between these
measurements likely arise from many factors. Perhaps the most important is the fact that
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neither measurement is a solution-based measurement, and perturbation of the binding
equilibrium is likely taking place in between the initial binding reaction and detection of
binding in a gel or on a filter.

The apparent K d of CarD to DNA is at least 1 μM
To study the affinity of CarD to a 150 bp fragment of DNA containing the Mtb rrnAP3
promoter, titrations of CarD over DNA were performed. The ability of CarD to nonspecifically bind DNA was already known, but my specific objective was to identify
concentrations of CarD that bind this specific promoter fragment in order to inform future
ensemble fluorescence experiments (2, 3).

Experiments performed with Msm CarD

indicated that [CarD] < 1 μM does not bind DNA as shown by EMSA (Figure 2,
Appendix B Figure 3) and double-filter binding (Figure 4). In some cases a super-shift
can be observed at sufficiently high concentrations of CarD (Appendix B Figure 3).
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Figure 1: EMSA for measuring MboRNAP holoenzyme’s binding affinity for 150
bp promoter DNA. Bottom: Native gel for probing MboRNAP-promoter binding.
Lower band represents free DNA, which shifts to the top-half of the gel at higher
concentrations of RNAP. Top: Densitometry for the top-half of the gel (RNAP-DNA)
and bottom-half of the gel (DNA). These results provided qualitative estimates of
MboRNAP binding affinity to promoter DNA (~120 nM), but were difficult to quantify
and fit to a binding isotherm due to poor signal-to-noise.
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Figure 2: EMSA for measuring CarD’s binding affinity for 150 bp promoter DNA.
A 4-20% non-denaturing PAGE gel was used to measure CarD-DNA binding
interactions. Lane 1 contained only the loading-dye. Lane 2 contained only 10 nM
DNA. Lanes 3-12 are reactions containing 10 nM DNA and [CarD] increasing from 1
nM to 24 μM as labeled. CarD’s apparent K d for this DNA substrate is estimated to be
~10 μM. No DNA-binding is observed at [CarD] = 1 μM.
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Figure 3. CarD increases the affinity of RNAP for DNA. Titrations of RNAP in the
absence of CarD only show shifted DNA when [RNAP] is increased from 140 nM to 280
nM (lanes 7 and 9). In the present of 1 uM CarD and 35 nM RNAP, most of the DNA has
been bound (lane 4).
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CarD increases the affinity of MboRNAP to promoter DNA
Titrations of MboRNAP over DNA indicated that the apparent affinity of MboRNAP for
the Mtb rrnAP3 promoter fragment increases in the presence of CarD (Figures 3 and 4).
This measurement of positive linkage between MboRNAP and CarD is perhaps not
surprising, since CarD is known to bind both RNAP and DNA. Notably, CarD increases
RNAP-promoter binding at sub-μM CarD concentrations (Figure 4 columns 1-6), which
do not bind DNA in the absence of MboRNAP. This demonstration of positive linkage
demonstrates that CarD has a higher affinity for MboRNAP-promoter complexes than for
DNA alone.

The ability of sub-µM CarD to increase the affinity of MboRNAP holoenzyme for
promoter DNA is linked to mutated SigA-FYWW
Interestingly, titrations of core RNAP (which binds DNA non-specifically) indicated that
core RNAP could bind DNA, but these titrations were not responsive to sub-μM CarD
(Figure 4, columns 7-9). These results demonstrate that CarD’s interactions with RNAP
and DNA depend on the specific manner in which holoenzyme interacts with DNA.
Furthermore, titrations of MboRNAP-FYWW indicated that MboRNAP-FYWW was
able to bind DNA. Interestingly, more DNA is observed on the nylon filter at high
concentrations of MboRNAP-FYWW compared to core RNAP (lanes 7-12, bottom
filter). These results demonstrate that the presence of SigA-FYWW reduces the ability of
RNAP to bind DNA compared to core alone. One possibility is that SigA-FYWW is
forming holoenzyme with core RNAP, and that the promoter-specific binding of
MboRNAP-FYWW binds DNA with lower affinity than core RNAP. Surprisingly, like
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core RNAP, the titration of MboRNAP-FYWW was also not responsive to CarD (Figure
4, columns 10-12). These results suggest that CarD’s effect on holoenzyme-promoter
complexes somehow depends on specific FYWW residues of wild-type SigA that were
mutated. One possibility is that CarD directly interacts with these residues in the ternary
complex of CarD-RNAP-DNA. Another possibility is that these residues promote a
conformation of RNAP-DNA interaction that has a higher affinity for CarD, such as the
RNAP-promoter open complex. This second possibility, which is also known as
“conformational selection,” is explored and included in a model for CarD in which it has
a higher affinity for open-complexes (Chapters 3 and 5).
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Figure 4: Sub-μM CarD increases affinity of promoter DNA only for MboRNAP
holoenzyme with wild-type SigA. Nitrocellulose filter (top) and nylon filter (bottom) are
shown for a double-filter binding experiment using Cy3-labeled DNA, and titrations of
RNAP and CarD. As CarD is increased from 0 to 1 μM (first 6 columns), the apparent
binding affinity of MboRNAP drops from ~400 nM to ~50 nM, indicating positive
linkage between CarD and MboRNAP. Titrations of Core RNAP (columns 7-9) and
MboRNAP-FYWW (columns 10-12) each showed DNA-binding activity that was not
sensitive to CarD.
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Figure 5: Fraction-bound calculated from double-filter binding RNAP holoenzyme
titrations with increasing CarD. Densitometry for Figure 4 columns 1-6 is shown
above. These results suggest that in the absence of CarD (blue), only ~50% of the DNA
is bound at 400 nM MboRNAP. However, with as little as 100 nM CarD, the apparent
K d of MboRNAP for the promoter drops to ~50 nM (teal). This represents positive
linkage, since the presence of CarD increases the apparent binding affinity of MboRNAP
for promoter DNA.
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Discussion and Future Directions
The results of these studies indicated that CarD does not shift DNA in an EMSA at subμM concentrations. These results also indicated that sub-μM CarD increases the affinity
of MboRNAP for the Mtb rrnAP3 DNA, demonstrating that CarD’s affinity to RNAPpromoter complexes is higher than the affinity of CarD to DNA alone. Interestingly,
titrations of core RNAP over DNA were not responsive to CarD. Furthermore, titrations
of MboRNAP-FYWW were also not responsive to sub-μM CarD. These experiments
suggested for the first time that interactions of sub-μM CarD with MboRNAP-promoter
complexes are not only linked to holoenzyme but also to specific residues of SigA.

One possible explanation for this dependence could be that CarD’s ability to increase the
affinity of MboRNAP holoenzyme for promoter DNA depends on the promoter-open
complex that is formed with wild-type holoenzyme. The FYWW residues in SigA are
highly conserved across all housekeeping bacterial sigma factors and are important for
open-complex formation in EcoRNAP (4, 5). All four residues are aromatic and are
thought to interact with unpaired bases that become flipped-open during the course of
promoter opening (4-6).

Assuming these residues perform the same function in

mycobacterial RNAP holoenzyme, the lack of linkage between CarD and MboRNAPFYWW suggests that CarD’s mechanism under these conditions is tightly linked to the
open-complex. This model is explored further in the context of a thermodynamic cycle
in Chapters 3 and 5.
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Suggested future directions are to more comprehensively characterize the binding
affinities within the mycobacterial transcription initiation complex, including all possible
combinations of sigma, core, holoenzyme, DNA and transcription factors.

The

development of solution-based binding assays such as fluorescence anisotropy,
fluorescence correlation spectroscopy, isothermal titration calorimetry and analytical
ultracentrifugation may prevent complications encountered here using non-equilibrium
methods such as EMSA and double-filter binding (13). Furthermore, such solution-based
assays offer greater flexibility to probe how the thermodynamics and kinetics of binding
depend on solution conditions such as pH, temperature and salt (13).

I hypothesize that CarD’s affinity for mycobacterial transcription components increases
qualitatively in the following manner: Sigma < RNAP < DNA < RP c < RP o . The
rationale for this hypothesis is as follows. Although CarD and Sigma are both found at
promoters throughout the mycobacterial genome, there is no evidence that they interact
directly in solution. Their overlapping ChIP-Seq profiles are likely to due to the fact that
both dissociate from RNAP upon promoter escape (2). The CarD-RNAP interaction has
been directly demonstrated using the bacterial two-hybrid approach, but has not yet been
studied using purified proteins in solution (14). The CarD-DNA interaction has been
characterized in solution, and has an apparent K d of at least 1 μM. CarD likely has a
higher affinity to RNAP-promoter complexes than either RNAP or DNA alone, because
these complexes provide multiple surfaces for interaction with CarD’s RID and CTD.
Lastly, CarD must have a higher affinity for RP o than RP c since it stabilizes open-
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complexes (see Chapters 3 and 5). Empirical measurements of these affinities will
provide valuable constraints for the further development of mechanistic models.
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Chapter 3
Mechanisms of CarD-regulated
mycobacterial transcription initiation
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Introduction
When I began my doctoral research, CarD’s effect on mycobacterial transcription opencomplex stability was unknown. In vitro transcription assays indicated that CarD
activated transcription at the Mtb rrnAP3 promoter (1). Structural models predicted that
CarD interacted with RNAP and the upstream edge of the transcription bubble (1). These
results led me to hypothesize that CarD stabilizes mycobacterial transcription open
complexes.
I used stopped-flow fluorescence spectroscopy to directly demonstrate that CarD
stabilizes mycobacterial transcription open complexes at the Mycobacterium tuberculosis
rrnAP3 promoter. This work was published in Nucleic Acids Research in February of
2015 and is included here as published (2). My finding that CarD stabilizes
mycobacterial open complexes matched results reached independently by another
research group using a different method (potassium permanganate footprinting), which
was published 2 months earlier in December of 2014 (3). Importantly, my experiments
included titrations of CarD and RNAP using an assay that reports on open complex
formation in real-time, thus I was able to report valuable information on the
concentration dependencies and kinetics of CarD’s effect on mycobacterial open complex
stability. I found that CarD’s effect on the kinetics of open complex equilibration is
concentration-dependent, and my data is consistent with a 5-state model in which CarD
stabilizes RPo using a conformational-selection pathway at low concentrations and
further stabilizes RPo using an induced-fit pathway at higher concentrations. This work
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was the first mechanistic study of CarD’s effect on open complex stability, and was
chosen by the editors of Nucleic Acids Research as a “Breakthrough Article,” which is a
designation for work that “present[s] high-impact studies answering long-standing
questions in the field of nucleic acids research and/or opening up new areas and
mechanistic hypotheses for investigation.”
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ABSTRACT
CarD is an essential and global transcriptional regulator in mycobacteria. While its biological role is
unclear, CarD functions by interacting directly with
RNA polymerase (RNAP) holoenzyme promoter complexes. Here, using a fluorescent reporter of open
complex, we quantitate RPo formation in real time
and show that Mycobacterium tuberculosis CarD has
a dramatic effect on the energetics of RNAP bound
complexes on the M. tuberculosis rrnAP3 ribosomal
RNA promoter. The data reveal that Mycobacterium
bovis RNAP exhibits an unstable RPo that is stabilized by CarD and suggest that CarD uses a twotiered, concentration-dependent mechanism by associating with open and closed complexes with different affinities. Specifically, the kinetics of opencomplex formation can be explained by a model
where, at saturating concentrations of CarD, the rate
of bubble collapse is slowed and the rate of opening
is accelerated. The kinetics and open-complex stabilities of CarD mutants further clarify the roles played
by the key residues W85, K90 and R25 previously
shown to affect CarD-dependent gene regulation in
vivo. In contrast to M. bovis RNAP, Escherichia coli
RNAP efficiently forms RPo on rrnAP3, suggesting an
important difference between the polymerases themselves and highlighting how transcriptional machinery can vary across bacterial genera.
INTRODUCTION
The regulation of gene expression via the control of DNA
transcription allows all living organisms to adapt their cel* To

lular biochemistry to changes in their environment. In bacteria, the transcriptional machinery consists of RNA polymerase (RNAP) holoenzyme composed of the catalytic core
enzyme (␤␤ ␣2 ) and a dissociable sigma factor () subunit that directs promoter recognition. Transcription initiates when RNAP holoenzyme recognizes a promoter sequence and forms the RNAP-promoter closed complex
(RPc ) where the DNA strands are still annealed in the
duplex. Through a series of conformational changes the
RNAP-promoter open complex (RPo ) forms where the
DNA strands are melted from the −10 to +2 positions
and the active site is accessible to the initiating nucleotide.
In Escherichia coli, the mechanism of open-complex formation includes multiple kinetic intermediates between the
initially bound complex and the stable open complex (1).
While the core machinery and major intermediate states
are conserved across bacteria, the detailed kinetics of transcription likely vary between bacterial species to accommodate different physiologies and niches. Therefore, a minimal
kinetic scheme describing promoter binding and opening
by RNAP in two reversible steps (R + P ↔ RPc ↔ RPo )
provides a useful starting point when investigating opencomplex formation in a non-model system.
Regulation of transcription initiation is achieved through
the modulation of the stabilities of intermediate states
and/or the rates of exchange between these states on the
pathway to promoter escape. Transcription factors can mediate this regulation by directly affecting the polymerasepromoter interaction, manipulating the equilibrium between RPc and RPo , or affecting rates of promoter escape
(2,3). Much of what has been studied in terms of the mechanisms of transcription initiation and its regulation has used
E. coli as a model system. However, it has become evident
that some bacteria require specialized factors to allow for
efficient gene transcription. For example, many of the se-
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between open-complex formation by E. coli and Mycobacterium bovis RNAPs suggest that E. coli does not posses
a homolog of CarD because its polymerase is intrinsically
more active in open-complex formation.
The work presented here reveals important details of the
mechanism of CarD-dependent transcription initiation in
mycobacteria and provides an example of the possible intrinsic differences between RNAPs from different classes
of bacteria. This observation highlights the importance of
research in prokaryotic transcription in organisms other
than E. coli, especially with respect to understanding mechanisms of transcriptional regulation in pathogenic species
such as M. tuberculosis. Lastly, our findings provide an important addition to the diverse paradigms of transcription
initiation in prokaryotes.
MATERIALS AND METHODS
Protein purification
Mycobacterium bovis core RNAP and  A were overexpressed and purified using methods slightly modified
from the literature (15). Mycobacterium bovis RNAP
holoenzyme is identical to M. tuberculosis RNAP except for
the 69th residue of ␤ which is a proline in M. bovis and
an arginine in M. tuberculosis. The M. bovis core RNAP
subunits were co-over-expressed from plasmid pAC22 in
BL21(DE3) pRARE2. Cells were grown at 37◦ C until an
OD600 of 0.8. Cells were induced with 250 M Isopropyl ␤D-1-thiogalactopyranoside (IPTG) and grown 4 h at 20◦ C.
Cell pellets were lysed and loaded onto a 10 mL Ni2+ affinity
column (HP HiTrap, GE Healthcare) using a 5–1000 mM
imidazole gradient. The eluted sample was dialyzed, concentrated and further purified by size exclusion chromatography (HiPrep Sephacryl 300, Pharmacia). The peak of core
RNAP was dialyzed in storage buffer (50% glycerol, 10 mM
Tris pH 7.9, 200 mM NaCl, 0.1 mM ethylenediaminetetraaceticacid (EDTA), 1 mM MgCl2 , 20 M ZnCl, 2 mM
Dithiothreitol (DTT)), concentrated to 4 M (Vivaspin 20,
MWCO 100 kDa, GE Healthcare), flash frozen in liquid nitrogen and stored at −80◦ C.
Mycobacterium bovis  A was over-expressed from plasmid pAC27 BL21(DE3) pRARE2. Cells were grown at
37◦ C until an OD600 of 0.8. Cells were induced with 250 M
IPTG and grown 4 h at 20◦ C. Cell pellets were lysed and  A
was purified by Ni2+ affinity chromatography (HP HiTrap,
Pharmacia) using a 5–1000 mM imidazole gradient. Eluted
protein was dialyzed into storage buffer (10 mM Tris pH
7.9, 250 mM NaCl, 0.1 mM EDTA, 1 mM MgCl2 , 20 M
ZnCl, 2 mM DTT), concentrated to 24 M (Vivaspin 20,
MWCO 30 kDa, GE Healthcare), flash frozen and stored
at −80◦ C.
Mycobacterium tuberculosis CarD was over-expressed
from a pETSUMO plasmid (13). Cells were grown at 37◦ C
until OD600 of 0.8, induced with 1 mM IPTG, and grown
3 h at 37◦ C. Cell pellets were lysed and His-SUMO-CarD
was purified by Ni2+ affinity chromatography (Ni-NTA
Agarose, Qiagen). Elution at 250 mM imidazole was quantified and His-Ulp1 protease added to cleave the His-SUMO
tag from CarD. This mix was dialyzed overnight in 3 l of 20
mM Tris pH 8.0, 150 mM NaCl and 1 mM ␤-ME and dialyzed again in fresh buffer for four more hours. Ni2+ resin
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quences and proteins required to regulate transcription initiation in E. coli are absent in mycobacteria, including Fis
(4), DksA (5), AT-rich upstream activating elements (6,7)
and GC-rich discriminator sequences (8). The question remains how bacteria missing these factors confer efficient
and regulable transcription.
CarD is a recently discovered RNAP-binding protein that
is conserved in numerous bacterial species but not present in
E. coli. CarD homologs are essential in Mycobacterium tuberculosis, Mycobacterium smegmatis (9) and Myxococcus
xanthus (10) and knockouts were not attainable in Borrelia burgdorferi (11). Furthermore, CarD is essential for the
response of M. tuberculosis to oxidative stress and certain
antibiotics, as well as the acute and persistent infection of
mice (9,12). Given the tremendous impact of M. tuberculosis on global health (1.3 million related deaths a year, WHO,
2013), it is of particular interest to understand unique biochemical pathways required by this pathogen. Yet, the reasons for CarD essentiality remain enigmatic primarily due
to a lack of understanding of its molecular mechanisms.
CarD is associated with all RNAP- A (mycobacterial
house-keeping sigma, homologous to E. coli  70 ) transcription initiation complexes within the M. smegmatis genome
(13) and interacts directly with the ␤1 region of the RNAP ␤
subunit through its N-terminal RNAP interaction domain
(RID) (9–10,12). The current model for CarD activity is
that this protein is directed to promoters via its interaction
with RNAP ␤ (13,14). At the promoter, a basic patch in
the C-terminus of CarD contacts the DNA and the association of RNAP-bound CarD with the promoter DNA stabilizes the RNAP-promoter complex (13,14). Within this stabilized CarD-RNAP-promoter complex, a conserved tryptophan in CarD is required for proper transcriptional regulation, however its exact role is still unknown. Together,
these three activities of CarD (RNAP binding, DNA binding and the conserved tryptophan) promote a gene expression profile that supports viability (9,12,14), but the mechanism by which CarD regulates transcription is unknown.
Understanding how CarD stabilizes RNAP-promoter complexes and regulates transcriptional activity is crucial for developing models of transcriptional regulation in mycobacteria and for furthering our knowledge of the molecular
physiology of M. tuberculosis.
Here, we perform a detailed mechanistic analysis of M.
tuberculosis CarD in the context of open-complex formation using a real-time fluorescence assay on the rrnAP3 ribosomal RNA promoter from M. tuberculosis. CarD is known
to regulate transcription from this promoter and is an activator of ribosomal RNA transcription (9). We show that
CarD has dramatic effects on both the equilibrium concentration of open complex and on the kinetics of the approach to equilibrium. Analysis of CarD concentrationdependent data suggest that CarD stabilizes open complex
via a two-tiered kinetic mechanism. First, CarD associates
with RNAP open complexes with high affinity and slows
the rate of DNA closing. Second, CarD associates with
RNAP closed complexes with lower affinity and increases
the rate of DNA opening. Thus, we propose that CarD regulates transcription by increasing the stability of RPo relative
to RPc by affecting both the effective forward and reverse
rates between these two states. Furthermore, comparisons
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was added to dialyzed proteins and, after incubating for 1 h
at 4◦ C, CarD was collected in the flow through. Protein was
concentrated to 100 M (Vivaspin 20, MWCO 3 kDa, GE
Healthcare), flash frozen and stored at −80◦ C.
Preparation of fluorescent promoter DNA fragments

Stopped-flow assay for real-time monitoring of open-complex
formation
Stopped-flow experiments were performed as previously described (17,18) with minimal exceptions. All experiments
were performed by mixing equal volumes of protein solution from one syringe with fluorescent promoter DNA from
the other syringe. Accordingly, initial syringe concentrations of protein and DNA were prepared at twice the desired final concentration for the reaction. Including contributions from protein storage buffers, final reaction buffer
conditions were as follows: 14 mM Tris pH 8.0, 120 mM
NaCl, 10 mM MgCl2 , 1 mM DTT, 0.1 mg/ml bovine serum
albumin (BSA) and 10% glycerol by volume.
Protein solutions for stopped-flow experiments were prepared as follows. In the case of MboRNAP, core was mixed
with saturating concentrations of  A and allowed to equilibrate for 15 min at room temperature. In the case of
EcoRNAP,  70 -saturated holoenzyme was used (New England Biolabs). When required, CarD was added to RNAP
holoenzyme and allowed to equilibrate for an additional 15
min at room temperature. Protein solutions were then diluted into a solution containing 10 mM Tris pH 8.0, 40 mM
NaCl, 10 mM MgCl2 , 1 mM DTT and 0.1 mg/ml BSA.
Since MboRNAP core storage buffer contained 50% glycerol, the protein solution contained 10% glycerol by volume.
For all experiments, any absence of protein volume was balanced by its appropriate storage buffer in order to preserve
identical buffer conditions for different reactions.
Promoter DNA solutions were prepared for stopped-flow
experiments as follows. Stock DNA was diluted to 20 nM

Triple exponential fits of kinetic traces to extract observed
rates
Fold changes as a function of time were fit to a sum of exponentials using the ProData Viewer software (Applied Photophysics). Single and double exponentials were insufficient
to capture the entire shape of the curve without substantial
systematic residual error and triple exponential fits of the
entire time course yielded inconsistent assignment of phases
(fast, medium and slow fits were interchangeable between
a1, k1, a2, k2, a3 and k3). To fit the curves with three exponentials while preserving assignment of fast, medium and
slow phases, 1–1200 s was fit to a double exponential and
the amplitudes and observed rates for the medium (a2, k2)
and slow (a3, k3) phases were fixed. Then, a third exponent
was added and the time for fitting was expanded to include
0.1–1200 s in order to capture the fastest phase (a1, k1). In
this manner, the curves could be fit with three exponentials
from 0.1 to 1200 s, and assignments of amplitudes and observed rates for all phases between traces remained consistent. In all figures, error bars of observed rates represent the
SEM for conditions that were repeated multiple times on
different days. From these SEMs, average errors were then
applied to conditions that were only repeated multiple times
on the same day to better estimate the real error for these
points.
Kinetic simulations
Simulation of the kinetic model of open-complex formation was carried out in MATLAB R2014b (Mathworks).
Model parameters were determined by manually adjusting
rate constants and comparing with the data. The model was
adjusted until the trends of equilibrium fluorescence and
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The DNA template contained the −41 to +4 bases of the
rrnAP3 ribosomal RNA promoter (16) of M. tuberculosis centered in a 150 bp template (Supplemental Information). Fluorescently labeled promoter DNA was prepared as previously described (17). In short, two 85-mer
oligonucleotides with a 20 bp overlapping sequence were
synthesized and high performance liquid chromatography (HPLC) purified (IDT). The 85-mer corresponding to
the non-template strand was ordered with a C6 aminemodification on the +2 thymine for covalent attachment to
Cy3-NHS (Lumiprobe). Labeled oligonucleotides were purified from unlabeled oligos and excess Cy3 using reversephase chromatography (C18 column, XTerra). Template
and Cy3-non-template strands were annealed and extended
with Taq polymerase (Invitrogen). The extension products
were then purified by HPLC (DNA Swift Column, Dionex).
Finally, the pure Cy3-labeled extension products were spinconcentrated and exchanged into Tris-EDTA buffer (Millipore Amicon Ultra, MWCO 30 kDa). Concentrations of dsDNA (A260 ) and Cy3 (A550 ) were measured by spectrophotometer (Nanodrop) and indicated a equimolar ratio of dye
to DNA template demonstrating 100% labeling. Labeled
DNA template was stored at −20◦ C.

into buffer containing 10 mM Tris pH 8.0, 40 mM NaCl,
10 mM MgCl2 , 1 mM DTT, 0.1 mg/ml BSA and 10% glycerol by volume. Glycerol was added to the DNA solution to
match the glycerol content of the protein solution, to minimize rapid mixing artifacts that can occur with asymmetric
viscosities between syringes.
Experiments were performed on an SX-20 stopped-flow
spectrophotometer (Applied Photophysics, dead-time < 2
ms) with a shot volume of 150 l, using excitation at 515
nm (monochromator), and emission at 570+ nm (long-pass
filter). Unless otherwise noted, data were collected for 20
min and at 25◦ C by sampling 10,000 points in a logarithmic
decay over the time course of the experiment. A circulating
water bath with active feedback was used to maintain temperature within 0.1◦ C. Multiple buffer shots as well as DNA
only shots were performed before every experiment. At least
two shots were collected for every protein condition, which
were averaged before plotting as fold change (FC) where FC
= (F − F0)/F0, where F = experimental signal − buffer signal in volts and F0 = DNA signal − buffer signal in volts. In
all figures, error bars of fold change represent the standard
error of the mean (SEM) for conditions that were repeated
multiple times on different days. From these SEMs, average errors were then applied to conditions that were only
repeated multiple times on the same day to better estimate
the real error for these points.
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observed rate as functions of RNAP and CarD concentrations were best fit. By assuming that the apparent bimolecular association rates were all equal, fixing the equilibrium
between closed and open complex based on the MboRNAP
data in the absence of CarD, and requiring that the model
satisfied detailed balance, only three adjustable rate constants remained. This allowed for the manual exploration
of parameter space and yielded a model that is able to capture the observed trends. The rate constants used to generate Figure 6 are listed in the Supplemental Information.

A real-time fluorescence-based assay of open complex
To detect the formation of open complexes, a Cy3 label
was incorporated on the +2 nucleotide of the non-template
strand of a M. tuberculosis rRNA promoter rrnAP3 DNA
template via a NHS-C6 amide linkage (Figure 1A). Cy3 exhibits a 2-fold enhancement in fluorescence intensity in the
open complex and has been used to monitor DNA opening
and promoter escape in E. coli (17). The rrnAP3 promoter is
the major ribosomal RNA promoter in M. tuberculosis (16),
has been used previously in studies of CarD, and is thought
to be regulated by CarD in vivo (13,14). Mixing of protein
components with labeled DNA templates was performed
via stopped-flow spectrophotometry and fluorescence was
monitored for 20 min. The addition of 21 nM E. coli RNAP
(EcoRNAP) sigma factor 70 ( 70 ) holoenzyme to rrnAP3
resulted in robust enhancement of the fluorescence intensity as compared to DNA alone (>60% increase or an
enhancement of 0.6, Figure 1B). In contrast, very small
(∼0.05) fluorescence enhancements are observed when the
same concentration of EcoRNAP is added to templates
lacking the rrnAP3 promoter sequence (Figure 1B), demonstrating that fluorescence enhancement is promoter dependent. Furthermore, an enhancement of approximately 0.3
is observed at low temperature where open-complex formation is inhibited (19–21) and the fluorescence enhancement increases with increasing temperature consistent with
the known temperature-dependence of open-complex formation (Figure 1C). A possible structural rational for the
specific dependence on open complex exhibited by the observed fluorescence enhancement is that the +2 position is
positioned downstream of closed complex DNase I footprints, but is located within the footprint of open complex
(22). Taken together, these control experiments confirm that
fluorescence enhancement of a non-template +2 Cy3 in the
M. tuberculosis rrnAP3 template DNA faithfully tracks the
formation of the open initiation complex. Importantly, as
with EcoRNAP, M. bovis RNAP (MboRNAP, identical to
M. tuberculosis RNAP except ␤ R69 is P69) also stimulates
fluorescence enhancement in a promoter- and temperaturedependent manner (Figure 1D and E). The time traces obtained in this assay exhibit multiple phases consistent with
the known kinetic complexity of transcription initiation (1)
and provide insight into both the kinetics of open-complex
formation and the equilibrium concentration of open complex.

We first studied the concentration dependence of
EcoRNAP ( 70 ) and MboRNAP ( A ) holoenzymes
on open-complex formation on the M. tuberculosis rrnAP3
promoter at 25◦ C. Fluorescence enhancements after the
addition of 2–283 nM EcoRNAP (Figure 2A) or 37.5–600
nM MboRNAP (Figure 2B) were monitored for 20 min.
Final fold enhancements were plotted versus RNAP
holoenzyme concentration and fit to extract a concentration at which the enhancement is half-maximal (Keff ,
Figure 2C). As expected, the amount of open complex
increases as concentration increases for both forms of
RNAP, however EcoRNAP exhibits a Keff almost 10-fold
smaller than MboRNAP (23 ± 5 nM versus 212 ± 43 nM,
95% confidence bounds). More strikingly, at saturating
concentrations of the respective polymerases, the fluorescence enhancement for EcoRNAP is 1.44 ± 0.1 while
MboRNAP only reaches an enhancement of 0.30 ± 0.1.
The enhancement for EcoRNAP is comparable to that
described previously for EcoRNAP on a consensus promoter (∼1.4) (17), suggesting that this signal is indicative of
fully open DNA (i.e. 100% open complex) on rrnAP3. By
comparison, MboRNAP  A holoenzyme, even when fully
occupying the DNA template at saturating concentrations
of polymerase, is not capable of opening a large percentage
of the promoters leaving the majority of bound complexes
in the closed state. This demonstrates that MboRNAP
forms a significantly less stable open complex as compared
to EcoRNAP, even on its own mycobacterial promoter.
CarD stabilizes the open complex of MboRNAP
We next looked at the effect of CarD on open-complex
formation. Holoenzyme was incubated with CarD for 15
min prior to mixing with the DNA template and recording changes in fluorescence intensity over time. While CarD
shows no fluorescence enhancement when added to DNA
alone and has little effect on the fluorescence signal from
EcoRNAP (Supplementary Figure S1), its presence leads
to a dramatic increase in the magnitude of fluorescence
enhancements observed when incubated with MboRNAP
(Figure 3A). As fluorescence enhancement serves as a reporter of open complex, we conclude that CarD significantly stabilizes open complex specifically for MboRNAP.
This is consistent with known differences in the ␤1 lobe of
EcoRNAP and MboRNAP on the CarD-binding interface
that would predict tighter binding of M. tuberculosis CarD
to MboRNAP than to EcoRNAP (23). In the presence of
225 nM MboRNAP, a rise in fluorescence fold change can
be seen as the concentration of CarD is increased from 0
- 1.1 M. The concentration of CarD that exhibits halfmaximal effect (77 ± 35 nM) and the fold fluorescence enhancement over 0 M CarD at saturation (6.2-fold) was
determined by normalizing the equilibrium (final) fluorescence enhancements relative to 0 M CarD and fitting to
a binding isotherm (Figure 3B). Assuming that EcoRNAP
generates 100% open complex at saturating concentrations
(283 nM, Figure 2A) and that MboRNAP generates the
same enhancement of signal per open complex, at saturating concentrations of CarD (≥ 1 M) the percent of DNA
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M. bovis RNAP forms open complex less efficiently than E.
coli RNAP on rrnAP3
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that are in open complexes at equilibrium in the presence of
225 nM MboRNAP increases from approximately 15% to
93% (Figure 3A).
To compare the MboRNAP holoenzyme concentration
dependence in the presence and absence of CarD, a holoenzyme titration (37.5–600 nM) was performed in the presence
of saturating CarD (1 M) at 25◦ C (Figure 4A). Comparing RNAP titrations in the presence and absence of CarD
shows that 1 M CarD reduces Keff from 212 ± 43 nM to
106 ± 3 nM and increases the amount of open complex 4.3fold at saturation (Figure 4B).
The ability of CarD to stabilize open complexes is
also temperature dependent. In experiments with 100 nM
MboRNAP in the presence and absence of 1 M CarD,
traces at different temperatures show different amounts of
CarD-dependent fold change (Figure 4C). Specifically, the
CarD effect is significantly larger at 25◦ C (4.2-fold) than
it is at either 10◦ C (1.5-fold) or 37◦ C (1.9-fold). These observations fit well with the known temperature-dependence
of open complex (19–21). At low temperature, opening is
severely inhibited and the binding energy from CarD is not
sufficient to tilt the landscape enough toward opening to
have a large effect. At 25◦ C, the energy landscape is more

balanced between closed and open and the extra binding
energy supplied by CarD is able to significantly affect the
equilibria between the two states. Lastly, at 37◦ C, open complex forms more readily than at lower temperatures and thus
there is an appreciable amount of open complex to begin
with (i.e. 50%). In this case, even if CarD is capable of stabilizing all bound complexes in the open form, it will exhibit a
lower fold change in open complex equilibrium concentration (i.e. 2-fold).
CarD pushes the equilibria of polymerase-bound states toward open complex
In the presence of a saturating concentration of MboRNAP
(450 nM) where the DNA templates are fully occupied by
holoenzyme, the amount of open complex observed in the
presence of CarD is dramatically increased in the presence
of 1 M CarD (Figures 2B and 4A). This can only be the
case if CarD stabilizes the open complex relative to closed
complex either by increasing the effective rate of opening or
decreasing the effective rate of closing or both.
Furthermore, the observation that CarD stabilizes open
complexes relative to closed complexes suggests that CarD
has a higher affinity to open complex than it does to closed
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Figure 1. A real-time fluorescence assay for monitoring open-complex formation. (A) The assay utilizes a Cy3 dye at the +2 position of the non-template
strand of a rrnAP3 ribosomal RNA promoter DNA template. The Cy3 has a baseline fluorescence in the free and closed complexes that is enhanced upon
the formation of open complex. (B) EcoRNAP-dependent (21 nM) fluorescence enhancement in the presence (green) and absence (red) promoter sequence
at 25◦ C. (C) EcoRNAP-dependent (21 nM) fluorescence enhancement at 10◦ C (blue), 25◦ C (green) and 37◦ C (red). (D) MboRNAP-dependent (100 nM)
fluorescence enhancement in the presence (green) and absence (red) of promoter sequence at 25◦ C. (E) MboRNAP-dependent (100 nM) fluorescence
enhancement at 10◦ C (blue), 25◦ C (green) and 37◦ C (red).
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complex. In a thermodynamic cycle (Figure 4D) where
binding of CarD is coupled to the open/closed equilibrium,
the sum of free energies around the cycle must be zero. The
data show that RPo is more stable relative to RPc in the presence of CarD (G4 < G1 ). Since the sum of free energies
along paths that begin and end in the same state must be the
same, G1 + G2 = G3 + G4 . This then requires the free
energy differences between RP and RP·CarD in the open
and closed states to satisfy G2 < G3 . Thus, as the free
energy difference determines the affinity (Kd = e−G/RT ), we
predict that CarD binds more tightly to open complex than
to closed complex.

Figure 2. RNAP concentration dependence of promoter opening. (A) Fluorescence enhancement as a function of time for increasing concentrations
of EcoRNAP (0–238 nM). (B) Fluorescence enhancement as a function of
time for increasing concentrations of MboRNAP (0–600 nM). (C) Equilibrium fluorescence fold change for both EcoRNAP and MboRNAP as a
function of polymerase concentration. Fits (solid lines) of the data allow
the extraction of concentrations of half-maximal effect (23 ± 5 nM and
212 ± 43 nM) and saturated fluorescence enhancements (1.44 and 0.28)
for EcoRNAP and MboRNAP, respectively.

The time-dependent traces allow for an analysis of the kinetics of open-complex formation. The traces are well fit by
a triple exponential resulting in three observed rates, consistent with the well-known multi-state kinetic complexity
of open-complex formation (1) (Figure 5A, Materials and
Methods). The three observed rates differ by orders of magnitude with a fast (k1 obs ∼ 1 s−1 ), intermediate (k2 obs ∼ 0.1
s−1 ) and slow (k3 obs ∼ 0.005 s−1 ) observed rates. In traces exhibiting robust opening (i.e. high polymerase or high CarD
concentrations), the amplitude of the curve is dominated
by the amplitude of the slowest observed rate (Supplementary Figure S2). Furthermore, although promoter-less control traces (Figure 1B and D) do exhibit a modest amount
of fluorescence enhancement, this enhancement occurs very
rapidly (< 1 s) and the slow phase (k3 obs ) is not observed.
Therefore, we reason that, to a first-approximation, the
fastest observed rates report on a protein–DNA interaction
not related to opening (i.e. binding) and the slowest observed rate (k3 obs ) specifically reports on the approach to
equilibration of open complex for MboRNAP.
Observed rates typically represent combinations of microscopic rate constants. In the simplest case, the two states
A and B are connected by a forward and a reverse rate constant. In this case, if one starts with the system entirely in
A and monitors the approach to equilibrium, the observed
rate will simply be the sum of the two rate constants. There
are two mechanisms by which B could be stabilized relative
to A: (i) the forward rate constant could be accelerated or
(ii) the reverse rate constant could be slowed. In the first
case, B would be stabilized and the observed rate would increase while in the second case, B would be stabilized and
the observed rate would decrease. In more complicated kinetic mechanisms, the interpretation may not be so straightforward, but nonetheless, these two limiting cases serve as
a useful backdrop for extracting mechanistic information
from trends in an observed rate (Supplementary Figure S3).
CarD exhibits a concentration-dependent effect on the kinetics of open-complex formation
To extract information regarding the effect of CarD on the
kinetics of open-complex formation, we first analyzed the
CarD-dependence of k3 obs using data collected at 150 nM
MboRNAP (Figure 5B). Here, k3 obs decreases with increasing CarD concentration suggesting that CarD slows a re-
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The kinetics of open-complex formation can be monitored via
the slowest observed rate
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Figure 4. MboRNAP titration at saturating CarD. (A) Fluorescence enhancement as a function of time for 1 M CarD with increasing concentrations
of MboRNAP (0–450 nM) at 25◦ C. (B) Equilibrium values of fluorescence enhancement fold change are plotted in the presence (red) and absence (green)
of 1 M CarD. The data were best fit with an amplitudes of 1.3 and 0.28 and Keff of 106 ± 3 nM and 212 ± 43 nM in the presence and absence of CarD,
respectively. (C) Observed traces for 100 nM MboRNAP in the presence or absence of 1 M CarD at 10◦ C (blue), 25◦ C (green) and 37◦ C (red). The bar
graph shows the fold increase in equilibrium fluorescence enhancement for each temperature. (D) The thermodynamic cycle linking closed complex (RPc ),
open complex (RPo ), closed complex bound to CarD (RPc CarD) and open complex bound to CarD (RPo CarD). The equality shown below follows since
the sum of the free energy differences along the two paths from RPc to RPo CarD must be equal.
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Figure 3. CarD increases open-complex formation with MboRNAP. (A) Fluorescence enhancement as a function of time for 225 nM MboRNAP with
increasing concentrations of CarD (0–5.55 M) at 25◦ C. (B) Equilibrium values of fluorescence enhancement are plotted as a function of CarD concentration. A fit (solid line) of the data reveals a concentration of half-maximal effect Keff = 77 ± 35 nM and an amplitude of 6.2-fold over 225 nM MboRNAP
alone.
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A kinetic model with CarD binding to both open and closed
complexes

Figure 5. Kinetics of open-complex formation. (A) Triple exponential fits
are required to obtain fits with good residuals for traces where DNA opening is occurring. A typical trace, the fits, and the resulting residuals are
shown for with double (red) and triple exponential (blue) fits. (B) The CarD
concentration dependence of k3 obs in the presence of 150 nM (black) or
225 nM (red) MboRNAP. (C) The MboRNAP concentration dependence
of k3 obs in the presence (black) and absence (red) of 1 M CarD.

To understand the concentration-dependent effects of
CarD, a kinetic model of open-complex formation in the
presence of CarD was constructed (Figure 6A). The model
consists of five states including unbound DNA (R + P),
closed complex (RPc ), open complex (RPo ), CarD-bound
closed complex (RPc CarD) and CarD-bound open complex (RPo CarD). In principle, CarD may interact both with
DNA alone and unbound RNAP. However, CarD has been
found by ChIP-seq only in genomic positions where RNAP
holoenzyme is also found (13). In addition, the interaction
between CarD and free RNAP is likely much weaker than

59

Downloaded from http://nar.oxfordjournals.org/ at Washington University, Law School Library on September 15, 2016

verse rate in order to stabilize open complex. This interpretation is consistent with recent results showing that CarD
increases the lifetime of open complexes in the presence of
competitor DNA (14) and suggests that CarD functions by
inhibiting bubble collapse.
Interestingly, when the above analysis is repeated with
a higher concentration of MboRNAP (225 nM), k3 obs exhibits a markedly different dependence on the concentration of CarD (Figure 5B). At low concentrations of CarD
(0–100 nM), k3 obs decreases with increasing concentration
as observed with 150 nM MboRNAP. However, at concentrations higher than 100 nM CarD, k3 obs accelerates as
a function of CarD concentration and almost reaches the
magnitude observed in the absence of CarD. This biphasic
dependence of the observed rate suggests that CarD stabilizes open complex via a more complicated mechanism and
points to models where CarD modulates more than one rate
constant in the kinetic mechanism. It further suggests that
it does so with different concentration dependencies. Therefore, we propose a model, discussed in detail below, where
CarD slows bubble collapse in the open complex at low concentrations and can also associate with closed complex at
high concentrations and accelerate DNA opening. Importantly, CarD is one of the highest expressed proteins in M.
tuberculosis (24) and quantitative western analysis shows
that the concentrations of CarD in the cell are similar to the
concentrations used for these assays (Supplementary Figure
S4) suggesting that CarD both accelerates DNA opening
and inhibits bubble collapse in vivo.
Since k3 obs depends on RNAP concentration at 1 M
CarD (Figure 3), we analyzed this dependence further by
titrating MboRNAP concentration in the presence of 1 M
CarD. At this concentration of CarD, k3 obs increases as a
function of polymerase concentration (Figure 5C). As increasing RNAP concentration increases the rate at which
bound complexes will form, this result suggests that the rate
of CarD-stimulated open-complex formation also depends
on the rate of polymerase binding to the DNA template.
Importantly, in the absence of CarD, k3 obs does not show
this dependency. Consistent with the rate limiting steps of
CarD-independent bubble formation taking place between
two bound complexes, k3 obs is independent of MboRNAP
in this concentration range in the absence of CarD (Figure 5C). These observations provide further constraints to
models of the kinetic mechanism of CarD-dependent regulation of open-complex formation.
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CarD mutants are deficient in open-complex stabilization
Single amino acid mutants of CarD have previously been
used in vivo and in vitro to understand the roles played
by different domains or regions of the protein (12,14).
Three groups of mutants have been identified according to
their distinct phenotypic effects in vivo, namely those with
DNA-binding defects, RNAP interaction defects and with
an alanine substituted for a conserved tryptophan residue
(W85A). Although W85 is part of the DNA-binding domain, it appears to play a more specific role in the stabi-
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Figure 6. A CarD-dependent kinetic model of open-complex formation.
(A) The model consists of five states: unbound DNA (R + P), closed
complex (RPc ), open complex (RPo ), closed complex bound to CarD
(RPc CarD) and open complex bound to CarD (RPo CarD). Values indicate the ratio of rate constants between each pair of states in the model.
For example, at 250 nM, the forward and reverse rates between R + P and
RPc are equal. Furthermore, the ratio of forward to reverse rates between
RPc and RPo are 0.125 and 40 in the absence and presence of CarD, respectively. The rates used to generate the figures below can be found in
Supplementary Information. (B) Simulations of the kinetic model titrating
CarD concentration with 150 nM (black) and 225 nM (red) MboRNAP.
(C) Simulations of the kinetic model titrating RNAP concentration with 0
nM (black) and 1 M (red) CarD.

the association of CarD to DNA-bound RNAP complexes
where it may interact with both polymerase and DNA cooperatively. For these reasons, CarD-DNA and CarD-RNAP
states are left out of the current model.
Initially models where CarD only associated with open
complex were attempted, but these models are unable to
capture the biphasic dependence of k3 obs on CarD concentration. However, a model where CarD also interacts with
closed complex is able to account for the concentration dependencies of both the polymerase and CarD with a single set of rate constants (Figure 6, Supplemental Methods).
The model has three key features: (i) CarD has a lower affinity to closed complex than it does to open complex; (ii) in
the open complex, CarD inhibits the rate of bubble collapse; and (3) in the closed complex, CarD accelerates the
rate of DNA opening. Importantly, the model was required
to satisfy detailed balance so that the energetics linking the
affinities of CarD to the equilibria between open and closed
complexes do not violate thermodynamics (Supplemental
Methods).
The model was used to simulate time-dependent traces of
open-complex formation and the resulting curves were fit
to extract an observed rate of the approach to equilibrium
(kobs ). The model captures the dependence of the observed
rate on CarD concentration at different fixed MboRNAP
concentration (Figures 5B and 6B). Specifically, the observed rate decreases initially at both polymerase concentrations and then increases more at 225 nM RNAP than it
does 150 nM RNAP. The model also captures the dependences of the observed rate on RNAP concentration in the
presence and absence of 1 M CarD (Figures 5C and 6C).
Specifically, at 1 M CarD, the observed rate increases with
increasing RNAP concentration whereas in the absence of
CarD, the observed rate is RNAP-concentration independent.
Lastly, the identical model parameters also reproduce the
trends in the equilibrium concentration of open complex as
a function of MboRNAP and CarD (Supplementary Figure
S5). Although the model does not explicitly include a CarDdependent change in the rates connecting free polymerase to
closed complex, the approximately 2-fold reduction in Keff
in the presence of 1 M CarD (Figure 4B) is captured by
the model (Supplementary Figure S5). This illustrates that
a lower Keff is not necessarily due to a change in the energetics of free polymerase relative to the closed complex. Since
open complexes cannot dissociate from the DNA without
closing first, any stabilization of open complex relative to
closed results in an increased apparent affinity of the polymerase for DNA.
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Figure 7. Mutants of CarD diminish the degree of open-complex stabilization. (A) Fluorescence enhancement as a function of time are shown
for 225 nM RNAP + 1 M WT and mutant CarDs at 25◦ C. W85A (green)
and K90A (red) traces generate less than half the open complex at equilibrium as compared to WT (blue) and R25E (purple) is even further compromised. (B) Equilibrium fluorescence enhancement as a function of CarD
concentration taken from titrations of mutant CarDs (Supplementary Figure S6). (C) The CarD concentration dependence of k3 obs for WT (blue),
W85A (green), K90A (red) and R25E (purple) mutant proteins.

creasing rate of opening. In contrast, it appears that the association of R25E with the complexes occurs with a much
lower affinity and that it may only be able to interact weakly
with open complex.
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lization of open complex, perhaps by interacting with the
upstream end of the DNA bubble (13,14).
CarD mutants that weaken the interaction with RNAP
(R25E, (12)), weaken the interaction with DNA (K90A,
(14)) and W85A (13,14) were used as representative mutants
from the three classes and were tested in the open-complex
formation assay. Fluorescence enhancement traces using
MboRNAP in the presence of 1 M CarD (Figure 7A) show
that all three mutants are partially deficient in stabilizing
open complex relative to WT, as evidenced by their lower
equilibrium (final) fluorescence enhancements. Increasing
the concentration of mutant CarDs showed more enhancement, but the final enhancements at the highest protein levels tested were still less than 50% that of wild type (WT)
(Figure 7B, Supplementary Figure S6). Fits of the mutant
CarD titrations result in estimates of open-complex stabilization and concentrations of half-maximal effect. K90A
and W85A both reach a maximum of 3-fold fluorescence
enhancement as opposed to the 6.2-fold enhancement seen
with WT CarD. The half-maximal concentrations of K90A
and W85A are 400 ± 48 nM and 381 ± 118 nM respectively
as compared to the 77 ± 35 nM observed with WT CarD.
The data for R25E were unable to be fit as we were unable to
reach saturation due to limitations of protein concentration,
but the activity of the RNAP-interacting domain mutant is
even further decreased relative to the other mutants. Taken
together, the data demonstrate that all three residues, and
by extension all three activities (polymerase binding, DNA
binding and W85 activity), are required for full CarD activity.
Fits of the time-dependent fluorescence enhancements
again showed three phases and the slowest rate (k3 obs ) in
the presence of CarD mutants depended on CarD concentration as with WT CarD (Figure 7C, Supplementary Figure S6). However, the degree to which k3 obs was decreased
was less in all the mutants compared to WT. Based on the
model that the decrease in k3 obs is due to CarD’s ability to
inhibit DNA closing, this suggests that the mutants are unable to prevent bubble collapse to the same extent as WT.
More specifically, the initial decrease of k3 obs observed as a
function of CarD concentration showed a similar concentration dependence as WT for the W85A and K90A mutants, but the observed rate decreased less (Figure 7C). In
contrast, R25E exhibited a much slower decrease suggesting a lower affinity to open complex (Figure 7C) consistent
with previous work showing that this mutant associates less
strongly with MboRNAP (12). At higher concentrations,
W85A and K90A show signs of an increasing k3 obs suggesting that they are able to interact with closed complex
to accelerate DNA opening, but not to the same extent of
WT. Even though the observed rate does not decrease as
much as with WT CarD at low concentrations, it is not as
fast at higher CarD concentrations either (i.e. at 1 – 2 M
CarD). In contrast, R25E shows no signs of the increasing
phase of k3 obs suggesting, perhaps, that it is unable to effectively interact with closed complex at these concentrations.
These observations coupled with the reduced fluorescence
enhancement observed at saturating levels of mutant CarD,
suggest that W85A and K90A mutants are able to associate
with both open and closed complexes as in WT, but are deficient in both inhibiting the rate of bubble collapse and in-
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A better understanding of the role of M. tuberculosis CarD
in transcription initiation will not only be relevant to mycobacteria, but also to the diverse bacterial species that encode CarD homologs (9,13). The result that MboRNAP is
less able to form rrnAP3 open complexes as compared to
EcoRNAP rationalizes the essentiality of CarD in M. tuberculosis (and its absence from E. coli) and suggests that
polymerases from organisms in which CarD is found may
also be deficient in open-complex formation. This observation also stresses the importance of directly studying transcription systems in a wide spectrum of bacteria, especially
in pathogens like M. tuberculosis, that may diverge from traditional model systems.
Previous studies of the effect of CarD on transcription
initiation focused on open complex lifetimes in the presence of competitor DNA (13–14,25). Specifically, proteins
and DNA were allowed to come to equilibration and opencomplex stability was assayed by the time-dependent decay of reporters of open complex (i.e. the production of
transcripts upon the addition of nucleoside triphosphate
(NTPs)). These valuable assays have led to the model where
CarD stabilizes open complex. However, in the cell, there is
no initial equilibration time and transcriptional regulation
must be enacted in real time. That is to say, the flux of transcript production must be attenuated or augmented. Therefore, both the rate at which open complexes are formed and
the rate at which they decay are crucial for gene regulation
in vivo. With this mindset, the rates at which DNA opens
and closes in DNA-bound holoenzyme complexes and their
dependence on CarD likely have important regulatory consequences.
In this study, we adapt a real-time, fluorescence-based assay to gain insights on the mechanisms used by M. tuberculosis CarD to stabilize mycobacterial open complexes. We
show that CarD stabilizes RPo for MboRNAP on rrnAP3 in
a concentration-dependent manner that saturates at 1 M
and approaches the level of stability displayed by EcoRNAP
on the same promoter. The fact that CarD increases the
concentration of open complex on RNAP-saturated DNA
templates demonstrates that CarD specifically affects the
equilibrium between promoter-bound complexes and stabilizes RPo with respect to RPc . This result, in combination
with a thermodynamic cycle coupling CarD binding and the
equilibrium between RPo and RPc , shows that CarD has a
higher affinity to open complex as compared to closed complex. The temperature dependence of CarD activity also
matches well with the known temperature dependence of
open complex (Figure 4C) (19–21). Furthermore, the kinetics of the approach to equilibrium display interesting
trends as a function of both RNAP and CarD concentrations. Specifically, the biphasic behavior of the slowest observed rate (k3 obs ) as a function of CarD concentration at
high RNAP concentrations suggests that CarD uses more
than one mechanism to stabilize open complex (Figure 5B).
Lastly, we have constructed a detailed kinetic model of the
formation of open complex in the presence of CarD that
captures all of the experimental trends in the slowest observed rate with a single set of parameters.

Importantly, k3 obs also depends on RNAP concentration
at high concentrations of CarD (Figure 5C). Since the concentration of the polymerase affects the rate at which it encounters and binds the template, this suggests that the effect of CarD on the kinetics of open-complex formation
depends on the rate of association of RNAP. One possibility is that CarD interacts with free polymerase and accelerates its association with DNA. However, while we do
not exclude this interaction as part of CarD’s overall mechanism, it is unlikely to play a major role as k3 obs shows no
RNAP concentration dependence in the absence of CarD
(Figure 5C, black) suggesting that only increasing the rate
of association of holoenzyme has no effect. Instead, to account for the above observations, we hypothesize that CarD
is able to associate with closed complex (Figure 6A). The
addition of this state to the mechanism has the potential to
account for all the data as the formation of a CarD-bound
closed complex will naturally depend on the concentrations
of both RNAP and CarD.
The full model postulates that at low concentrations,
CarD associates with pre-formed open complex and stabilizes it, thus inhibiting its isomerization to closed complex.
At higher concentrations, CarD associates with closed complex as well and destabilizes it, thus promoting its isomerization to open complex (Figures 6 and 8). The model satisfies detailed balance and is also consistent with the observation that CarD must have a higher affinity to RPo as
compared to RPc . We caution that we do not interpret the
presented model parameters as measurements of affinities
or equilibria. These parameters will need to be determined
via future experiments, however the ability of the model to
capture all the trends we observe with a single parameter
set suggests that the model topology is correct and is able to
capture the critical interactions between MboRNAP, CarD
and DNA. At saturating concentrations of both RNAP and
CarD, the model predicts that CarD interacts with both
open and closed complexes and tilts the equilibrium toward
open complexes. As both proteins are present in high concentrations in the cell (> 1 M, Supplemental Methods,
Supplementary Figure S4 and (24)), both activities of CarD
are apt to play important roles in transcriptional regulation
in vivo.
Recently, DNA footprinting and transcription assays
were used to measure the effect of CarD on the stability of
the open complex and transcript production (25). This work
nicely shows that although mycobacterial RNAP makes the
same contacts with the promoter as E. coli RNAP, it forms
an unstable open complex on the rrnAP3 promoter. Furthermore, the addition of CarD at high concentrations led
to the stabilization of the open complex and stimulated single rounds of transcript production. Our results are consistent with these data with regard to CarD’s ability to inhibit bubble collapse in the open complex. Additionally, the
concentration-dependent kinetic analysis of the formation
of open complex significantly expands our understanding
of the mechanism of CarD and shows that it also functions
by accelerating bubble formation.
The two-step binding and opening model is able to capture all of the trends in observed rates presented in this
work. The model has served as a useful tool for analyz-
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ing open-complex formation of E. coli RNAP on a range
of promoters (18,26) and to analyze open-complex formation for mycobacterial RNAP in the absence of transcription factors (27). Given that the mechanism of initiation in
E. coli is known to be significantly more complex (1), we expect that the two-step model will serve as a starting point for
more detailed studies of CarD’s kinetic mechanism of regulating transcription initiation in mycobacteria. Promoterspecific initiation in E. coli involves transitions through multiple closed and open complexes of varying stabilities which
are defined by conformational changes in both the DNA
as well as RNAP (1). One subtle possibility with respect to
the interpretation of the data presented is that early open
intermediates in the E. coli mechanism (i.e. I2 ) also exist in
the M. bovis mechanism and do not generate fluorescence
enhancement. In this case, the data could be explained via
the CarD-dependent acceleration of the formation of RPo
via its association with these intermediates instead of with
RPc . However, as transitions between intermediates prior
to melting of the transcription bubble are thought to be rate
limiting, transcription factors which act on these intermediates (i.e. CRP (28) and DksA (29)) can have more dramatic
effects on open-complex kinetics. Thus, while we favor the
model presented where CarD interacts directly with RPc , we
exclude neither the possibility that multiple closed and open
intermediate states exist in the mechanism of mycobacterial
open-complex formation, nor the possibility that CarD may
act on more than one of these states.
To dissect the roles played by different domains of CarD
within the context of the proposed kinetic mechanism, realtime fluorescence enhancements were acquired using pointmutants of CarD. Mutants of CarD that weaken its interactions with DNA or the polymerase, or lack the critical tryptophan W85 all show defects in open-complex stabilization.
The equilibrium concentration of open complex and the relative changes of the slowest observed rate with the DNAbinding (K90A) and W85A mutants are consistent with a
model where they are able to associate with RNAP-bound
complexes, but are unable to generate full stabilization (Figure 7B). This interpretation suggests that K90 and W85 are
more important for the activity of CarD once it has bound
than they are for the recruitment of CarD to the initiation

complex. Furthermore, the trends in the observed rates for
these mutants suggest that they are defective in both the
inhibition of bubble collapse and the acceleration of DNA
opening (Figure 7C).
In contrast, in the case of the R25E mutant, the CarD
concentration dependence of both open-complex stability
and observed rate show significant shifts to higher concentrations (Figure 7B and C). This result is consistent with
the RID domain playing a role in the overall recruitment of
CarD to RNAP-DNA complexes. Furthermore, the effect
of 1 M R25E CarD is similar to the effect of WT CarD
on EcoRNAP (Supplementary Figure S7). This corroborates previous immunoprecipitation data that M. tuberculosis CarD associates with E. coli RNAP with low affinity
(9), possibly due to the fact that EcoRNAP lacks glutamate
138 which is thought to form a salt bridge with R25 that is
critical for CarD binding to RNAP ␤ (12,23). Lastly, at the
highest concentration of R25E, the observed rate is slower
than the other mutants, but the equilibrium stabilization of
open complex is less. Based on this result, we speculate that
the dramatically reduced affinity of R25E completely prevents it from interacting with closed complex at the concentrations tested.
Structural modeling has positioned W85 in a position to
interact with the upstream edge of the DNA bubble present
in open complex (13). Given this location and its chemical nature, predictions of its role have included promoting formation of open complexes, in a way analogous to
the tryptophan residues in  factors (14,30), or stabilizing
the open complex by intercalating into the distorted backbone of the DNA at the upstream edge of the open complex
(13,14). The data presented here are consistent with a model
in which W85 performs both of these roles. While it is not
clear what interactions would lead to a different affinity between open and closed complex in WT CarD, one possibility is the hypothesized steric clash between W85 and closed
complex DNA (13). This clash would result in non-optimal
binding between the C-terminal domain of CarD and DNA
and could lead to a destabilization of CarD-bound closed
complex. This destabilization would naturally lead to an increase in all rates leading out of the CarD-bound closed
complex. This would increase the rate of CarD dissociation,
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Figure 8. Energy diagram. Schematic energy diagrams showing the relative free energies of closed (RPc ) and open (RPo ) complexes. In the proposed model,
in the absence of CarD (0 nM), RPc is more stable than RPo . In the presence of low concentrations (100 nM), CarD binds to and stabilizes RPo , effectively
increasing the energy barrier for closing and inhibiting bubble collapse. In the presence of high concentrations (1 M), CarD additionally interacts with
and destabilizes RPc , effectively decreasing the energy barrier for opening and accelerating the formation of RPo .
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SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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explaining the decreased affinity of CarD to closed complex
and would also lead to an increase in the rate of isomerization to open complex resulting in an acceleration of DNA
opening.
In conclusion, the kinetic model of CarD-dependent
open-complex stabilization proposed here might have important consequences in terms of the gene-specific effects
of CarD. While CarD is localized in vivo at every  A dependent promoter (13), its role at each promoter is unclear. The ability of CarD to accelerate opening and inhibit bubble collapse will likely lead to complex dependencies on both promoter sequence and the presence of additional transcriptional regulators. More specifically, CarD
could either inhibit or promote transcription, depending on
the basal kinetics of a given promoter and the basal rates of
DNA opening, bubble collapse and promoter escape. Future research along these lines will be required to elucidate
the role of CarD across the genome.
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SUPPLEMENTAL METHODS
Template sequence
The full non-template strand sequence of the 150 bp rrnAP3 DNA template used in the
fluorescent assay. The italics/underline indicate genomic sequence and the green, blue, red, and
orange type indicate the -35 box, -10 box, start-site, and Cy3 label position respectively.
AAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAAGAATTCGTCTTGACTCCATTGCCG
GATTTGTATTAGACTGGCAGGGTTGAAGCTTATGTATCACCTGACGTCATGATGAACTC
AGAAGTGAAACTACGTATATCCGATGGTAGTG
Kinetic simulations
The model as presented in the paper was constructed with five states and seven
independent rates. The three effective bimolecular on rates were linearly dependent on the
concentrations of the binding partners and were all set to be equal. Furthermore, the dissociation
rate of CarD from open complex was calculated to satisfy detailed balance. Specifically, k6 =
(k3*k8*k5)/(k4*k7).

The values of the rates used to generate the plots in the main text are as follows: k1 = 0.3 s-1nM-1,
k2 = 75 s-1, k3 = 0.0005 s-1, k4 = 0.004 s-1, k5 = 400 s-1, k6 = 2.0 s-1, k7 = 0.0125 s-1,
k8 = 0.0005 s-1.
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Measurements of protein concentration in vivo
Five mL of 4 replicate cultures of Mycobacterium smegmatis Mc2155 in exponential
growth phase were collected and the cells were pelleted and lysed in 500 µl of NP-40 (10 mM
sodium phosphate, pH 8.0, 150 mM NaCl, and 1% Nonidet® P-40) by bead beating (FastPrep;
MP Bio). Before lysing, the OD(λ600) was measured for each culture and the conversion of OD
(λ600) of 1 corresponds to 5 x 108 cells/ml was used to determine the number of cells in each
sample. The total protein concentrations of the lysates were also measured by BCA assay
(Pierce). Undiluted, 1:5 dilution, and 1:10 dilution of cell lysates were run on a denaturing
polyacrylamide gel adjacent to lanes containing 0.05, 0.1, 0.5, or 1.0 pmol each of M. smegmatis
CarD, M. bovis RNAP core, and M. bovis RNAP σA purified protein. Following SDS PAGE,
western blot analyses were performed and CarD, RNAP σ, and RNAP β were detected using
mouse monoclonal antibodies specific for CarD (clone 10F05; Memorial Sloan-Kettering Cancer
Center Monoclonal Antibody Core Facility), RNAP σ (clone 2G10, Neoclone, Madison,
WI), and RNAP β (clone 8RB13; Neoclone, Madison, WI), respectively. Western blots were
imaged and quantified using an Odyssey CLX imaging system (LI-COR). Standard curves for
CarD, RNAP σA, and RNAP β were generated and used to determine the pmol/lane for each
protein in the lysates. The molecules/cell calculation assumes 100% cell lysis and a cell count
given by OD. The conversion of molecules/cell to protein concentration assumes a cell volume
of 4 µM3.
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Figure S1: CarD-dependent fluorescent enhancement depends on MboRNAP. (A) The trace
of 1 µM CarD in the absence of RNAP shows no fluorescent enhancement. (B) In the presence
of 21 nM EcoRNAP, the addition of 1 µM CarD shows only a slight fold change relative to
EcoRNAP alone. (C) The magnitude of the fluorescence fold change when CarD is added to
concentrations of EcoRNAP and MboRNAP in the middle of their respective concentration
dependences. Specifically, 21 nM EcoRNAP is compared to 225 nM MboRNAP. This
comparison shows the effect of CarD on the respectively polymerases under conditions where
they alone generate about half open complex. This demonstrates that CarD has a much greater
effect on MboRNAP.
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Figure S2: Fractional amplitudes of the three observed rates. Each observed rate (k1obs, k2obs,
k3obs) obtained from the triple exponential fit carries an amplitude (a1, a2, a3) which describes
that phase’s contribution to the total fluorescent enhancement signal. The majority of the increase
of the overall opening signal (fluorescent enhancement) as a function of CarD concentration is
mostly due to increases in the amplitude of slowest observed rate (a3). This is shown by plotting
the fractional amplitude of the rates (i.e. a1/A where A is the total amplitude of the trace) as a
function of CarD concentration. The fraction of the total signal accounted for by the amplitude of
the slow phase (red) increases while it decreases for the faster phases (blue and green). This is
true for both concentrations of MboRNAP tested (150 nM and 225 nM).
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Figure S3: Observed rates in a three state example. (A) A simpler model is used to
demonstrate the effect of microscopic rate constants on observed rate. In this model k1 and k-1
describe the association and dissociation of RNAP with DNA respectively. Similarly, k2 and k-2
describe the opening and closing rates respectively. (B) The CarD effect is captured simply by
running the simulation with different combinations of k2 and k-2 to represent different
concentrations of CarD. The dependence on CarD concentration for k2 (red) and k-2 (green) show
the values input into the simulation used to generate time-dependent curves of the equilibration
of open complex concentration (not shown). These curves are fit by an exponential to extract a
measure of the observed rate (black). The concentration dependence of the measured observed
rate (black) closely follows the trend of the sum of the two rates controlling the equilibrium
between open and closed complex, k2 + k-2 (blue). This example demonstrates how combinations
of microscopic rate constants lead to observed rates and how trends in observed rates can be
analyzed to extract mechanistic information.
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Figure S4: Concentrations of RNAP and CarD in vivo. (A) Western blot used for quantitation
of protein levels found in lysates of M. smegmatis during logarithmic growth. Dilutions of lysate
are shown next to lanes loaded with known amounts of each protein. (B) Bar graph shows the
mean ± SEM of for each protein in the 4 replicates. The number of molecules/cell and the
equivalent concentration are shown on the 2 y-axes. The conversion of the raw data to
molecules/cell assumes 100% lysis of the collected cells and the conversion to concentration
assumes a cell volume of 4 µm3.
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Figure S5: Simulated equilibrium fold enhancements. (A) Using the kinetic model,
equilibrium fold changes were simulated and plotted as a function of RNAP concentration in the
presence (red) and absence (green) of 1 µM CarD. (B) Experimental equilibrium fold changes
for the same conditions from the main text (Figure 4B).
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Figure S6: Concentration titrations of mutant CarDs. Fluorescent fold change as a function
of time for the (A) W85A, (B) K90A, and (C) R25E mutant CarDs in the presence of 225 nM
MboRNAP.
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Figure S7: Comparison of mutant CarD-dependent fold-changes. The fluorescent fold
changes for 21 nM EcoRNAP or 225 nM MboRNAP with WT or mutant CarD. The largest effect
is seen for MboRNAP and WT CarD. Both W85A and K90A show about half the effect and
R25E with MboRNAP shows an effect almost as low as EcoRNAP with WT CarD.
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Epilogue
The work presented in this chapter was continued by testing point mutants of CarD-I27
(I27W and I27F) with higher affinity for RNA polymerase. This data is part of a larger
manuscript in submission titled “Effects of Increasing the Affinity of CarD for RNA
Polymerase on Open-Complex Formation at the Mycobacterium tuberculosis rrnAP3
Promoter” by Ashley Garner et al. The work presented here represents the collective
work of Eric Galburt and members of his laboratory (Ana Ruiz-Manzano and Drake
Jensen) as well as Christina Stallings and members of her laboratory (Ashley Garner,
Jeremy Huynh and Leslie Weiss). Importantly, the results with these point mutants are
also consistent with the 5-state model of CarD stabilization of RPo presented in this
chapter, in the sense that open complex stabilization and acceleration both occur at lower
concentrations of CarD. Interestingly, as CarD-I27 approaches saturating concentrations,
the equilibrium approaches approximately the same fold change as wild-type CarD,
suggesting that the higher affinity CarD does not lead to more open complex at
saturation.

Results and Conclusions
CarDI27F and CarDI27W mutants stabilize open complexes at lower concentrations
than CarDWT.
CarD regulates transcription initiation by binding to and stabilizing RNAP-promoter open
complexes (1-5). We have previously developed a fluorescence assay for CarD activity
that reports on open complex formation in realtime. In this assay, a Cy3 label, which
exhibits a 2-fold fluorescence enhancement in open complex, is incorporated at the +2
position on the nontemplate strand of the Mtb rrnAP3 promoter within a linear fragment
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of Mtb genomic DNA containing nucleotides 1,470,151 to 1,470,300 (8). Mbo RNAP-σA
holoenzyme with or without Mtb CarD is then mixed with the labeled DNA fragment via
stopped-flow spectrophotometry and fluorescence is monitored for 20 minutes. The Cy3
label increases fluorescence in the open complex conformation and thus the rate of open
complex formation can be monitored as a change in fluorescence. The amplitude of the
fluorescence intensity curve correlates to the equilibrium amount of open complex in a
given condition (4). To monitor the effect of increasing the affinity of CarD for RNAP on
the formation and stability of open complexes, we performed this assay with
concentrations of CarDI27F and CarDI27W ranging for 0 to 1800 nM and fixed
concentrations of RNAP (225 nM) and promoter DNA (10 nM) (Fig. 2A). We found that
the CarD concentration necessary to reach half of the maximum level of open complex at
saturation (half-maximal 3 concentration) was lower for CarDI27F (17 ± 2 nM) and
CarDI27W (23 ± 3 nM) than for CarDWT (59 ± 10 nM), consistent with a higher affinity
of the CarD I27 mutants for RNAP in initiation complexes compared to CarDWT (Fig.
2A).

CarDI27F and CarDI27W mutants accelerate promoter opening at lower concentrations
than CarDWT.
We have previously reported modeling based on the trends of the slowest observed rate in
the real-time fluorescent traces (kobs 3) that suggests that CarD stabilizes open complex
through a two-tiered concentration-dependent mechanism where CarD associates with
both open and closed complexes with different affinities (4). More specifically, the model
predicts that at low concentrations (i.e. < 100 nM), CarDWT binds to open complex and
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prevents bubble collapse, resulting in more open complex and a slower observed rate.
The model further predicts that at higher concentrations, CarDWT binds to the closed
complex and accelerates the rate of opening, resulting in still more open complex and an
acceleration in the observed rate. Analysis of kobs 3 as a function of CarD concentration
was performed for the CarD I27 mutants as previously described (4) (Fig. 2B). We found
that the I27 mutants begin to accelerate kobs 3 at lower concentrations (< 50 nM) than
WT CarD (100 nM). In fact, for CarDI27W we did not observe a deceleration in kobs 3
even at the lowest concentration tested (16 nM). The two-tiered kinetic model predicts
that acceleration in kobs 3 arises from CarD binding to closed complex, which increases
the rate of promoter opening. Thus, our working model predicts that, even at 16 nM,
CarDI27W is associating with closed complex and accelerating opening. The acceleration
of the observed rate at lower concentrations coupled with the lower half-maximal
concentration for open complex stabilization is consistent with a model where the CarD
I27 mutants have higher affinities to both closed and open RNAP-promoter complexes as
compared to CarDWT.
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Figure 1. Effects of increasing the affinity of CarD for RNAP on open complex
stability. (A) Equilibrium fluorescence fold-change normalized to the fold-change at
high CarD concentrations (saturation) for each mutant of CarD with 225 nM Mbo RNAPσA and 10 nM Cy3-labeled Mtb rrnAP3 promoter. Both Mtb CarDI27F (red triangles)
and CarDI27W (blue squares) mutants achieve a half-maximal effect (dashed line) at
lower concentrations (17 ± 2 nM for CarDI27F, and 23 ± 3 nM for CarDI27W) than Mtb
CarDWT (black circles, 59 ± 10 nM). (B) kobs 3, calculated using ProData Viewer
software from Applied Photophysics, of open complex formation as a function of CarD
concentration for Mtb CarDWT (black circles), CarDI27F (red triangles), and CarDI27W
(blue squares). The legend for B is shared with A. (C) In vitro transcription assay
showing a representative gel and a graph of the ratio of the amount of 3nt initial transcript
formed by 200 nM Mbo RNAP-σA from 10 nM of a linear DNA fragment in the
presence of 2 μM CarD versus in the absence of CarD for reactions containing no CarD,
Mtb CarDWT, CarDR25E, CarDI27F, or CarDI27W. The graph shows the mean ± SEM
of data from at least four replicates. Statistical significance was analyzed by ANOVA and
Tukey’s multiple comparison test. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; or ****, p ≤
0.0001.
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Chapter 4
Cooperative stabilization of
Mycobacterium tuberculosis rrnAP3
promoter open complexes by RbpA and
CarD
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Introduction
Like CarD, the transcription factor RbpA is known to activate transcription from the Mtb
rrnAP3 promoter, however the effect of RbpA on open complex kinetics is unknown.
Structural modeling predicts that both transcription factors interact with the transcription
initiation complex at different sites (Figure 1 below), but no studies have been performed
to test this hypothesis directly. I studied the effect of RbpA on the kinetics of rrnAP3
promoter-opening in the presence and absence of CarD. I found that RbpA. I found that
RbpA stablizes open complexes using a distinct kinetic mechanism from that of CarD.
Furthermore, the two factors cooperatively stabilize RPo and this cooperativity can be
captured by a simple model of positive linkage. The work presented here represents a
step towards understanding how multiple essential transcription factors can work in
concert for regulating transcription initiation in Mtb.

Figure 1. Structural model of CarD and RbpA simultaneously bound to the transcription
open complex. (PyMol image courtesy of Ashley Garner).
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ABSTRACT
The essential mycobacterial transcriptional regulators RbpA and CarD act to modulate transcription
by associating to the initiation complex and increasing the flux of transcript production. Each of
these factors interacts directly with the promoter
DNA template and with RNA polymerase (RNAP)
holoenzyme. We recently reported on the energetics of CarD-mediated open complex stabilization on
the Mycobacterium tuberculosis rrnAP3 ribosomal
promoter using a stopped-flow fluorescence assay.
Here, we apply this approach to RbpA and show that
RbpA stabilizes RNAP-promoter open complexes
(RPo ) via a distinct mechanism from that of CarD. Furthermore, concentration-dependent stopped-flow experiments with both factors reveal positive linkage
(cooperativity) between RbpA and CarD with regard
to their ability to stabilize RPo . The observation of
positive linkage between RbpA and CarD demonstrates that the two factors can act on the same transcription initiation complex simultaneously. Lastly,
with both factors present, the kinetics of open complex formation is significantly faster than in the presence of either factor alone and approaches that of E.
coli RNAP on the same promoter. This work provides
a quantitative framework for the molecular mechanisms of these two essential transcription factors
and the critical roles they play in the biology and
pathology of mycobacteria.
INTRODUCTION
The regulation of gene expression serves as a gateway between genotype and phenotype. By modulating the output of specific genes, cells tune their molecular makeup to
* To

best suit environmental conditions. Much of this regulation
is enacted by modulating the rates of transcription initiation to control the flux of RNA production. In bacteria,
the basal transcriptional machinery is composed of RNA
polymerase holoenzyme which consists of a catalytic core
enzyme (␤␤’␣2 ) and a dissociable sigma factor () that
directs promoter recognition. Transcription initiation proceeds via the binding of RNAP holoenzyme to promoter
DNA to form closed complex (RPc ) followed by the spontaneous unwinding of approximately a turn of DNA to form
open complex (RPo ). In RPo , the single-stranded DNA
template is correctly positioned in the polymerase active
site, incoming ribonucleotides may bind and RNA polymerization may ensue. The polymerization of the initial ribonucleotides leads to promoter escape, the formation of a stable elongation complex and the production of transcript. In
Escherichia coli, transcription initiation mechanisms have
been well-studied and multiple kinetic intermediates have
been identified between the initial DNA-holoenzyme closed
complex and open complex (1). These details are of crucial
importance in understanding the structural transitions that
the complexes go through during the isomerization to open
complex. However, a minimal kinetic scheme that describes
promoter binding and opening in two reversible steps (R+P
↔ RPc ↔ RPo ) has proven to be a useful and practical starting point when investigating mechanisms of open-complex
formation and regulation (2).
The regulation of transcription initiation involves factordependent tuning of the stabilities of transcription intermediates and the rates of interconversion between these states.
Examples include modulation of polymerase-promoter
affinity, changing the equilibrium between RPc and RPo
and influencing the rate of NTP-dependent promoter escape (3–5). It has recently become apparent that initiation
in Mycobacterium tuberculosis (Mtb) is controlled via mechanisms that are distinct from those found in E. coli. For example, mycobacteria lack Fis (6), DksA (7) and AT-rich up-
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rrnAP3 promoter using a real-time fluorescence assay (25)
and show that RbpA stabilizes open complex. Furthermore,
RbpA accelerates the approach to equilibrium providing insight into the kinetic mechanism at play. Interestingly, this
trend is qualitatively distinct from that of CarD, suggesting that the two factors function in fundamentally different
ways.
Furthermore, stopped-flow fluorescence experiments
performed in the presence of both factors reveal positive
linkage between the effect of CarD and RbpA on RPo stability at the Mtb rrnAP3 promoter. The observation that
the two factors bind cooperatively demonstrates for the first
time that RbpA and CarD can act on the same initiation
complex simultaneously. This is consistent with the prediction that CarD and RbpA have distinct binding sites on
initiation complexes (15,18). We present a thermodynamic
analysis to quantitatively describe the positive linkage between the two factors. Lastly, we observe a dramatic acceleration in observed rates when both factors are present, and
the approach to equilibrium under these conditions resembles that of E.coli RNAP acting on the same promoter.
The data and analysis presented here reveal important
details regarding the mechanistic differences between CarD
and RbpA and provide a kinetic framework for the function
of these two essential mycobacterial transcription factors
both independently and cooperatively. This work brings us
a step closer to understanding the functional logic of transcription regulation in a pathogenic bacteria that represents
a significant burden to human health worldwide.

MATERIALS AND METHODS
Protein purification
Mbo RNAP, Mbo  A and Mtb CarD were prepared as previously described (12). Mtb RbpA was cloned into a pETSUMO-His6 vector and introduced into E. coli BL21(DE3)
cells. After growth at 37◦ C to an OD600 of 0.8, protein overexpression was induced by the addition of 1 mM Isopropyl
␤-D-1-thiogalactopyranoside (IPTG). The tagged protein
was purified by nickel affinity chromatography (HP HiTrap,
GE Healthcare) and the SUMO tag was cleaved overnight
with His-tagged Ulp1 protease. Pure untagged RbpA was
collected in the flow through of a second nickel affinity column. The protein was stored in 20 mM Tris (pH 8.0), 150
mM NaCl and 1 mM beta-mercaptoethanol at −80◦ C.

Promoter DNA
A total of 150 base-pair Mtb rrnAP3 promoter fragments
with a Cy3 label on the +2 non-template dT were prepared
as previously described (12), with one notable exception:
residues flanking the promoter sequence were replaced with
those native to the Mtb genome (H37Rv coordinates 1 471
577–1 471 727, Supplemental Sequence) (26,27). Control
experiments indicated that this change had no effect on previously published results describing the effect of CarD on
open-complex stabilization on the same promoter with random flanking sequence (12).
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stream activating elements (8,9). Furthermore, mycobacteria possess unique transcription factors not found in E. coli
including CarD (10–12) and RbpA (13–15).
CarD is an RNAP- and DNA-binding protein that is essential for growth in M. tuberculosis, other mycobacteria
(10–12). Furthermore, CarD is required for the response
of Mtb to oxidative stress, some antibiotics and infection
of mice (10). In vitro, CarD binds to initiation complexes
and stimulates the production of RNA by stabilizing the
relatively unstable RPo generated by mycobacterial RNAP
holoenzyme on ribosomal promoters (11,12,16). In initiation complexes, it makes direct molecular interactions with
the ␤1 lobe of the RNAP ␤ subunit through its N-terminal
RNAP-interaction domain (RID) (10,17,18) (Figure 1A
and B). CarD also binds DNA non-specifically through
its C-terminal domain (CTD) (19, Srivastava: 2013ga; 20),
which contains a tryptophan residue that interacts with
the upstream edge of the transcription bubble to stabilize
RPo (18). Mutations in the RID, CTD or tryptophan lead
to distinct in vivo and in vitro effects suggesting that full
CarD activity requires each of these three functional modules (12,17,20). Based on these studies and previous analyses by our group, our working model for how CarD stabilizes open complex and stimulates transcription consists
of a two-tiered, concentration-dependent mechanism. The
model predicts that at low concentrations (i.e. <100 nM),
CarD binds RPo and slows the rate of bubble collapse by
conformational selection, while at higher concentrations,
CarD binds RPc and accelerates the rate of DNA unwinding by induced fit (12). We expect both of these kinetic effects to play roles in vivo where the concentration of CarD
is well in excess of 100 nM (12).
RbpA is also an essential RNAP- and DNA-binding protein found in M. tuberculosis and other Actinobacteria, but
not in E. coli (13,15). RbpA consists of an unstructured Nterminal tail, a central core ␤-barrel domain, a 15 amino
acid basic linker (BL) and a C-terminal sigma-interacting
domain (SID) (15,21) (Figure 1A). The SID binds to the
second domain of sigma ( 2 , domains 1.2, 2.3 and the nonconserved region) in both the presence and absence of the
core RNAP enzyme and has specificity to the housekeeping sigma factor  A and the stress-response sigma factor
 B (15,21,22). A crystal structure of a BL/SID construct
bound to  A 2 has been solved (15) and can be used to position RbpA in the initiation complex (Figure 1B). RbpA’s
sigma specificity has led to proposals that RbpA plays a role
in the competition of sigma factors for RNAP core (14,23).
RbpA potentially stabilizes RNAP holoenzyme by binding
both sigma and either ␤2 or another region of the core subunits (14,15). Furthermore, RbpA can increase the affinity
of holoenzyme to the promoter, presumably via the interaction of the BL with DNA (15,24). An arginine residue (R79)
in the BL is thought to play a role in RbpA’s ability to bind
DNA, although it is unknown whether this interaction may
contribute to RbpA’s promoter specificity (15). RbpA stimulates transcription in vitro and the BL/SID region of the
protein are sufficient for partial stimulation (15). However,
the mechanism of transcriptional stimulation by RbpA remain unclear.
Here, we perform a mechanistic analysis of the function
of Mtb RbpA during open complex formation on the Mtb
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Stopped-flow fluorescence assay
The stopped-flow assay was performed as previously described (12). In brief, Mbo RNAP core was mixed with 3- to
6-fold molar excess Mbo  A at 25◦ C to form holoenzyme.
Holoenzyme was mixed with transcription factor(s) or an
equivalent volume of transcription factor storage buffer
such that the proteins were initially at twice the desired final
reaction concentrations. Promoter DNA was also prepared
at twice the desired final reaction concentration. Equal volume mixing was performed in a stopped-flow apparatus
(Applied Photophysics SX-20, total shot volume 150 l,
dead time < 2 ms), so the initial protein and DNA solutions
were each diluted by half in order to reach their final reaction concentrations. All experiments were performed using
a final MboRNAP holoenzyme concentration of 225 nM
and a DNA concentration of 10 nM unless otherwise noted.
Excitation light was provided by a 510 nm LED light source,
as opposed to a 515 nm light source from an arc lamp passed
through a monochromator. Emission was collected at 570+
nm using a long-pass filter. Control experiments indicated
that this subtle change in excitation wavelength had no effect on previously published results describing the effect of
CarD on mycobacterial open-complex stabilization. All experiments were performed at 25◦ C in the following final solution conditions: 14 mM Tris pH 8.0, 120 mM NaCl, 10
mM MgCl2 , 1 mM DTT, 0.1 mg/ml BSA and 10% glycerol
by volume.
Two to three traces were collected per condition. Traces
for each condition were averaged and plotted as fold-change
over DNA by first subtracting the buffer signal from all
traces and then plotting the data as (F−F0 )/F0 , where F0 is

the signal for DNA alone and F is the signal for DNA mixed
with protein. The fold-change traces were fit to a triple exponential from 0.1–1200 s using the ProData Viewer software from Applied Photophysics:
F(t) =

3


Aobs,i · e−kobs,i t

(1)

i =1

where Aobs,i and kobs,i are the amplitude and observed rate of
the ith kinetic phase. To facilitate consistency in assignment
of fast, intermediate and slow phases, traces were anchored
to the intermediate and slow phases using either a single or
double exponential before fitting the fast phase of the trace.
Fractional amplitudes were calculated according to:
Aobs,i
A f r c,i =  N
i =1 Aobs,i

(2)

In order to estimate an overall rate for the approach to
equilibrium, an amplitude-averaged rate was calculated using the intermediate and slow phases according to:
kobs =

(Aobs,2 · kobs,2 ) + (Aobs,3 · kobs,3 )
Aobs,2 + Aobs,3

(3)

Conditions that were repeated multiple times on different days were used to estimate standard error of the mean
(SEM). An average SEM was used to estimate uncertainty
for specific conditions that were only repeated multiple
times on the same day to better estimate the actual error
for these points.
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Figure 1. Mycobacterial transcription factors and a fluorescence assay for following open complex formation. (A) CarD is made up of an N-terminal
RNAP-interaction domain (RID, light blue) and a C-terminal DNA-binding domain (dark blue). RbpA consists of a core domain (white), a basic linker
domain (BL) and a sigma-interacting domain (SID, red). (B) Ribbon representations of both factors are shown in the context of an open complex structure.
Both domains of CarD and the SID of RbpA are modeled together based on the structure of CarD bound to open complex (4XLS (18)) and the structure
of the RbpA SID domain bound to domain 2 of  A (4X8K (15)). (C) Fluorescence assay for following the formation of open complexes. A Cy3 fluorophore
attached to the +2 non-template dT undergoes fluorescence enhancement upon open-complex formation.
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In vitro aborted transcription assay

RESULTS
RbpA stabilizes rrnAP3 open complexes
To study the effect of RbpA on transcription open complexes (RPo ) we used a fluorescence assay that reports on
RPo formation in real-time as previously reported (12,25).
For these experiments, we use M. bovis (Mbo) RNAP which
is virtually identical to MtbRNAP differing only in the
69th amino acid of the ␤’ subunit which is a proline in
MboRNAP and an arginine in MtbRNAP. A stopped-flow
apparatus was used to mix Mbo  A -saturated MboRNAP
with Cy3-labeled Mtb rrnAP3 promoter, and fluorescence
intensity was monitored over time. The dye is conjugated
to the +2 non-template thymine and exhibits enhanced fluorescence intensity upon RPo formation, providing a way
to measure the kinetics of open complex formation as well
as the amount of open complex at equilibrium (Figure 1C).
Several control experiments support our interpretation of
Cy3 fluorescence enhancement as a reporter of promoteropening. First, promoter-less templates do not show fluorescence enhancement, demonstrating sequence dependence (12). Second, experiments performed at 10◦ C, 25◦ C
and 37◦ C showed increasing fluorescence enhancement by
RNAP with increasing temperature, consistent with the
known temperature dependence of promoter-melting (12).
Third, at high concentrations of RNAP, where promoters
are saturated with holoenzyme, CarD leads to a large fluorescence enhancement showing that CarD specifically affects a step after holoenzyme binds the promoter (i.e. promoter opening). Lastly, the CarD-dependent fluorescence
enhancement follows the same trend of open-complex stabi-

Figure 2. RbpA and CarD stabilize open complex. (A) Fluorescent foldchange is plotted over time from mixing MboRNAP and Mtb factors with
a +2 T Cy3-labeled Mtb rrnAP3 promoter template. DNA alone mixed
with buffer (black), a titration of RbpA from 0–2 M (red) and 1 M
CarD (blue) are shown. (B) The equilibrium fluorescence fold change
over 225 nM RNAP alone is plotted versus the concentration of either
RbpA (red) or CarD (blue). The data are fit with the binding model
A*[factor]/([factor]+Keff ) to extract amplitudes (ACarD = 6.1 ± 0.1 and
ARbpA = 2.9 ± 0.1) and effective binding constants (Keff,RbpA = 177 ± 23
nM and Keff,CarD = 73 ± 4 nM). Two to three shots were collected for each
condition and error bars represent standard error of the mean.

lization observed in potassium permanganate experiments
(12,16).
Incubating MboRNAP with increasing concentrations
of wild-type RbpA results in increasing equilibrium fluorescence, demonstrating that RbpA stabilizes RPo at the
rrnAP3 promoter (Figure 2A). The R79A mutant of RbpA,
which is known to play an important role in transcriptional
activation (15), results in approximately half the increase in
equilibrium fluorescence when added at a concentration at
which WT RbpA saturates (2 M, Supplementary Figure
S1). A fit of the equilibrium fluorescence fold-change generated by WT RbpA normalized to RNAP alone to the binding isotherm 1 + A*[RbpA]/([RbpA]+Keff ) gives a value of
the concentration of half-maximal effect, Keff = 177 ± 23
nM. This Keff is approximately 2-fold weaker than that of
CarD (73 ± 4 nM). At saturation, RbpA produces ∼3 times
(A = 2.9) more fluorescence enhancement than MboRNAP
alone, compared to CarD which saturates at ∼6-fold (A =
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CarD and RbpA used in this assay were diluted into 1×
dialysis buffer (20 mM Tris pH 8.0, 150 mM NaCl and
1 mM BME). Mbo  A was mixed in 8-fold molar excess
with core RNAP to reconstitute the RNAP holoenzyme.
A total of 85 bp overlapping primers (IDT) were annealed
and extended to prepare a linear fragment of dsDNA Mtb
Erdman strain genomic DNA containing nucleotides 1 470
151 to 1 470 300 which includes the Mtb rrnAP3 promoter.
The final reaction conditions were: 225 nM Mbo  A -holo
RNAP, 1–2 M CarD or equivalent volume of buffer, 1–
2 M RbpA or equivalent volume of buffer, 10 nM linear
DNA template, 210 M GpU dinucleotide, 21 M UTP,
0.1 L [␣ - 32 P]-UTP, 14 mM Tris pH 8.0, 100 mM NaCl,
10.2 mM MgCl2 , 5% (vol/vol) glycerol, 1 mM DTT and 0.1
mg/ml BSA (NEB) in a total volume of 20 l. Mbo core
and  A were incubated for 10 min at room temperature.
CarD, RbpA and/or dialysis buffer were added to the polymerase and the proteins were incubated for 10 more minutes
at room temperature. The DNA template was added and the
reactions were diluted to 17.5 l, followed by an additional
10 min at room temperature. Reactions were initiated with
addition of a 2.5 l mixture containing GpU, UTP and the
radiolabeled UTP. After 20 min incubation at room temperature, the reactions were stopped with 2x formamide buffer
[98% (vol/vol) formamide, 5 mM EDTA] and run on a 22%
urea PAGE gel.
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RbpA stabilizes open complexes through a different kinetic
mechanism than CarD
Although RbpA and CarD are unique proteins that bind
the transcription initiation complex at distinct sites, the two
factors share several important structure-function properties. Specifically, both factors bind RNAP-holoenzyme and
DNA, and both factors stabilize RPo . For these reasons,
we considered the possibility that RbpA stabilizes opencomplexes using a similar kinetic mechanism as CarD (12).
Curves in the presence of either RpbA or CarD were well-fit
by a triple exponential (see Materials and Methods) and the
phases were separable by approximately an order of magnitude. The low fractional amplitude of kobs,1 made it challenging to measure, so we cannot exclude the possibility that
RbpA or CarD influence the kinetics of the fastest observed
phase.
We observed dramatic differences between RbpA and
CarD in the intermediate and slow phases. CarD traces
are dominated by the slowest phase (kobs,3, ), whereas RbpA
traces contain significant contributions from both the intermediate and slowest phases (kobs,2 and kobs,3 , respectively)
(Supplementary Figure S2). Analysis of the trends in the observed rates themselves also indicated differences between
RbpA and CarD (Figure 3B and C). We observe monotonic
and saturable increases in kobs,2 and kobs,3 with increasing
RbpA concentration (Figure 3B). Conversely, we were unable to discern a systematic trend in kobs,2 as a function of
CarD concentration (Figure 3B). Furthermore, kobs,3 displays a non-monotonic trend with increasing CarD concentration (Figure 3C and Supplementary Figure S3). Thus,
RbpA accelerates the approach to equilibrium at all concentrations tested while CarD decelerates equilibration at low
concentrations and accelerates equilibration at high concentrations.
We considered the mechanistic implications of the distinct kinetic trends observed for RbpA and CarD. CarD’s
non-monotonic trend in kobs,3 can be explained in the con-

Figure 3. Concentration dependence of observed rates. (A) The intermediate phase of stopped-flow time courses is different between RbpA and
CarD. For RbpA (red), kobs,2 increases in a monotonic and saturable
manner with increasing concentration. For CarD, kobs,2 , does not show
any systematic concentration dependence. (B) RbpA and CarD exhibit
different concentration-dependent trends in kobs,3 . The slowest phase of
time courses increases monotonically with increasing RbpA concentration
(red), unlike CarD (blue), which decelerates at low concentrations and accelerates at higher concentrations. Two to three shots were collected for
each condition and error bars represent standard error of the mean.

text of a two-step reversible model coupled to factor binding (12) (Supplementary Figure S4A). However, the observation of multiple saturable observed rates in the presence of RbpA demonstrates that the simple two-step reversible mechanism of open complex formation cannot account for the observed kinetics. Therefore, our data suggest that the mechanism of RpbA open complex stabilization must involve more states. Since RbpA is known to bind
sigA, RNAP core and holoenzyme, one possibility is that
RbpA’s protein-binding interactions contribute to the observed kinetics (Supplementary Figure S4B). Another possibility is that RbpA interacts with additional intermediates on pathway to RPo (Supplementary Figure S4B). These
possibilities are not mutually exclusive, and a detailed anal-
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6.1) over RNAP (Figure 2B). Assuming equilibrium fluorescence enhancement correlates with the extent of RPo stabilization, the lower equilibrium fluorescence generated by
RbpA at saturation suggests that RbpA stabilizes RPo to a
lesser extent than CarD. However, given that Cy3 fluorescence enhancement is sensitive to local changes in the dye’s
microenvironment, we do not exclude the possibility that
the assay reports on multiple open complexes, each with
subtle conformational differences leading to different fluorescence enhancements. With this in mind, it is possible
that the RbpA-stabilized RPo produces lower fluorescence
enhancement than the RPo stabilized by CarD. If this were
the case, the extent of fluorescence enhancement would not
correspond to the extent of open complex stabilization, but
instead would report on the average fluorescence enhancement of an ensemble of open complexes. Clearly, the difference in fluorescence enhancements contains information
regarding the mechanisms of open complex stabilization by
the two factors. Here, we can only speculate on the molecular details that lead to the observed enhancements, however,
these details do not impact the conclusions drawn from the
analyses that follow.
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ysis of the kinetic mechanism of RbpA’s stabilization of RPo
remains an active area of investigation.
RbpA and CarD cooperatively stabilize open complex

RbpA and CarD act together to accelerate the approach to
RPo equilibrium
To identify any cooperative kinetic effects stemming from
the presence of both RbpA and CarD on open complex
equilibration, we used a triple exponential to fit the raw data
traces and examined the manner in which the observed rates
(Figure 5B and C) and the fractional amplitudes (Supplementary Figure S7) depended on transcription factor concentration with both factors present.
Compared to RbpA and CarD individually, we found
that kobs,2 and kobs,3 were faster when both factors were
present. While the presence of CarD did not affect the dependence of the observed rates on RbpA concentration, the
presence of RbpA did affect the dependence of the observed
rates on CarD concentration. Titrations of CarD performed
in the presence of RbpA at saturation indicated that both
kobs,2 (Figure 5B) and kobs,3 (Figure 5C) now increase in a
saturable and monotonic manner. This trend is quite different than what is observed for CarD titrations performed in
the absence of RbpA, in which kobs,2 does not exhibit a discernible trend, and kobs,3 exhibits non-monotonic behavior.
To facilitate a general kinetic comparison of RbpA and
CarD acting individually and together, we calculated an
amplitude-averaged rate as a means to quantify an overall, apparent rate of open-complex equilibration (Materials
and Methods). This analysis supports the conclusion that
open-complex equilibration is faster in the presence of both
factors (Figure 6). Specifically, the averaged rate (k<obs> )
observed with saturating concentrations of both factors is
at least 3 times faster than in the presence of either factor alone. Interestingly, the presence of both factors leads
to traces with similar kinetics and equilibrium fluorescence
to those obtained using the RNAP holoenzyme from E. coli
(Figure 7).
DISCUSSION
We have presented a study of RbpA and CarD acting individually and together to stabilize mycobacterial transcription open complexes. Like CarD, we found that RbpA stabilizes RPo at the Mtb rrnAP3 promoter, albeit via a different kinetic mechanism. Using a stopped-flow fluorescence
assay that reports on open-complex formation in real time,
we observed that, compared to CarD, RbpA generates a
lower equilibrium fluorescence at saturating concentrations
and has a weaker apparent affinity for initiation complexes.
In addition, RpbA exhibits two observed rates (kobs,2 and
kobs,3 ) with appreciable fractional amplitudes in contrast
to the one dominant observed rate (kobs,3 ) detected in the
presence of CarD. The magnitudes of both of these rates
show monotonic and saturable acceleration with increasing
RbpA concentration. These results all suggest that the ki-
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As each factor stabilizes RPo and structural modeling suggests that they could both bind RP complexes concurrently
(15), we tested the effect of RbpA and CarD together on
open-complex stability. Since RbpA generates a lower fluorescence enhancement compared to CarD, we reasoned that
if RbpA competed with CarD for binding to the initiation
complex, the addition of both factors would lead to an intermediate enhancement. However, in the presence of both
factors at saturating concentrations, the equilibrium fluorescence fold change is actually greater than that for saturating CarD alone (Figure 4A).
If RbpA and CarD bind concurrently to the rrnAP3
promoter-RNAP complex, one expects to measure positive
linkage or cooperativity between the two factors as both
stabilize the same conformation, namely open complex. To
test this model, we performed titrations of each factor in the
presence of the other factor at saturation and asked whether
we observed a shift in Keff relative to each factor alone. Indeed, titrating RbpA in the presence of 1 M CarD results
in a Keff (48 ± 10 nM) that is lower than that obtained from
a titration of RbpA alone (177 ± 23 nM), suggesting that
the presence of CarD increases the binding affinity of RbpA
to transcription initiation complexes (Figure 4B). Likewise,
a CarD titration in the presence of 2 M RbpA results in a
Keff (16 ± 2 nM) that is lower than a titration of CarD alone
(73 ± 4 nM), indicating that the presence of RbpA allows
CarD to interact with the complex at lower concentrations
(Figure 4C). This observation of heterotropic, positive linkage between RbpA and CarD demonstrates that they act
cooperatively on transcription initiation complexes at the
Mtb rrnAP3 promoter.
To provide an overall quantification of the observed linkage, we consider the thermodynamic cycle involving four
states: (i) RP, (ii) RP-CarD, (iii) RP-RbpA and (iv) RPRbpA-CarD, where RP represents promoter-bound RNAP
and includes an ensemble of states (i.e. RPc , RPo and all
intermediates) (Figure 4D). We globally fit the four experimental binding curves (CarD titrations ± 2 M RbpA and
RbpA titrations ± 1 M CarD) to a model where each factor has an effective affinity (Keff ) and linkage is captured
by the cooperativity factor ␣ (Supplementary Figure S5).
In the context of this model, the effective affinity of a factor in the presence on the other is given by Keff /␣. A fit of
the data with this three-parameter model results in values
of Keff,CarD = 66 ± 7 nM, Keff,RbpA = 175 ± 20 nM and ␣ =
3.8 ± 0.4. All four Keff values are within error of the values
obtained from fits of the individual titrations alone. Thus, a
simple model of cooperativity captures the positive linkage
between RbpA and CarD at initiation complexes.
Given that RbpA and CarD cooperatively stabilize open
complex, we hypothesized that they would also stimulate
transcription above the level of either factor acting alone.
To test this hypothesis, we performed an aborted transcription assay in which we measured the production of a three
nucleotide transcript from the rrnAP3 using a dinucleotide
primer (GpU) and a radio-labeled UTP. RbpA and CarD

acting individually at saturating concentrations stimulate
transcription of the 3-nt product over RNAP alone (Supplementary Figure S6). The presence of both factors results in a
further increase in 3-nt production over either factor acting
alone. These results are consistent with a model in which
CarD and RbpA cooperatively stabilize a transcriptioncompetent open complex.
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netic mechanism by which RbpA stabilizes mycobacterial
open complexes is distinct from that of CarD.
A two-step reversible model (R+P ↔ RPc ↔ RPo ) can
capture the kinetics of open complex formation under certain conditions. However, this model is almost certainly
an over-simplification of the real mechanism. For example, we have shown that kinetic traces of open complex formation by MboRNAP alone exhibit three observed rates
which cannot be accounted for in the context of the twostep reversible model. Furthermore, the kinetic mechanism
of open-complex formation by E. coli RNAP includes multiple closed and open intermediates (1,28–30) and transcription with mycobacterial RNAP has previously been analyzed with E. coli derived models (31). Therefore, the kinetic mechanism of mycobacterial open complex formation
likely involves intermediates between the initial closed complex and the final transcription-competent open complex.
We hypothesize that the distinct kinetic signatures of RbpA
and CarD are due, in part, to their differential affinities with
these intermediates. Furthermore, intermediate open complexes may have different fluorescence properties leading

to the differential enhancements observed between RbpA
and CarD. Another possible way to expand the two-step
reversible model to account for the complexity of the observed kinetics is to add the interaction of these factors with
free polymerase in the absence of DNA. RbpA is known to
bind sigma factor, core RNAP and holoenzyme (14,15,22)
and CarD binds to RNAP (10,18,19). In light of these possibilities, analysis using kinetic models that include multiple intermediates and DNA-independent assembly states
remains an ongoing research direction (Supplementary Figure S4B).
In addition to studying each factor individually, we performed experiments using both RbpA and CarD together.
Stopped-flow titrations indicated that the presence of one
factor increases the apparent affinity of the other factor to
the RNAP-promoter complex, demonstrating positive linkage between the two factors. The observation of positive
linkage demonstrates that not only can CarD and RbpA
bind the initiation complex simultaneously, but also that
they do so cooperatively. Cooperativity between transcription factors has been observed for transcription initiation
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Figure 4. RbpA and CarD bind to initiation complexes cooperatively. (A) Fluorescent fold change as a function of time for DNA alone (black), MboRNAP
alone (green), 2 M RbpA (red), 1 M CarD and 2 M RbpA + 1 M CarD (magenta). (B) Normalized fluorescence fold-change as a function of RbpA
concentration in the absence (red) and presence (magenta) of 1 M CarD. (C) Normalized fluorescence fold-change as a function of CarD concentration
in the absence (red) and presence (magenta) of 2 M RbpA. (D) A thermodynamic cycle between apo-RP, CarD-bound RP, RbpA-bound RP and the
doubly-bound RP. Here, RP represents the total population of DNA-bound polymerase and includes RPc and RPo . The four titrations shown in (B) and
(C) were globally fit with three parameters: Keff,CarD , Keff,RbpA and a cooperativity factor ␣ which relates the ratio of Keff of a factor in the presence and
absence of the other. The fits are shown in (B) and (C) along with the values for Keff . The fit cooperativity factor, ␣ = 3.8 ± 0.4, corresponds to a G =
–RTln(␣) = −3.3 kJ/mol (−0.8 kcal/mol). Two to three shots were collected for each condition and error bars represent standard error of the mean.
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Figure 5. Kinetic effects of cooperative stabilization. (A) The intermediate
phase (kobs,2 ) increases monotonically with concentration for either RbpA
titrated in the presence of CarD (red) or CarD titrated in the presence of
RbpA (blue). (B) The slowest phase (kobs,3 ) increases monotonically with
concentration for either RbpA titrated in the presence of CarD (red) or
CarD titrated in the presence of RbpA (blue). Two to three shots were
collected for each condition and error bars represent standard error of the
mean.

(32–34), elongation (35) and termination (36). This cooperativity can lead to activation or repression and affords
complexity and tunability to gene regulation (37). Furthermore, cooperativity amongst transcription factors can occur between the same factors (homotropic) or different factors (heterotropic) (32–34). In Mtb specifically, cooperative
binding of DevR factors to their DNA sites plays a role
in the activation of a regulon required for the induction of
dormancy in response to hypoxic conditions (38,39). However, to our knowledge the cooperative association of RbpA
and CarD is the first example of heterotropic cooperativity
between transcription factors that directly bind initiation
complexes to stabilize open complex.
When speculating about the mechanism of cooperativity
between RbpA and CarD, we consider two general possibilities that are not mutually exclusive: (i) a ‘direct’ mechanism
in which RbpA and CarD physically interact, so that the

presence of one factor provides an additional binding surface for the other; and (ii) an ‘allosteric’ mechanism where
the binding of one factor results in conformational changes
in the initiation complex that lead to higher affinity binding of the second factor (i.e. conformational selection). Although a ‘direct’ interaction between RbpA and CarD is
not predicted by structural modeling, we do not exclude the
possibility that direct interactions between the two factors
contribute to the observed positive linkage. In particular,
the location of RbpA’s core domain in the initiation complex is unknown and predicted to be in close proximity to
the C-terminal domain of CarD. The allosteric mechanism,
however, must contribute to the observed positive linkage
through conformational selection of RPo . RbpA and CarD
each must have a higher affinity to RPo than to RPc as they
both stabilize RPo . Thus, the binding of one factor shifts
the population of initiation complexes to the higher affinity
open-complex conformation(s), resulting in a lower Keff for
the other factor. Whether the allosteric mechanism of conformational selection accounts for all or just some of the
positive linkage remains an active area of investigation.
When studying the effect of both factors acting together
on the kinetics of open-complex equilibration, we noticed
a substantial acceleration in kobs,2 and kobs,3 , demonstrating
that the overall approach to equilibrium is faster compared
to either factor acting alone (Figures 5 and 6). Based on this
observation, we hypothesize that the interactions of both
factors with the initiation complex accelerate distinct forward rates on the pathway to open-complex formation. The
pathway to open complex determined with the E. coli system involves many structural intermediates including DNA
bending and wrapping, DNA unwinding and loading of the
template strand, assembly of the clamp/jaw domains and
closing of the clamp/jaw domains around the downstream
DNA (1,30). More specifically, the bending of downstream
duplex into the polymerase cleft has been linked with the
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Figure 6. The kinetics of equilibration are accelerated by the presence of
both factors. An amplitude-averaged rate is plotted as a function of factor
concentration for RbpA titrations (red) and CarD titrations (blue) and in
the absence (solid lines) and presence (dashed lines) of the other factor at
saturation. Two to three shots were collected for each condition and error
bars represent standard error of the mean.
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Figure 7. The kinetics of open complex formation for MboRNAP in the
presence of RbpA and CarD resemble those for EcoRNAP on the rrnAP3
promoter. Fluorescence time courses collected with RbpA and CarD (solid
red) dramatically increase the fluorescence signal at equilibrium and accelerate the kinetics compared to RNAP alone (green). The kinetics of
MboRNAP with RbpA and CarD approaches that of 85 nM EcoRNAP
(dashed red), which equilibrates to the same fluorescence fold-change (1.4).

nucleation of DNA melting (30). The basic linker of RbpA
interacts with the extended −10 motif (15) and tryptophan
85 in CarD’s DNA-binding domain interacts with the upstream edge of the transcription bubble at the junction between the double-stranded −12 base-pair and the singlestranded −11 position (11,18), precisely where nucleation of
promoter melting occurs (Figure 1B). Taken together, these
structural considerations suggest the possibility that RbpA
and CarD cooperate to facilitate promoter bending and nucleation of promoter-melting. This combined mechanism of
RbpA and CarD may be similar to the induced-fit mechanism of bending and opening used to describe the effect
of the transcription factor Mtf1 on mitochondrial opencomplex kinetics (40). Importantly, this model is also compatible with the proposed conformational-selection mechanism in which CarD acts to prevent bubble collapse after
the promoter DNA has been opened (11,12,18).
We also show that RbpA and CarD jointly lead to
transcriptional dynamics for MboRNAP similar to E. coli
RNAP (Figure 7). This result leads us to speculate that
RbpA and CarD play the role of general transcription factors for Mtb, at least at housekeeping  A -dependent promoters. In light of the cooperativity between the two factors,
the preference of RbpA (14,22) for  A and  B holoenzymes
and the presumed sigma-independence of CarD raise interesting questions regarding the regulatory logic behind each
of these essential factors. For example, the cooperativity
may provide a mechanism for the preferential recruitment
of CarD to RbpA-dependent promoters. Alternatively, the
association of CarD with other sigma factors may lead to
RbpA binding at non- A or  B promoters. In addition, our
data predict that the overall effect on open complex equilibrium at initiation complexes containing both factors will be
greater than those containing either factor alone. This effect
could lead to the different regulatory outcomes depending
on which factors are present at specific promoters.
In summary, we describe the kinetics and concentration dependencies of RbpA and CarD acting individually
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Supplemental Sequence
Non-template strand of 150 bp Mtb rrnAP3 promoter fragment used in this study (genome coordinates 1471577 – 1471727). The -10 and -35 boxes (blue), +1 start site (red), and +2 T modified
with a C6-amine and labeled with Cy3-NHS (green) are indicated {GonzalezyMerchand:1996va}.
GGCGACGGTCACCTATGGATATCTATGGATGACCGAACCTGGTCTTGACTCCATTGCCGGATTTGTATTAGACTGGCAGGGTTGCCCCGAAGCGGGCGGAAACAAGCAAGCGTGTTGTTTGAGAACTCAATAGTGTGTTTGGTGGTTTCA
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Supplemental Figure 1: RbpA R79A mutant is defective in open complex stabilization. The
fluorescence fold change over RNAP alone is shown for 2 µM WT RbpA, 2 µM R79A RbpA,
and 1 µM WT CarD. Error bars represent standard error of the mean. The inset shows the raw
time traces for 10 nM DNA alone (black dashed), 225 nM RNAP and 10 nM DNA (black), and
225 nM RNAP, 10 nM DNA, and 2 µM R79A RbpA (red).

95

Supplemental Figure 2: Fractional amplitude dependence on factor concentration for each
factor individually. Triple exponential fits to RbpA and CarD time courses exhibit different
fractional amplitudes. For both RbpA (dashed lines) and CarD (solid lines), the amplitude of the
fastest phase (kobs,1, blue) drops below 10% as the concentration of each factor approaches 1 µM.
Unlike CarD, the fractional amplitudes of RbpA fits are not dominated by the slowest phase (kobs,
3, red); instead, the intermediate phase (kobs,2, green) exhibits a more significant contribution.
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Supplemental Figure 3: Concentration dependence of the observed rates with factor concentration plotted in log scale. (A) The second observed rate (kobs,2) as a function of the concentration of CarD (blue) and RbpA (red). (B) The third observed rate (kobs,3) as a function of the
concentration of CarD (blue) and RbpA (red). (C) The second observed rate (kobs,2) as a function
of the concentration of CarD in the presence of 2 µM RbpA (blue) and of the concentration of
RbpA in the presence of 1 µM CarD (red). (D) The third observed rate (kobs,3) as a function of the
concentration of CarD in the presence of 2 µM RbpA (blue) and of the concentration of RbpA in
the presence of 1 µM CarD (red).
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Supplemental Figure 4: Models for factor mechanisms. (A) The binding of RNAP polymerase
(R) to the promoter (P) creates the closed complex (RPc) which can isomerize to open complex
(RPo). A ligand (L) that may represent CarD or RbpA or any other factor, may bind to either RPc
or RPo. Isomerizations between RPc and RPo may also occur in their ligand-bound states (RPc·L
and RPo·L). (B) As described in the text, the observed kinetics dictate that a more complicated
kinetic scheme be considered to account for the data. Here, we illustrate two possible additions
to the scheme to consider. The first is the addition of the state (R·L + P) which represents the association of either CarD or RbpA to free, promoter-unbound holoenzyme subunits. The R here
can be further expanded to specifically include contributions from core-, sigma-, and holoenzyme-bound complexes. The second is the explicit representation of intermediates (RPi) between
RPc and RPo as well as the possible complexes between these intermediates and CarD or RbpA
(RPi·L).
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Supplemental Figure 5: Distributions of global fit parameters for cooperative binding model. Data points were randomly selected with replacement and then fit with a cooperative binding
model with 3 parameters. The distributions of the affinity (Keff) of (A) CarD and (B) RbpA alone
to polymerase bound promoter complexes are shown along with (C) the cooperativity factor alpha. These distributions were fit with a gaussian to determine the both the mean and uncertainty
for each parameter based on the data.
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Supplemental Figure 6: Three nucleotide aborted transcription. The relative amount of 3-nt
product compared to that generated by MboRNAP holoenzyme alone is shown as a function of
the addition of CarD (2 µM), RbpA (2 µM), or both factors. Error bars represent standard errors
of the mean from 8 replicates. The inset shows a gel from one of the replicates and includes lanes
for each factor at both 1 µM and 2 µM as well as the combination of both factors at saturating
concentrations.
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Supplemental Figure 7: Fractional amplitude dependence on factor concentration in the
presence of both factors. The titration of RbpA in the presence of 1 µM CarD (dashed lines)
and the titration of CarD in the presence of 2 µM RbpA (solid lines) reveal similar trends in the
fractional amplitudes of the fastest (kobs,1, blue), intermediate (kobs,2, green), and slowest (kobs,3,
red) phases. Interestingly, CarD titrations performed in the presence of RbpA no longer show a
dominance of the slowest phase (kobs,3).
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Epilogue
The work presented in the chapter was extended to include mutants of CarD and RbpA.
Titrations of RbpA were performed in the presence of 1 µm CarD-W85A, and titrations
of CarD were performed in the prensence of 2 µM RbpA-R79A. Less positive linkage
was observed when RbpA was titrated with 1 µM CarD-W85A (Figure 1). This result is
intuitive, since CarD-W85A exhibits reduced ability to stabilize open complexes and
RbpA’s linkage must in part arise from conformational selection to the open complex.
Surprisingly, titrations of CarD performed in the presence of RbpA-R79A showed
negative linkage, indicating that the presence of RbpA-R79A reduced the affinity of
CarD to transcription initiation complexes (Figure 2). These results suggest the
possibility that RbpA-R79A interferes with CarD binding, whereas wild-type RbpA does
not. These titrations were only performed once, and more repetitions are needed to verify
these preliminary observations.

One future direction that remains unexplored is a more general model of cooperativity. I
have analyzed the positive linkage between CarD and RbpA in terms of ternary complex
formation. This linkage must arise in part from conformational selection, since each
factor stabilizes the open complex, and each factor has a higher affinity for the open
complex. However, there may be additional components that contribute to the observed
linkage, for instance direct interactions between CarD and RbpA within the complex.
This more complex model of cooperativity can be visualized as a cube (Figure 3), and
represents a more general kinetic scheme which describes factor-dependent opencomplex stabilization in mycobacteria.
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Figure 1. Titration of RbpA in the presence of CarD-W85A. These traces indicate a
half-maximal effect for RbpA ~ 50 nM, indicating reduced positive linkage compared to
titrations of RbpA performed in the presence and absence of wild-type CarD.
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Figure 2. Titration of CarD in the presence of RbpA-R79A. These traces indicate a
half-maximal effect for CarD ~ 100 nM, indicating negative linkage compared to
titrations of CarD performed in the presence and absence of wild-type RbpA.
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Figure 3: General model for CarD-RbpA-RPc-RPo cooperativity. CarD and RbpA
binding and linkage to closed and open complexes can be modeled as a cube. This model
includes cooperativity factors α, β, and γ which describe various typics of linkage
between binding and conformational exchange as indicated above.
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Chapter 5
Kinetic Models for Factor-Dependent
Stabilization of Mycobacterial OpenComplexes
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Introduction and Background
We have studied the kinetics of mycobacterial transcription open-complex formation
using Cy3-labeled DNA and stopped-flow fluorescence spectroscopy. We have shown
that CarD stabilizes mycobacterial open complexes using a two-tiered concentrationdependent kinetic mechanism, which can be semi-quantitatively described by a 5-state
model (1). We have also shown that RbpA stabilizes mycobacterial open complexes
using a kinetic mechanism distinct from that of CarD, and that RbpA exhibits two
saturable observed rates for the intermediate and slow phases (2). In order to aid our
interpretation of the experimental data, I have evaluated kinetic models that could
potentially be used to account for the trends in observed rates. I have focused this
evaluation on two objectives as described below.

Objective 1: Evaluate the sensitivity and uncertainty in the published 5-state model used
to describe CarD stabilization of mycobacterial open complexes. I have performed a
detailed, local exploration of the rate constants published for the 5-state model. I have
identified rate constants that are well constrained as well as pairs of rate constants which
are poorly constrained. For rate constants that are well constrained, I have quantitatively
determined the ranges of values that qualitatively fit the experimental data.

Objective 2: Evaluate alternate kinetic models that could potentially reproduce observed
trends for CarD and RbpA. For CarD, I have evaluated and excluded two 4-state schemes
that are unable to capture the experimental trends. For RbpA, I have identified a kinetic
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scheme that is able to qualitatively reproduce the monotonic and saturable increase in
intermediate and slowest rates, with semi-quantitative agreement to experimental data.

Objective 1: Estimate sensitivity and uncertainty in rate constants of the reported
5-state kinetic scheme describing CarD stabilization of open complex.
We recently reported a working model for CarD stabilization of open-complexes that
consists of a 5-state kinetic scheme (Figure 1). We estimated values for all 10 rate
constants in this scheme by inspecting their ability to qualitatively capture empirical
trends. However, we do not know the relative importance of each of these parameters,
and the extent to which they can vary.

(1) We do not know if the set of 10 rate constants originally proposed uniquely
describes the trend in observed rates. In some cases, kinetic schemes with very
different sets of rate constants are capable of producing the same concentrationdependent trends in observed rates. To this end, I have investigated whether other
combinations of rate constants can reproduce the experimentally observed trends
in observed rates.

(2) We do not know which rates are more important than others with regard to
recapitulating the trends in observed rates. In certain kinetic models, rate
constants can vary over wide ranges without affecting the ability of the model to
describe the data. In other cases, particular rate constants may be tightly
constrained and even slight variation can dramatically affect the ability of the
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model to describe the data. To this end, I have identified which rate constants in
the 5-state model can vary over wide ranges, and which rate constants are well
constrained.

My approach is to compare eigenvalues to observed rates to quantify uncertainty in our
estimation of model parameters, and characterize the manner in which rates (or pairs of
rates) affect the concentration-dependent relaxations of the system. An alternative
approach is to choose rate constants and simulate timecourses assuming fluorescence
enhancement for each state. Programs such as KinTek Explorer can perform global
fitting of raw data in order to identify ranges of rate constants that are able to reproduce
the observed trends (3-5).

Currently, I have been unable to reproduce the raw

fluorescence timecourses using a 3-step reversible model coupled to factor-binding,
therefore those results are not presented here.
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Figure 1: Kinetic model of CarD stabilization of mycobacterial open complexes. The
values of the rates used to generate the plots in the main text are as follows: k 1 = 0.3 nM1 -1
s , k 2 = 75 s-1, k 3 = 0.0005 s-1, k 4 = 0.004 s-1, k 5 = 0.3 nM-1s-1, k 6 = 450 s-1, k 7 = 0.3 nM1 -1
s , k 8 = 1.4 s-1, k 9 = 0.02 s-1, k 10 = 0.0005 s-1.
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METHODS
A system of differential equations was used to describe the manner in which the
populations of each of the 5-states change with time and concentration.

A Matlab

program was used to calculate eigenvalues of this matrix for a given set of rate constants
and concentrations, where each nonzero eigenvalue represents a (potentially) observable
rate.

Using the reported rate constants, I plotted all 5 eigenvalues of the system for 0 < [CarD]
< 10 µM, with a fixed [RNAP] = 225 nM. Each of the 4 non-zero eigenvalues showed
unique dependencies on [CarD]. Interestingly, I found that a single eigenvalue (eig2) was
approximately the same magnitude as k obs,3 . Additionally, eig2 exhibited the same nonmonotonic dependence on [CarD] as k obs,3 , namely deceleration at low [CarD] and
acceleration at higher [CarD].

Furthermore, calculations of eig2 vs. [CarD] performed at different [RNAP] qualitatively
reproduced empirical dependence of k obs,3 on [RNAP]. Specifically, at lower [RNAP],
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we observe less acceleration with increasing [CarD] (see below). Taken together, these
results suggest that eig2 can be compared to k obs,3 in order to evaluate the ability of model
parameters to describe empirical trends.

Figure 2: A single eigenvalue captures non-monotonic dependence of observed rate on
concentrations of CarD and RNAP. (Top) Experimental data for kobs,3 vs. [CarD]
measured at two different concentrations of [RNAP] (1). (Bottom) Eig2 vs.
[CarD] calculated at different concentrations of [RNAP].
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I applied several constraints when considering whether or not a parameter set could
qualitatively account for the experimental data:
1) For [CarD] = 0, 0.003 s-1 <= k obs,3 <= 0.006 s-1
2) 25 nM < [CarD] for minimum k obs,3 < 150 nM
3) For [CarD] = 10 µM, 0.003 s-1 <= k obs,3 <= 0.015 s-1

Figure 3: Constraints for qualitatively reproducing CarD-dependent observed
kinetics. First, for [CarD] = 0, 0.003 s-1 ≤ k obs,3 ≤ 0.006 s-1. Second, 25 nM < [CarD]
for minimum k obs,3 < 150 nM. Third, for [CarD] = 10 uM, 0.003 s-1 ≤ k obs,3 ≤ 0.015 s1
.
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To examine the sensitivity and uncertainty of parameters within the 5-state model, I
evaluated the effect of varying individual rate constants on an eigenvalue vs. [CarD]. To
do this, I apply a scaling factor to one of the rates, and plot the eigenvalue vs. [CarD]
overlaid with the experimentally-measured k obs,3 vs. [CarD] in order to visually inspect
how the model compares to the data. To quantify goodness-of-fit, I calculate the sumsquared residual error (SSE) as a function of the magnitude of the scaled rate constant. I
applied scaling factors to vary a rate constant over 5 orders of magnitude (i.e. 0.001*k to
100*k), as well as finer scaling (i.e. 0.1-2.5) to examine how global versus local variance
relates to SSE. For instances in which the SSE was “low” (≤ 1 x 10-5), the fit was
considered to quantitatively describe the trend within error, and the SSE cutoff was used
to estimate uncertainty in the rates as shown below.

In addition to k 1 and k 2 , which are the on- and off- rates for RNAP-promoter binding,
there are 28 pairs of rates that need to be studied in order to fully characterize all of the
parameters of the 5-state model. This is because for any of the 8 rates (k 3 – k 10 ) that are
part of the scheme’s thermodynamic cycle, when one rate constant is varied another rate
must also vary in order to maintain detailed balance. To study how pairs of rates may be
related, I evaluated all 28 pairs of rate constants twice (scaling one over 5 orders of
magnitude and calculating the other member of the pair, as well as the converse), and
identified parameter sets that were able to reasonably describe the experimental data.
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Results
The ability of the model to reproduce experimental trends depends on both k 1 and k 2
I have studied the effect of independently varying k 1 (on-rate of RNAP to promoter) and
k 2 (off-rate of RNAP from promoter) over 5 orders of magnitude. The plots look the
same as what is shown for the titration of [RNAP] (Figure 2), indicating that for this
particular trend, the fraction of bound promoter is more important than the magnitudes of
the on- and off-rates themselves.

Pairs of on- and off-rates of CarD binding to the same state are poorly-constrained
When scaling/calculating a pair of rate constants over a large range, in some instances I
have observed almost no change in the plot of eigenvalue vs. [CarD]. In these instances,
the rate constants themselves can vary widely over a large range with virtually no effect
on the goodness-of-fit. These rates correspond to the on- and off-rates of CarD to RP c (k 5
and k 6 ) and to RP o (k 7 and k 8 ). For these pairs of rates, it is not their absolute magnitude
that matters, but rather their ratio.

One example of this can be seen when scaling k 5 (on-rate of CarD to RP c ) and
calculating k 6 (off-rate of CarD from RP c ) in order to maintain detailed balance. In this
case, the plots of eig2 vs. [CarD] for each parameter set look virtually the same even
though the rates are being varied over 5 orders of magnitude (Figure 4). Interestingly, the
SSE indicates an improvement in fit as the rate is increased, suggesting that the rate
constants themselves do actually affect the shape of the curve. The improvement in SSE
is modest at best when compared to the improvement in SSE observed for other pairs of
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rate constants, and is only bounded on the lower end. However, this improvement is
imperceptible in the plot of eig2 vs. [CarD], demonstrating that the observation of a
decreasing SSE needs to drop below a meaningful number that is representative of a good
fit to the data.

All other pairs of rate constants in the cycle (besides pairs of on- and off-rates of CarD to
the same state) are well constrained
An example of a well-constrained rate pair is the result of scaling k 5 over 5 orders of
magnitude and calculating k 3 to maintain detailed balance (Figure 5, top). In this case, the
plot of eig2 vs. [CarD] changes dramatically as the rates are scaled. Some of the curves
overlay with the experimental data within error. These curves have an SSE < 10-5, and
this cutoff can be used to estimate uncertainty in a given rate (Figure 5, bottom).

One pair of rate constants (k 3 and k 10 ) has at least two non-unique, well-constrained
values that provide good fits
I found that using 1/SSE instead of SSE made it easier to visualize the error, and in this
case a “good fit” is 1/SSE > 105 (instead of SSE < 10-5). When k 3 and k 10 were varied
together, there are multiple, separable values that each provide good fits to the data. This
can easily be seen when plotting 1/SSE versus k 3 (Figure 6, top) and 1/SSE versus k 10
(Figure 6, bottom).
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Figure 4: Pairs of on- and off-rates for CarD to/from the same state are poorly
constrained. (Top) When k 5 is varied with k 6 , the rates can change over 5 orders of
magnitude without any perceptible change in eig2 vs. [CarD]. (Bottom) Plot of SSE vs.
k 5 shows that the fit slightly improves as k 5 increases, however the improvement is
imperceptible in the plot of eig2 vs. [CarD].
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Figure 5: Example of well-constrained pairs of rate constants. (Top) When k 5 is scaled
over 5 orders of magnitude and k 3 is calculated to maintain detailed balance, the shape of
eig2 vs. [CarD] changes dramatically. Some of these curves describe the experimental
data within error, and others do not. (Bottom) The plot of SSE vs. k 5 shows that an SSE
< 10-5 provides a reasonable range for k 5 , where the optimal value is determined at the
minimum SSE.
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Figure 6: Example of a well-constrained, non-unique pair of rate constants. When k 3
and k 10 are scaled together, two different combinations of rate pairs fit the experimental
data very well. 1/SSE is used to better visualize error in the data, and in this case a peak
over 105 indicates a good fit. (Top) 1/SSE vs. k 3 indicates 2 separable peaks, each of
which represent sets of rate constants that fit the data well. (Bottom) 1/SSE vs. k 10
indicates 2 separable peaks, each of which represent sets of rate constants that fit the data
well. The two different combinations of k 3 and k 10 represented by each set of peaks are
shown in boxes in black and blue text.
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Summary and Future Directions
The results are summarized below (Figure 7). In some cases, the pair of rates is poorly
constrained (red squares, below), since they can be varied over several orders of
magnitude without affecting the goodness-of-fit. In these cases, the ratio of the rates is
more important than their absolute values. In all other cases, the pair of rates were well
constrained qualitatively according to criteria described above (yellow squares, below)
and in some cases described the experimental data very well (SSE ≤ 10-5, green squares,
below).

Figure 7: Graphical summary of scaling all 28 pairs of rate constants in the
thermodynamic cycle. Scaled rates are shown on the top row, and calculated rates are
shown on the left column. Red squares indicate poorly constrained rate pairs, yellow
squares indicate well-constrained rate pairs, and green squares indicate good fits (SSE <
10-5). The bold outlines are for k 3 and k 10 , which have 2 well constrained, non-unique
sets.
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The model below summarizes ranges of each rate constant that can be used to
qualitatively describe the CarD trend (presented as mean and standard deviation). These
were calculated by averaging the mean values of an individual rate when calculated from
every other scaled rate pair that was well constrained.

Figure 8: Summary of estimates of rate constants and uncertainty. Best estimates for
each of the rate constants are shown above along with their estimated error. For k 3
(opening in the absence of CarD) and k 10 (closing in the presence of CarD), two different
pairs of rate sets could each fit the data equally well (corresponding pairs are shown in
black or blue).

For future work, it would be efficient to utilize a program that could explore a wider
range of rate space so that combinations of rate constants far outside of the starting rate
set can be evaluated in an efficient manner. Such approaches have been used to evaluate
kinetic models using Mathematica programs (6).

121

Objective 2: Evaluate alternative kinetic schemes for CarD and RbpA.
To this point, we have only considered in detail one kinetic scheme to describe the
mechanism of RP o stabilization by CarD. It is possible that other schemes of equal or
lesser complexity could potentially be used to capture empirical trends. Furthermore, we
have not proposed a kinetic scheme that can potentially be used to account for RbpA. To
this end, I have evaluated alternative kinetic schemes with regard to their ability to
reproduce experimentally observed trends.

My approach had been to (1) identify alternative kinetic schemes other than the 5-state
model that could also potentially be used to describe factor-dependent stabilization of
RP o , and (2) calculate eigenvalues for these schemes across a range of concentrations and
rate constants to determine which, if any, could be used to reproduce observed trends.
These models are evaluated using Matlab to calculate eigenvalues as a function of ligand
concentration. Priority has been given to testing models with fewer than 5 states to see if
they are capable of reproducing experimental trends.
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Results
Non-monotonic CarD data can be reproduced using a 4-state cycle, but this cannot
account for [RNAP] dependence

Figure 9: A 4-state thermodynamic cycle reproduces non-monotonic trend in observed
rates, but cannot account for [RNAP] dependence.

I have been able to qualitatively reproduce the trend in non-monotonic observed rates
using a kinetic scheme simpler than the 5-state model. Specifically, the non-monotonic
trend can be reproduced using only a 4-state cycle in which conformational exchange is
linked to ligand binding. This classic cycle represents two general pathways of ligand
binding to substrate, namely conformational-selection and induced-fit. However, while
this scheme can reproduce the non-monotonic dependence of k obs,3 on [CarD], it needs
more states in order to account for the [RNAP]-dependence, and thus cannot reproduce
all of the experimentally-observed trends.
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A linear 4-state mechanism cannot account for CarD data
An induced-fit model is capable only of increasing rates with ligand concentration,
therefore it cannot account for CarD data. Conversely, conformational selection is
capable of producing increasing or decreasing observed rates, depending on the relative
values of the rate constants in the model. Since a linear 4-state conformational-selection
kinetic scheme has the potential to exhibit deceleration and acceleration, I have evaluated
this model with regard to its ability to exhibit both (a non-monotonic trend) with
increasing [CarD]. I have explored ranges of rates that exhibit both increasing and
decreasing rates, however so far using this scheme I cannot reproduce the non-monotonic
dependence of k obs,3 on [CarD] (Figure 10).

A 4-state mechanism of conformational-selection and induced-fit can potentially account
for RbpA data
Using a 4-state scheme in which conformational-selection is followed by induced-fit, I
have identified a kinetic scheme that semi-quantitatively reproduces the trend in multiple
observed rates with increasing [RbpA] (Figure 11). This scheme involves a preequilibrium of the RNAP-promoter complex, followed by preferential RbpA binding
(conformational-selection), followed by conformational exchange in the presence of
ligand (induced-fit). Interestingly, this scheme suggests the possibility that RbpA
associates with more than one state. This scheme can serve as a starting point from which
to build our understanding of how RbpA stabilizes mycobacterial open complexes.
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A

B

C

Figure 10: A 4-state linear mechanism is unable to reproduce a non-monotonic trend in
observed rate. (A) 4-state linear kinetic scheme. (B) With a slow pre-equilibrium and fast
binding, only deceleration is observed with increasing [CarD]. (C) With a fast preequilibrium and slow binding, either acceleration or deceleration can be observed with
increasing [CarD], depending on [RNAP].
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A

B

Figure 11: A 4-state linear scheme which incorporates conformational selection and
induced fit can account for RbpA’s trend in observed rates. (A) Kinetic scheme. (B) Eig2
and Eig3 vs. [RbpA] semi-quantitatively agree with experimentally-observed results.
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Summary and Future Directions
In summary, I have presented a quantitative evaluation of multiple kinetic schemes with
regard to their ability to reproduce empirical trends in CarD and RbpA data. Schemes
with more states (5 or more) should be evaluated with regard to their ability to reproduce
trends. For these studies it will be useful to use a more sophisticated computational
approach that explores a larger rate space in a more efficient manner (6).
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Chapter 6
Promoter Escape
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Introduction
The flux of transcription from a given promoter depends on all phases of transcription
initiation, including promoter-binding, promoter-opening, nucleotide incorporation, and
promoter escape. The stability of these states and the rates of conversion between them
represent quantitative biophysical parameters that can be used to understand
transcriptional flux at a mechanistic level.

We have used an ensemble fluorescence assay to study CarD stabilization of
mycobacterial transcription open complexes. These studies showed that CarD’s kinetic
mechanism of open-complex stabilization is concentration-dependent and is consistent
with a model in which at low concentrations, CarD stabilizes RP o by conformationalselection and at high concentrations, CarD stabilizes RP o by induced-fit. These studies
provide a useful quantitative framework to understanding the initial stages of
transcription initiation.

To use this model to understand CarD’s overall effect on

transcriptional flux, I sought to measure the effect of CarD on NTP-dependent processes
such as nucleotide incorporation and promoter escape by using the ensemble fluorescence
assay in the presence of NTPs.
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Results and Conclusions
Dilution due to symmetric mixing has different effects on pre-assembled MboRNAP- and
EcoRNAP-promoter complexes

Initial experiments were designed using standard equal-volume mixing in which one
syringe contained pre-equilibrated MboRNAP-promoter complexes, and the other syringe
contained buffer, competitor (dsDNA), or competitor and NTP’s (Figure 1). When the Fsyringe contained pre-mixed MboRNAP/CarD/Cy3-promoter DNA, and it was mixed
with excess dsDNA (100 bp consensus promoter), the fluorescence level gradually
decreased over the course of 20 min (Figure 1, green trace). When this F syringe was
mixed with dsDNA/NTP’s, a slight increase in fluorescence was observed in the first 5
seconds, followed by a dramatic multi-exponential decrease in fluorescence intensity that
equilibrated over the course of 20 minutes (Figure 1, red trace). At first glace, one might
be compelled to interpret the green dsDNA trace as a measure of the rate of dissociation,
and the red dsDNA/NTP trace as a measure of dissociation combined with promoter
escape. However, when this same F syringe was mixed with buffer alone, the
fluorescence intensity showed an increase over time that equilibrated over the course of
20 min (Fig 1, blue trace). This result suggests that when the protein/DNA mix is diluted
two-fold, the proteins re-equilibrate with the DNA over the course of 20 min. Therefore,
it is difficult to interpret the traces with competitor and/or NTP’s as solely reporting on
dissociation and/or promoter escape, because these traces likely include some reequilibration of the system.

131

Figure 1: Dilution-dependent dissociation/re-equilibration must be accounted for
when studying dissociation and promoter escape by MboRNAP. Pre-equilibrating
MboRNAP, CarD, and promoter DNA and then performing an equal-volume mix with
buffer (blue), dsDNA competitor (green) or dsDNA and NTPs (red) each show different
time courses over 20 minutes. Importantly, the buffer trace indicates that the MboRNAPCarD-promoter complexes must re-equilibrate after dilution due to mixing, which is an
effect that must be accounted for when analyzing dissociation and single-turnover
promoter escape.
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Using symmetric mixing, pre-equilibrated RNAP-promoter complexes were mixed with
dsDNA +/- NTPs (Figure 2). Final reaction concentrations were 10 nM Cy3-DNA, 225
nM MboRNAP, 1 µM CarD, 400 nM dsDNA competitor, and 150 µM NTP. In the
absence of CarD, complexes mixed with dsDNA appear to be competitor-resistant over
10 minutes (Figure 2, blue trace), and in the presence of dsDNA and NTPs (Figure 2,
green trace) there appears to be a slight decay over time but almost no difference from the
trace with dsDNA only. In the presence of CarD, complexes mixed with dsDNA (Figure
2, red trace) appear competitor-resistant but a gradual decay can be observed over the
course of 10 minutes (k obs = 0.0013 s-1). When mixed with dsDNA and NTPs (Figure 2,
yellow trace), a decay over the course of 10 minutes can be clearly distinguished from the
red trace. The rate of this decay can be fit to a single-exponential decay from 1-600 (k obs
= 0.0043 s-1) or from 20-600 seconds to avoid the contribution of the initial part of the
trace (k obs = 0.0056 s-1). Alternately, the decay can be fit to a double exponential from
20-600 s (k obs,1 = 0.0163 s-1, k obs,2 = 0.0036 s-1) which captures a fast and slow
component of the decay. Interestingly, the dissociation kinetics of CarD-MboRNAPpromoter complexes in the presence of competitor DNA and NTP’s has been probed
using runoff transcription as a readout and was also described using a double exponential
(k obs,1 = 0.0290 s-1, k obs,2 = 0.00013 s-1) (1). Differences in the observed rates may be due
to many factors including their use of a different competitor (AC50 bubble promoter),
solution conditions (glutamate instead of chloride) and time-resolution of the assay (8
time points collected over the course of 200 minutes).
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Figure 2: Equal volume mixing in the presence and absence of CarD using dsDNA
competitor under single-turnover conditions. The traces shown above indicate
fluorescence fold change over 10 min, and include traces for Cy3-promoter alone (black),
MboRNAP-promoter complexes mixed with dsDNA (blue) and dsDNA+NTPs (green),
and CarD-MboRNAP-promoter complexes mixed with dsDNA (red) and dsDNA+NTPs
(yellow).
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The observation of an NTP-dependent decay that is distinguishable from the dsDNAdependent decay indicates that the signal is providing information on nucleotide
incorporation and promoter escape. Interestingly, a small increase in signal can be
observed over the first few seconds of the trace before the decay begins. This lag
preceding the signal decay was observed in previous experiments, and could be due to
fluorescence arising from intermediate states during initial nucleotide incorporation,
which precede the transition into elongation and subsequent reannealing of the
transcription bubble at the +2 to become double-stranded once again. Importantly, this
experiment did not include mixing the RNAP/promoter complexes with buffer alone,
which is an important negative control. Previous experiments (described above) suggest
that there is a dilution-induced dissociation that occurs with this system that must be
accounted for when measuring rates of dissociation and escape. It is therefore useful to
develop a method of performing these experiments that minimizes dilution-induced
dissociation.

Symmetric mixing performed using EcoRNAP indicate that EcoRNAP binds this
promoter with much higher affinity than MboRNAP, and forms a more stable RP o (2). As
a result, the two-fold dilution may not perturb the system enough to cause dissociation
and subsequent re-equilibration of EcoRNAP over time. To examine this system, I
studied reactions containing final concentrations of 10 nM Cy3-DNA, 42.5 nM
EcoRNAP, 400 µg/ml Heparin and NTP ranging from 25 µM to 1 mM. First, I mixed
EcoRNAP in the F syringe with DNA in the C syringe and collected a typical “melting”
curve and measure fluorescence increase over time (Figure 3, green trace). When pre-
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mixed EcoRNAP/promoter DNA was mixed with buffer, I found that the trace was
relatively flat and almost exactly as the same fluorescence level of where the melting
curve ended (Figure 3, black trace).

This is consistent with almost no dilution/re-

equilibration effect for the EcoRNAP system, which is in stark contrast the MboRNAP,
which re-equilibrates over the course of 20 min. When pre-mixed EcoRNAP/promoter
DNA complexes were mixed with Heparin (Figure 3, blue trace), the trace almost
overlays with that of the EcoRNAP/DNA mixed with buffer trace, suggesting that the
EcoRNAP transcription complexes are Heparin-resistant. This is consistent with previous
results indicating that EcoRNAP has a higher affinity and forms much more stable open
complexes at Mtb rrnAP3 than MboRNAP (2). I tested the effect of mixing RNAP/DNA
with Heparin/NTPs using [NTP] = 25, 250, and 1000 µM (Figure 3, yellow, orange, and
red traces respectively) and was able to observe faster decay with increasing NTP
concentration. The effect seems to saturate a concentration of [NTP]’s that is comparable
with previous studies using EcoRNAP at a different promoter (3). Plots of the observed
rate vs. [NTP] could be used to constrain kinetic models of EcoRNAP promoter escape
from the Mtb rrnAP3 promoter.
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Figure 3: Promoter escape by E. coli RNAP can be measured using equal volume
mixing under single-turnover conditions. EcoRNAP was mixed with Cy3-promoter to
collect a melting curve (green). A control traces indicated that EcoRNAP-promoter
complexes in one syringe mixed with buffer equilibrated to approximately the same
fluorescence fold change value (black). EcoRNAP-promoter complexes mixed with
Heparin (blue) almost overlay with buffer traces, demonstrating Heparin resistance that is
typical of stable open-complexes. In addition to Heparin, NTP’s were included at
concentrations of 25 (yellow), 250 (orange) and 1000 (red) µM, and these traces
exhibited decay that reports on the kinetics of promoter escape under single-turnover
conditions.
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Figure 4: Calibration of 10:1 asymmetric mixing using Cy3-labeled DNA. Traces
shown are 10 s of raw fluorescence intensity resulting from 10:1 mixes of buffer-buffer
(blue), buffer-DNA (teal), DNA-buffer (red) and DNA-DNA (green).
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Calibration of asymmetric 10:1 mixing using Cy3-DNA
To measure promoter escape using the mycobacterial transcription system, I had to
identify a strategy to observe competitor/NTP-dependent fluorescence decay even though
the MboRNAP’s affinity to promoter DNA will result in dissociation due to dilution upon
1:1 mixing. One way to mitigate the dilution effect, and thus minimize re-equilibration of
MboRNAP-promoter complexes upon mixing, is to perform asymmetric 10:1 mixing
experiments. This can easily be accomplished by replacing one of the 2.5 mL syringes in
the Applied Photophysics SX-20 with a 250 µl syringe. Care should be taken to increase
the total shot volume to at least 250 µl (For example, 230 µl F syringe + 23 µl C syringe
= 253 µl total shot volume), to ensure that enough fluid from the smaller syringe enters
the reaction cell of the instrument. Also, the pressure should be reduced to < 2 bar using
the control knob behind the instrument to avoid damaging the smaller syringe.

Calibration experiments using a 2.5 ml F syringe and a 250 µl C syringe were performed
to measure dilution effects. Four samples were tested (Figure 4), and the results are
summarized below:
F
Buffer
Buffer
DNA
DNA

C
Buffer
DNA
Buffer
DNA

Raw Signal (V)
0.358563
0.843319
5.516577
6.139301

Signal-Buffer
0
0.484757
5.158014
5.780738

% max (predicted)
0 (0)
8.4 (9.1)
89.2 (90.9)
100 (100)

These control experiments demonstrate that for the given experimental setup (2.5 ml Fsyringe, 250 µl C-syringe, shot volume ~ 250 µl, pressure < 2 bar), the experimentally
measured dilution of fluorescence signal almost exactly matches the predicted dilution
effects. Therefore, asymmetric 10:1 mixing offers a potential way to mix pre-equilibrated
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RNAP-promoter

complexes

in

the

large

volume

syringe

with

either

buffer/competitor/NTPs in order to collect measurements of dissociation and promoter
escape, while minimizing effects of dissociation due to dilution alone.

Dissociation and promoter escape in the absence of CarD
Asymmetric mixing performed with pre-mixed MboRNAP/promoter complexes in the Fsyringe and buffer in the C-syringe dramatically reduced the level of signal change upon
mixing compared to 1:1 mixing tests (Figure 5, black trace vs. Figure 1, blue trace).
There is a still a slight increase in signal over time, which suggests that even a dilution of
~9% is enough to cause dissociation and re-equilibration of MboRNAP/promoter
complexes. However, the magnitude of this much smaller than what is observed for equal
volume mixing, so this approach minimizes dilution-induced dissociation. In these
experiments, I tested Heparin as a competitor for RNAP. Heparin is a highly-negatively
charged molecule that binds RNAP with high affinity. It is considered a stronger
competitor than dsDNA for RNAP because it can potentially “strip” RNAP from
promoter-closed complexes. However, as a stronger competitor, the chances of RNAP rebinding the fluorescent promoter are less than if dsDNA were used as a trap.
Asymmetric mixing of MboRNAP/promoter DNA with 205 µg/ml and 818 µg/ml
Heparin resulted in rapid decay of fluorescence over the course of 10 minutes (Figure 5,
green and red traces). The rate of decay for 205 µg/ml and 818 µg/ml were very close,
indicating that 205 µg/ml was a saturating amount of competitor under these reaction
conditions.
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Figure 5: Dissociation and promoter escape by MboRNAP in the absence of CarD.
Using asymmetric 10:1 mixing with MboRNAP-promoter complexes in the larger
volume syringe, traces were collect mixing the complexes with buffer (black) to control
for dilution effects. Mixing MboRNAP-promoter complexes with Heparin at 205 µg/ml
(green) and 818 µg/ml (red) provide information on dissociation and also possibly
stripping of MboRNAP closed complexes. Mixing MboRNAP-promoter complexes with
Heparin and NTP’s (purple trace) provides information on nucleotide incorporation and
promoter escape, although aside from the initial lag it is difficult to distinguish this
information from the Heparin traces. Mixing MboRNAP-promoter complexes with
NTP’s in the absence of competitor (blue) provides information on nucleotide
incorporation and promoter escape in multi-turnover conditions, because this nonmonotonic and multiphasic curve is qualitatively discernable from the buffer control
(black).
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Figure 6: Promoter escape with CarD can be observed under single-turnover
conditions. Pre-equilibrated CarD-MboRNAP-promoter complexes were mixed with
buffer (black) as well as Heparin at 205 µg/ml and 818 µg/ml in order to study
dissociation. CarD-MboRNAP-promoter complexes were mixed with Heparin and
NTP’s at 45 µM (teal) and 455 µM (purple) to study nucleotide incorporation and
promoter escape in single-turnover conditions.
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Figure 7: Promoter escape with CarD can be observed under multi-turnover
conditions. CarD-MboRNAP-promoter complexes were mixed with buffer (black), and
NTP’s at 45 µM (yellow) and 455 µM (blue) in order to study nucleotide incorporation
and promoter escape in multi-turnover conditions.
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Table 1: Summary of observed rates of dissociation and promoter escape in the
presence of CarD.
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I performed experiments using pre-formed MboRNAP/promoter complexes mixed with
455 µM NTP’s in the presence and absence of a saturating amount of Heparin (205
µg/ml). In the absence of Heparin, I observed a trace that almost overlaid with the buffer
trace, however this trace was multiphasic (Figure 5, blue).

The trace increased in

fluorescence intensity for the first 30-60 seconds, decreased over the next 30-60 seconds,
and finally increased for the remaining 8 minutes of the trace. This NTP-dependent signal
is qualitatively distinguishable from the buffer trace, which indicates that promoter
escape

can

be

measured

in

multi-turnover

conditions.

Mixing

pre-formed

MboRNAP/promoter complexes with NTP’s and Heparin resulted in rapid decay of
fluorescence signal almost matching traces collected with Heparin alone (Figure 5,
purple). Interestingly, however, these traces include a lag before the decay. The
observation of the NTP-dependent lag indicates that these traces can potentially provide
information regarding nucleotide incorporation and promoter escape under singleturnover conditions.

Dissociation and promoter escape in the presence of CarD
I performed experiments using pre-formed CarD-MboRNAP-promoter complexes in
single- and multi-turnover conditions to study the effect of CarD on transcription
initiation (Summary of observed rates shown in Table 1). Single-turnover conditions
were studied using Heparin at 205 and 818 µg/ml, which resulted in almost identical rates
and extents of signal decay (Figure 6, red and green traces). These results indicated that
under the conditions studied, 205 µg/ml Heparin has a saturating effect with regard to its
ability to serve as a trap. Mixing CarD-MboRNAP-promoter complexes with 205 µg/ml
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Heparin and 45 µM NTPs resulted in a trace that was almost identical to those of Heparin
alone (Figure 6, teal trace), indicating that an NTP-dependence could not be obviously
discerned at this concentration and therefore the observed signal is most likely arising
entirely from Heparin-dependent stripping/dissociation. However, when the NTP
concentration was increased to 455 µM, an initial increase in fluorescence for the first
few seconds was followed by a biphasic decay (Figure 6, pink trace) that was
qualitatively faster than Heparin-only decays, indicating that under these conditions the
NTP-dependent trace can be used to extract information on initial nucleotide
incorporation and promoter escape.

I examined the effect of mixing RNAP/CarD/promoter with NTPs in the absence of
competitor in order to study this process under multi-turnover conditions. At low
concentrations of NTP (45 µM) I observed a non-monotonic multi-phasic trace that
slightly increased for ~1 min and then slightly decayed over the remaining 9 minutes
(Figure 7, yellow trace). Interestingly, the trace collected at 455 µM NTP was also nonmonotonic, exhibiting a slight initial increase in fluorescence intensity for the first few
seconds followed by a multiphasic decay for the remainder of the 10 minute reaction
(Figure 7, blue trace). These results were both distinguishable from the buffer-only trace,
indicating that this process can be studied under multi-turnover conditions. The transition
from initial increase in signal to eventual decay seems to depend on [NTP] concentration,
in the sense that the transition takes longer at 45 µM NTP (> 1 minute) compared to 455
NTP (< 10 seconds). A titration of NTPs under these conditions would likely provide a
quantitative measure of how the time of this inflection point depends on NTP
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concentration, and the amplitudes and rates of these non-monotonic multiphasic curves
could potentially be used to provide kinetic constraints for a model of multi-round
transcription initiation on the presence of CarD.

The small bump in the initial part of the NTP curves, seen in both single- and multiturnover conditions, could be due to initial nucleotide incorporation. I explored this
possibility by adding initial nucleotides to pre-equilibrated EcoRNAP/AP3 complexes as
well as MboRNAP/CarD/AP3 complexes using manual mixing in the fluorometer.
EcoRNAP traces showed NTP-dependent trends, however it was difficult to tell if
MboRNAP transcription complexes changed fluorescence due to poor signal-to-noise
(data not shown). I continued exploring the effect of initial nucleotide incorporation on
fluorescence by performing asymmetric mixing experiments in the stopped-flow. For
these experiments, I used pre-equilibrated MboRNAP/AP3 mixed with subsets of
initiating nucleotides, including dinucleotides, and saw no increase in fluorescence (data
not shown).

Discussion and Future Directions
These experiments demonstrate the utility of asymmetric mixing for studying RNAPpromoter dissociation and NTP-dependent processes such as nucleotide incorporation and
promoter escape. It is expected that these experiments will provide a foundation for
studying the processes in a more comprehensive and controlled manner so that we may
learn about the effect of CarD and RbpA on all phases of transcription initiation.
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One specific area of investigation that may prove fruitful is the comparison of dsDNA
and Heparin as competitors. The fact that Heparin can potentially strip RNAP from
closed complexes, while dsDNA cannot, could potentially be leveraged to use these
competitors to probe closed-complex stability (4). In other words, if one were to mix
RNAP/promoter complexes with a saturating amount of dsDNA and compare the rate of
decay to a reaction in which RNAP/promoter complexes are mixed with a saturating
amount of Heparin, the decay with Heparin should in principle be faster and the
difference may be attributable to active stripping of RNAP from closed complexes. This
information in turn could be used to probe open-complex stability, since unstable opencomplexes spend more time in the strippable closed-complex state.

Perhaps the most useful way to advance this work is to titrate [NTP] to characterize the
concentration-dependence of NTP-dependent rates (i.e. initial nucleotide incorporation
and promoter escape). These kinetic signatures will allow the development of kinetic
models that can be used to describe the effect of transcription factors on NTP-dependent
phases of transcription initiation in both single- and multi-turnover conditions. In this
manner, the model for rRNA transcription initiation can be expanded and the regulation
of transcriptional flux arising from this operon can be understood at a mechanistic level.
Furthermore, the same strategy can be generally applied to understand transcriptional flux
at promoters throughout the mycobacterial genome.
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Chapter 7
Potassium glutamate increases
mycobacterial open complex stability
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Introduction
The ionic environment of Mtb is dynamic and it experience high fluxes of chloride as part
of the host immune response (1). To this point, in vitro studies of mycobacterial
transcription initiation have primarily been performed in NaCl or KCl based reaction
buffers (2-6). These studies provide an important link between in vitro and in vivo
conditions. However, chloride is not always the dominant anion in bacterial transcription.
In E.coli cells, the most physiologically relevant anion is not chloride but rather
glutamate, which can vary between 30-260 mM depending on the media (7). Estimates
suggest that intracellular glutamate concentration is even higher in Mtb than in E.coli (8).
Studies have shown that at certain promoters, increasing concentrations of potassium
glutamate have stabilized EcoRNAP-promoter interactions compared to KCl or NaCl (9).
Interestingly, sensitivity to chloride vs glutamate is promoter specific and has been
demonstrated for the Eco rrnB promoter, suggesting that anion species and concentration
can regulate of rRNA transcription in E.coli (10).

Mycobacterial RP o stability at the Mtb rrnAP3 promoter has been studied in chloride and
glutamate buffers using a 3-nt transcription assay (11). This study demonstrated that
CarD-regulated transcription from the Mtb rrnAP3 promoter was sensitively inhibited
from 10 mM < [Cl-] < 100 mM, where at 100 mM NaCl almost no transcription could be
observed even in the presence of CarD. In contrast, the reaction was able to easily
tolerate up to 150 mM [Glu-] without reduction in transcriptional activity, and a dramatic
effect of CarD over RNAP could be seen (11).
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I have investigated the effect of chloride versus glutamate on mycobacterial open
complexes in the ensemble fluorescence assay by changing the buffer conditions from a
“NaCl buffer” to a “KGlu buffer” (final reaction buffer compositions below).

NaCl buffer: 14 mM Tris pH 8.0, 100 mM NaCl, 10.2 mM MgCl 2 , 4 uM ZnCl 2 , 10%
glycerol (v/v), 0.1 mg/ml BSA, 1 mM DTT
KGlu buffer: 14 mM Tris pH 8.0, 40 mM NaCl, 1.2 mM MgCl 2 , 75 mM K-Glu, 4 uM
ZnCl 2 , 10% glycerol (v/v), 0.1 mg/ml BSA, 1 mM DTT

Methods
Proteins were prepared as previously described, with notable exceptions as follows (5).
RNAP core was dialyzed into a KGlu storage buffer (10 mM Tris pH 8.0, 250 mM KGlu,
1 mM MgCl 2 , 20 µM ZnCl 2 , 1 mM EDTA, 50% glycerol by volume) instead of the
standard NaCl-based storage buffer. When designing the experiment, the “10X MTB
+/+” buffer was prepared without any NaCl and 10-fold less MgCl 2 . This resulted in a
total [Cl-] = 40 mM in the final reaction conditions, compared to 100 mM in the NaClbased reaction conditions. Importantly, this approach reduced the total reaction
concentration of [Mg2+] from 10.2 mM in the NaCl buffer to 1.2 mM in the KGlu buffer.
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Results and Conclusions
KGlu increases RP o stability compared to NaCl
Titrations of MboRNAP indicated that in KGlu buffer produced dramatically more
equilibrium fluorescence compared to titrations of [MboRNAP] performed in NaCl (Fig
1A). A fit of the equilibrium binding isotherm yielded a K eff of [RNAP] = 187 nM (95%
confidence intervals: A = 2.238 +/- 0.573, K = 186.9 +/- 107.67 nM, which is slightly
less but within error of the NaCl K eff of [RNAP] = 212 nM (A = 0.3, K eff = 212 +/- 43
nM) (5). These results indicate that the increased fluorescence enhancement is not due to
increased binding of RNAP to the promoter.

Possible explanations for the increased fluorescence fold change in KGlu compared to
NaCl include (1) a photophysical effect of the buffer conditions on the quantum yield of
the Cy3 (resulting in greater fluorescence from the same amount of open complex), or (2)
an increased amount of open complex. To distinguish between these two possibilities, I
performed the experiment using a fixed amount of [MboRNAP] = 240 nM and including
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CarD at 100 nM and 5 µM. If KGlu simply increased the quantum yield of Cy3 without
affecting RP o stability, one would expect the same fold effect of CarD over RNAP that is
observed in NaCl. I found that compared to NaCl, CarD has a lower fold effect over
RNAP in K-Glu (22% in K-Glu versus ~600% in NaCl), and saturates at a lower
concentration (100 nM, versus 1 µM in NaCl) (Figure 1A, Figure 3 bottom). These
results are consistent with an increased basal amount of RP o for the following reasons.
First, a higher basal RP o means that CarD would have a smaller relative effect on RP o
stability. Second, we have shown that since CarD stabilizes RP o it must have a higher
affinity for RP o than RP c , therefore the half-maximal effect of CarD would decrease with
increasing basal RP o stability.

Increased RP o stability is due to changing the anionic species from Cl- to GluTranscription assays performed using equimolar concentrations of KCl and KGlu
indicated that addition of [Glu-] to the NaCl buffer was not able to increase
transcriptional activity as observed in a 3-nt assay. Reduction of [Cl-] accompanied by
addition of [Glu-] were both required to observe increased transcriptional activity (results
not shown). These results are consistent with an explanation for the increased observed
fluorescence resulting from changing the primary anionic species of the buffer from Clto Glu-.

KGlu changes the kinetics of RP o formation
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Analysis of the kinetics indicated that traces collected in KGlu buffer fit well to a triple
exponential, just like traces in NaCl. However, there were several important differences
between the observed rates in KGlu compared to NaCl. The fastest phase (k obs,1 ) was fit
by fixing to a 1-1200 s double-exponential (as previously done for traces collected in
NaCl buffer), but interestingly in KGlu k obs,1 can be fit starting from 0.01 s (as opposed to
0.1 s for NaCl), since burst phase has a stronger signal (larger amplitude). All three
phases contributed significantly to the fit (Figure 2).

The [RNAP]-dependence of the fastest phase (k obs,1 ) could be reasonably approximated
with a line (y = 0.009327x + 2.355, R-square = 0.9603) (Figure 3). This slope of this fit
could potentially be reporting on a bimolecular rate of association of ~107 M-1s-1 (9.327 x
106 M-1s-1). In this case, the off-rate can be estimated from y-intercept of linear fit: 2.355
± 0.489 s-1. If these numbers represented the actual rate constants, K d can be estimated
from k off /k on ~ 25 nM. It is not surprising that this is so different than K eff from fit of the
equilibrium titration (189 nM), since K eff also includes signal from isomerizations of the
bound complex and not just burst phase of the traces. Interestingly, the intermediate
(k obs,2 ) and slow (k obs,3 ) phases also exhibited a dependence on [RNAP] that could be
approximated by a linear fit (Figure 3). It is unlikely that these observed rates are
reporting on binding, since their slopes would yield unusually slow bimolecular rates of
association (9.2 x 104 M-1s-1 and 6.7 x 104 M-1s-1, for intermediate and slow phases,
respectively). It possible that these observed rates have a hyperbolic dependence on
[RNAP] which will only be observed at concentrations higher than what was tested.
Interestingly, in all three cases the observed rate for 50 nM RNAP is faster than 100 nM
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RNAP, which could potentially result from binding under conditions that deviate from
the pseudo-first-order approximation (10-fold molar excess RNAP over 5 nM DNA is the
lower limit for this approximation). Collectively, all of these kinetic signatures are in
sharp contrast to titrations in NaCl, in which k obs,3 did not depend on [RNAP], and
fractional amplitude for k obs,2 was too low to interpret.

CarD has different qualitative effects on each of the 3 observed rates
When comparing no CarD, low CarD (100 nM) and high CarD (5 µM), one can observe
qualitatively different effects on each of the fast, intermediate and slow phases. With
increasing CarD, k obs,1 decreases, while k obs,2 and k obs,3 both increase (Figure 4). The net
result of kinetic changes result in more RP o and faster equilibration of RP o . However,
interpreting the manner in which rate constants produce these observed effects will
require detailed kinetic modeling.

Discussion and Future Directions
These experiments demonstrate that in the KGlu buffer, mycobacterial RP o is more stable
than in the NaCl buffer. This results in a smaller fold effect of CarD on open complex
stability, and a lower K eff , and a faster overall approach to equilibrium.

The most logical next steps to utilize the data for future experiments are as follows:
1. Control for cation species and concentrations. When switching between NaCl and
KGlu, KCl can be used to isolate the effect of the anion from effects that might be

156

associated with switching from Na+ to K+. Additionally, the concentration of Mg2+ was
reduced from 10.2 mM in the NaCl buffer to 1.2 mM in the KGlu buffer. Mg2+ is
required for enzymatic activity of transcription. Although Mg2+ is not required for RP o
formation, controls should be performed to quantitatively test the dependence of
mycobacterial RP o stability on concentration of Mg2+.
2.

Choose a fixed [MboRNAP] for upcoming transcription factor titration

experiments. Maximizing the dynamic range for CarD’s effect would be ideal, so try
[MboRNAP] = 60 nM and perform a CarD titration. This combination will show a much
larger effect of CarD, since the equilibrium fluorescence fold change of MboRNAP at 60
nM is lower (~0.4) than equilibrium fluorescence of MboRNAP at 240 nM (~1.3).
3. Perform titrations of CarD mutants and RbpA at this same fixed [MboRNAP].
These experiments will provide kinetic data that will allow direct comparison between
transcription factors, in a manner similar to comparisons made in in NaCl-based buffers
(6).
4.

Consider how to interpret these curves since the amplitude for k obs,3 no longer

dominates the fits. The data suggests that the mechanism for RP o -formation in KGlu is
different than in NaCl-based reaction buffer. This could be due to (1) changes in rate
between the same states, or (2) new intermediates that are formed in one buffer but not
the other. The equilibrium fluorescence can still be interpreted as the relative
concentration of RP o . An amplitude-averaged rate could potentially be used to quantify
the overall approach to equilibrium as a crude measure of the overall reaction kinetics.
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The implications of characterizing factor-dependent mechanisms of RP o stability (and all
phases of transcription) in KGlu are numerous and of great value to this project.
Depending on the energetics of these interactions, transcription factors may have a
dramatically different effect on transcriptional flux in KGlu compared to NaCl. For
instance, it is possible that in KGlu CarD and RbpA together hyperstabilize RP o at Mtb
rrnAP3 to the extent that promoter escape is inhibited, thus reducing the amount of fulllength rRNA transcription. This is analogous to the effect of the E.coli transcription
factor H-NS, which is able to stabilize RP o and increase transcription of abortive
transcripts, but decreases overall transcription due to hyperstabilization of RP o (12).
Considering the dynamic nature of the ionic environment experienced by Mtb, it is
important to compare mycobacterial transcription under conditions where either chloride
or glutamate are the dominant anion. By the same rational, studies performed at 37 C will
be informative with regards to linking in vitro mechanisms to in vivo phenotypes.
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(A)

(B)

Figure 1: Experiments performed in KGlu buffer exhibit increased basal opencomplex stability. (A) In the absence of transcription factors, titration of MboRNAP in
KGlu buffer saturates at a higher equilibrium level of fluorescence (~1.5 fold over DNA)
compared to NaCl buffer (~0.4 fold over DNA, not shown) indicating a higher level of
RP o stability in the absence of transcription factors. (B) In KGlu buffer, saturating CarD
(purple and red traces) has a lower effect over RNAP alone (blue trace) compared to that
in NaCl-based buffer. CarD’s effect has already saturated at 100 nM (purple trace). All
data collected at 25OC.
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Figure 2: Fractional amplitudes as a function of [MboRNAP]. Fractional amplitudes
for the fast (a1, red), intermediate (a2, green) and slow (a3, red) phases are shown as a
function of [MboRANP].
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Figure 3. Observed rates as a function of [MboRNAP]. Observed rates for the fast
(top), intermediate (middle) and slow (bottom) phases are shown as a function of
[MboRNAP]. If the lowest concentration were excluded (red x in each plot), each
titration can be approximated to a line (blue, in each plot).
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Figure 3: Kinetic measurements as a function of [CarD] in KGlu. (Top) Fractional
amplitudes of the slow (a1, blue), intermediate (a2, green) and fast (a3, red) phases are
shown as a function of [CarD]. (Bottom) Equilibrium fold change over DNA is shown
for CarD = 0, 100, and 5000 nM.
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Figure 4: Observed rate dependence on [CarD]. Observed rates for the fast (top),
intermediate (middle) and slow (bottom) phases are shown as a function of [CarD].

163

References
1. Tan,S., Sukumar,N., Abramovitch,R.B., Parish,T. and Russell,D.G. (2013)
Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the
immune status of its host cell. PLoS Pathog., 9, e1003282.
2. China,A., Tare,P. and Nagaraja,V. (2010) Comparison of promoter-specific events
during transcription initiation in mycobacteria. Microbiology, 156, 1942–1952.
3. Tare,P., China,A. and Nagaraja,V. (2012) Distinct and Contrasting Transcription
Initiation Patterns at Mycobacterium tuberculosis Promoters. PLoS ONE, 7, e43900.
4. Agarwal,N. (2006) Mycobacterial transcriptional signals: requirements for recognition
by RNA polymerase and optimal transcriptional activity. Nucleic Acids Research, 34,
4245–4257.
5. Rammohan,J., Ruiz Manzano,A., Garner,A.L., Stallings,C.L. and Galburt,E.A. (2015)
CarD stabilizes mycobacterial open complexes via a two-tiered kinetic mechanism.
Nucleic Acids Research, 10.1093/nar/gkv078.
6.

Rammohan,J., Ruiz Manzano,A., Garner,A.L., Prusa,J., Stallings,C.L. and
Galburt,E.A. (2016) Cooperative stabilization of Mycobacterium tuberculosis rrnAP3
promoter open complexes by RbpA and CarD. Nucleic Acids Research,
10.1093/nar/gkw577.

7. Cayley,S., Lewis,B.A., Guttman,H.J. and Record,M.T. (1991) Characterization of the
cytoplasm of Escherichia coli K-12 as a function of external osmolarity. Implications
for protein-DNA interactions in vivo. Journal of Molecular Biology, 222, 281–300.
8. Tian,J., Bryk,R., Itoh,M., Suematsu,M. and Nathan,C. (2005) Variant tricarboxylic
acid cycle in Mycobacterium tuberculosis: identification of alpha-ketoglutarate
decarboxylase. PNAS, 102, 10670–10675.
9. Leirmo,S., Harrison,C., Cayley,D.S., Burgess,R.R. and Record,M.T. (1987)
Replacement of potassium chloride by potassium glutamate dramatically enhances
protein-DNA interactions in vitro. Biochemistry, 26, 2095–2101.
10. Gralla,J.D. and Vargas,D.R. (2006) Potassium glutamate as a transcriptional inhibitor
during bacterial osmoregulation. EMBO J., 25, 1515–1521.
11. Davis,E., Chen,J., Leon,K., Darst,S.A. and Campbell,E.A. (2015) Mycobacterial
RNA polymerase forms unstable open promoter complexes that are stabilized by
CarD. Nucleic Acids Research, 43, 433–445.
12. Schröder,O. and Wagner,R. (2000) The bacterial DNA-binding protein H-NS
represses ribosomal RNA transcription by trapping RNA polymerase in the initiation
complex. Journal of Molecular Biology, 298, 737–748.
164

Chapter 8
Single Molecule Magnetic Tweezers for
Real-Time Detection of Mycobacterial
Promoter Unwinding
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Introduction
Transcription initiation involves RNA polymerase (RNAP)-promoter binding, promoteropening during which 10-12 bases of DNA are unwound, nucleotide incorporation and
promoter escape. Understanding the mechanisms of regulating transcription initiation in
Mycobacterium tuberculosis (Mtb) represents a clinically relevant challenge to
biomedical research. CarD and RbpA are essential transcription factors that are known to
regulate mycobacterial transcription initiation at the Mtb rrnAP3 promoter, which is the
major promoter for ribosomal RNA (rRNA) in Mtb (1-3). We have shown that CarD and
RbpA stabilize the RNAP-promoter open complex using an ensemble fluorescence assay
(4, 5). These studies have provided valuable information about the thermodynamics and
kinetics of factor-dependent regulation of mycobacterial transcription initiation.
However, ensemble measurements arise from the average behavior of many molecules,
and the stochastic and unsynchronized transitions that underlie molecular mechanism can
only be accessed indirectly in these ensembles (6).

Single-molecule magnetic-tweezers is an established approach to measure all phases of
bacterial transcription initiation in real-time (6-8). In addition, the assay allows for the
study of topological variables such as super-helicity, which are known to have dramatic
effects on the process of transcription. Briefly, individual DNA tethers are attached at one
end to a flow cell surface and at the other end to a superparamagnetic bead. A magnet
that is positioned above the surface can be used to control the tension in the DNA tether
by adjusting its height above the surface. Furthermore, for nick-free torsionally
constrained DNA, supercoils can be introduced in the DNA tether by rotating the magnet.
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The height of the bead above the surface is monitored using video microscopy. On
supercoiled DNA, promoter unwinding by RNAP results in a detectable change in bead
height above the surface (6-8).

This approach offers several strengths that are complementary to ensemble fluorescence
studies of promoter-opening. First, the signal arises directly from the nanomechanical
unwinding of DNA, and therefore interpretation of the signal is unambiguous and does
not depend on the oft-mysterious photophysical basis of a fluorophore’s quantum yield.
Second, the assay is performed on supercoiled DNA, which is more representative of the
in vivo state of DNA and can have a dramatic effect on the ability of RNAP to unwind
promoter DNA (negatively supercoiled DNA favors unwinding, while positively
supercoiled DNA inhibits unwinding). Third, the relationship between rotation and bead
height enables detection of promoter opening with near-bp resolution (7). This offers the
possibility to observe important transcription initiation intermediates such as DNA
“scrunching”, which involve bubbles larger than the initial 10-12 basepairs that are
typically unwound in the RNAP-promoter open complex (7, 8). Scrunching can have
dramatic effects on transcriptional flux, especially at rRNA promoters, and it is unknown
whether this process occurs in mycobacteria.

There are also limitations to using single-molecule magnetic-tweezers to study
transcription initiation. First, the response time of the bead’s movement is limited by
hydrodynamic drag, which results in a time-resolution of the assay on the order of ~ 1
second. This is useful for observing states with lifetimes longer than 1 second, but it is
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Figure 1: Single molecule magnetic tweezers for real-time detection of promoter
unwinding (adapted from Revyakin et al.). Rotation-extension curve shows how DNA
extension is related to supercoiling. Linear regimes on the positive and negative sides
allow conversion between changes in bead height and loss of twist. Promoter unwinding
by RNAP removes 1 twist of DNA, which results in a gain of 1 writhe due to
conservation of linking number. Example data traces show raw data (green) and
averaged data (red) for promoter opening events on positively supercoiled DNA by
EcoRNAP.
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challenging to use the assay to detect transient opening events that last less than 1 second
(i.e. from unstable open complexes). Secondly, magnetic tweezers (and single molecule
force spectroscopy approaches in general) suffer from low throughput, since it is difficult
to measure many individual molecules simultaneously. Approaches exist for
microcontact printing of surfaces in order to enable multiplexing, but these methods are
still experimental and under development (9). As a result, the assay is most useful when it
can be reproducibly used to collect many measurements of individual molecules, and for
measuring states that have lifetimes greater than 1 second.

I have used this assay to study mycobacterial promoter binding and opening at the Mtb
rrnAP3 promoter using MboRNAP and MtbCarD. I have observed stable promoter
opening in the presence of CarD on positively supercoiled DNA templates. The extent of
promoter unwinding was larger than expected which could be due to (1) a larger
transcription bubble in the open complex, (2) scrunching, or (3) some combination of the
two. These measurements represent the first single molecule observations of
mycobacterial transcription initiation.

Methods
DNA tether construction
4 kb DNA tether fragments containing the Mtb rrnAP3 promoter were prepared as
previously described. Briefly, PCR was used to amplify a 2 kb “core” fragment that
contained the promoter as well as unique restriction sites at either end. Two 1 kb
“handles” were prepared by PCR-amplification using either digoxigenenin- or biotin-
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modified dUTP. The core and handles were digested and ligated to form a 4-kb DNA
tether with unique 1 kb handles. The handles were used to attach the tether to antidigoxigenin (flow cell surface) and streptavidin (1 µm magnetic bead).

Flow cell preparation
Several methods have been used to construct flow cells with surface chemistry that is
amenable to DNA tether attachment, yet also passivated to sufficiently prevent nonspecific adsorption of molecules to the glass surface. Perhaps the most frequent strategy
employs modified PEG surfaces (10). I used a nitrocellulose-coated flow cell decorated
with anti-digoxigenin and passivated with BSA. I found that this surface chemistry could
more reproducibly allow analysis of many torsionally constrained tethers compared to the
alternate PEG surface chemistry.

Results and Conclusions
Collection of symmetric rotation-extension curves on torsionally constrained DNA
DNA tethers containing the Mtb rrnAP3 promoter were constructed with 1 kb handles
and a 2 kb stretch of DNA between the flow-cell surface and a magnetic bead. Forcecalibrations indicated that at a magnet height of ~2.5 mm produced a force of
approximately 0.3 pN in the DNA tether. A typical rotation extension curve collected at
this force is shown in Figure 1. The symmetric curve is centered around 21 turns
(arbitrary units). Subtraction of 10 turns (from 21 to 11) results in a decrease in bead
height from 0.48 um to 0.15 um, which is due to the incorporation of negative supercoils
in the DNA. Likewise, addition of 10 turns (from 21 to 31 on the x-axis) results in a
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Figure 2: Rotation-extension curve for torsionally constrained DNA containing the
Mtb rrnAP3 promoter. Relaxed DNA is centered at approximately 21 turns (arbitrary
units). Removal of 10 turns (21 to 11 turns) results in a decrease in bead height as
negative supercoils are introduced. Likewise, addition of 10 turns (21 to 31 turns) results
in an increase in bead height as positive supercoils are introduced. The slope of each side
in the linear regime is 50 nm/turn.
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decrease in bead height from 0.48 um to 0.11 um, which is due to the incorporation of
positive supercoils in the DNA. The linear regime on the negative supercoiled side has a
slope of 50 nm/turn, and the linear regime on the positive supercoiled side also has slope
of 50 nm/turn. Thus, removal of 1 twist of DNA (i.e. due to promoter-unwinding) would
result in a gain of 1 writhe of DNA that would be equivalent to a 50 nm change. On the
negatively supercoiled side, this would result in the bead moving up by 50 nm, and on the
positively supercoiled side this would result in the bead moving down by 50 nm.

DNA-only traces collected in the absence of protein are steady over the course of minutes
As a negative control, data was collected for relaxed, positively supercoiled and
negatively-supercoiled DNA in the absence of any protein. An example trace is shown in
Figure 2. For this particular tether, the height of the bead above the surface is 0.53 µm,
and the addition or removal of 6 supercoils results in a bead height of approximately 0.45
µm. Over the course of minutes, the supercoiled DNA has a peak-to-peak noise of
approximately 60 nm.

Positively supercoiled DNA shows increased noise in the presence of MboRNAP
When MboRNAP was introduced into the flow cell at either 2 nM (Figure 4) or 20 nM,
the peak-to-peak noise observed over the course of minutes for positively supercoiled
DNA approximately doubled that of DNA alone (~100 nm). However, the height of the
bead appeared to be relatively constant on both positively and negatively supercoiled
DNA, and the height of the bead appeared to be relatively symmetric. It is possible that
increased noise on the positively-supercoiled DNA is the result of MboRNAP binding the
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Figure 3: Signal for DNA only with positive and negative supercoils. Raw data (gray)
and averaged data (red) are shown for a trace of DNA in the absence of protein. The
trace starts out with relaxed DNA. 6 positive turns (going from 0 to +6 supercoils) were
introduced at ~100 s, and 12 negative turns (going from +6 to -6 supercoils) were
introduced at ~ 250 s. At 400 s, 6 positive turns were introduced (going from -6 to 0
supercoils).
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Figure 4: Single molecule trace for MboRNAP on positively and negatively
supercoiled DNA. Raw data (gray) and averaged data (red) are shown for a single DNA
tether in the presence of 2 nM MboRNAP. At ~100 s, +5 turns are introduced (going
from 0 to +5 supercoils). Some possible transient activity can be seen from 100 to 750 s.
At ~750 s, -10 turns were introduced (going from +5 to -5 supercoils). At ~ 1350 s, +5
turns were introduced (going from -5 to 0 supercoils).
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promoter and forming unstable open-complexes that do not persist long enough to be
detected by this assay.

Positively supercoiled DNA shows stable promoter opening in the presence of MboRNAP
and CarD
The introduction of MboRNAP (2 nM or 20 nM) with CarD (1 µM) resulted in clear
hopping between two states for positively-supercoiled DNA (Figure 5). These states were
qualitatively easily distinguishable by eye and differed in bead height by approximately
70 nm (Figure 6). The lifetime of these states lasted approximately tens of seconds to
minutes (Figure 8). Mapping the change in height of the bead to the rotation-extension
curve predicts that if the entire change in bead height were due to unwinding, then
approximately 1.5 turns of DNA were being unwound (Figure 7). Alternately, the
observed change in bead height could be the result of a combination of unwinding and
wrapping. Measurements of promoter unwinding on negatively supercoiled DNA would
allow for this distinction, however no changes in bead height were observed on
negatively supercoiled DNA.

Puzzlingly, the observed change in bead height appears to increase from the baseline
position on the positively supercoiled DNA, which is the opposite direction from the
predicted direction. The same phenomenon was observed for multiple experiments
performed on three different days. One remote possibility is that the DNA was not Bform (right-handed double-helix) but rather Z-form (left-handed double-helix), which
would have resulted in the bead moving up instead of down upon promoter unwinding of
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A

B

Figure 5. Observation of promoter-opening in the presence of CarD. Raw data
(gray) and averaged data (red) are shown for traces collected with 1 µM CarD and
MboRNAP. (A) For 2 nM MboRNAP, the trace begins with relaxed DNA and at ~600 s
+5 turns were introduced (going from 0 to positive 5 supercoils). From 600 – 1200s, the
signal hops between 2 clearly distinguishable states, which is presumably the result of
CarD-mediated promoter unwinding by MboRNAP. At 1200 s, -10 turns were
introduced (going from +5 to -5 supercoils). No activity is observed, and at ~1800s +5
turns were introduced to return the DNA back to 0 supercoils. (B) For 20 nM
MboRNAP, +6 supercoils were introduced at the beginning of the trace and hopping
between two clearly distinguishable states is observed until ~800 s, when -12 turns were
introduced (going from +6 to -6 supercoils). A transient drop in signal is observed
followed by a spike, and then no further activity is observed until +6 turns were
introduced at ~1500 s (going from -6 to 0 supercoils).
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Figure 6: DNA extension analysis. Plotting a histogram of DNA extension states over
time for 20 nM MboRNAP and 1 µM CarD shows a clear bimodal distribution, which is
indicative of 2 states. These states are centered around DNA extensions of approximately
0.35 µm and 0.42 µm.
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Figure 7: Unwinding analysis. For 20 nM MboRNAP and 1 µM CarD, DNA extension
can be mapped onto the rotation-extension curve in order to measure the number of turns
that would lead to the observed change in bead height. In this case, the change of ~70 nm
is approximately equal to 1.5 turns of DNA.
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A

B

Figure 8: Dwell-time distribution analysis. The amount of time spend in the “lower”
state (A) and the “higher” state (B) are shown as histograms. Building up such
histograms can provide information on the relaxation times of each state.
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positively supercoiled DNA. To confirm rotational direction before every experiment, I
recommend that rotation-extension curves on DNA only should be collected at high force
in order to observe asymmetry on the negative supercoiling side.

Discussion and Future Directions
These results are the first single molecule observations of mycobacterial promoter
unwinding by single molecule methods. Stable promoter unwinding was only observed in
the presence of CarD and only on what is assumed to be positively supercoiled DNA.
Lifetimes of the states lasted tens of seconds to minutes, and the change in bead height
(~70 nm) predicts ~1.5 turns of unwound DNA. Previous measurements of promoter
unwinding by EcoRNAP suggest that closed to 1 turn of B-form DNA is unwound by
RNAP. The observation that more than 1 turn of DNA is being unwound raises 2
possibilities. First, the bubble size formed by MboRNAP/CarD could be bigger than that
formed by EcoRNAP on this same promoter.

Potassium permanganate footprinting

studies of MboRNAP +/- CarD compared to EcoRNAP on the Mtb rrnAP3 promoter
predicted that the bubble sizes are the same, however the resolution of this technique is
limited to single-stranded thymines and it is possible that a larger bubble formed by
MboRNAP/CarD would not be detectable in that assay.

The potential observation of 1.5 turns of unwound DNA also raises the possibility that
scrunching is taking place in the absence of NTP’s, which has recently been reported for
EcoRNAP (11). This is an especially intriguing possibility, since mycobacterial RNAP
may use scrunching as a mechanism to store energy for increased efficiency of promoter
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escape from ribosomal promoters which are known to have unstable open-complexes
(12).

Future directions for this project would be greatly enhanced by observation of promoter
unwinding in the absence of transcription factors, so that factor-dependent promoter
unwinding can be compared to the basal system. Possible ways to increase the stability
of RP o for MboRNAP acting along include changing the buffer (Glu- instead of Cl-) (see
Chapter 7) and increasing the temperature form 25 C to 37 C (4).

In the event that the magnetic tweezers approach proves to be low throughput or not
reproducible, an attractive alternative single molecule approach is TIRF microscopy. This
approach could be used with a single fluorophore or with multiple fluorophores (13-15).
A single Cy3 fluorophore has been used at the -4 nontemplate promoter position to detect
promoter opening in real time for EcoRNAP. These studies found that fluorescence
lifetime provided better signal-to-noise than fluorescence intensity, and this signal could
be used to detect not only promoter binding and opening but also DNA scrunching (13).
The use of multiple fluorophores can be used for colocalization single molecule
spectroscopy (CoSMoS) or for fluorescence resonance energy transfer (FRET), and these
approaches can be used to measure all phases of transcription initiation including
binding, opening, scrunching, abortive initiation and promoter escape (14, 15).
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Table 1: Single molecule magnetic tweezers file index. This spreadsheet details
different experiments in which promoter opening was observed, and includes information
on [MboRNAP], [CarD], date, raw file information, supercoiling, and number of events
per trace.
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Summary
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Summary of research
When this research was initiated in 2012, CarD was recently discovered as an essential
transcription factor in Mycobacterium tuberculosis (Mtb) important for global regulation
of transcription (1). CarD was known to bind RNAP and DNA, and was found at
promoters throughout the mycobacterial genome including both promoters in the Mtb
rRNA operon known as rrnAP1 and rrnAP3. RbpA was also a recently discovered
transcription factor that is essential in Mtb (2, 3). CarD and RbpA were each known to
activate transcription from the rrnAP3 promoter, but the mechanisms by which each
factor regulated transcriptional flux were unknown (4, 3). All phases of bacterial
transcription initiation were possible opportunities for factor-dependent regulation
including RNAP-promoter binding, promoter opening, nucleotide incorporation and
promoter escape.
I have studied the effect of CarD on all phases of transcription initiation. Using EMSA
and double-filter binding assays, I found that CarD increased the apparent affinity of
MboRNAP for promoter DNA. I found that this positive linkage was dependent not only
on holoenyme formation, but also on specific residues within SigA (FYWW), which are
predicted to be important for promoter opening. Using ensemble fluorescence, I studied
the effect of CarD on RNAP-promoter binding and opening and found that CarD
stabilizes mycobacterial transcription open complexes using a concentration-dependent
two-tiered kinetic mechanism (5). Experiments performed with CarD point mutants
demonstrated that the ability of CarD to stabilize RP o depends on all three of its
functional domains (RID, DNA-binding, and tryptophan). The data is consistent with a
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model in which CarD stabilizes RP o by conformational selection (at low concentrations
of CarD) and induced fit (at high concentrations of CarD) acting in parallel (5). I
established an asymmetric mixing approach to observe transcription in the presence of
competitors and NTP’s, so that this work can be extended to measure the effect of
transcription factors on nucleotide incorporation and promoter escape. Considering the
dynamic buffer environment experienced by Mtb in vivo, I performed ensemble
fluorescence experiments in a glutamate-based buffer and found that RP o is more stable
when compared to chloride-based buffers (6). To study the system in more detail, I
collected single-molecule magnetic-tweezers traces to measure the size of the
transcription bubble in real time (7). These experiments indicated that stable promoter
opening could only be observed in the presence of CarD, and estimates of the size of the
transcription bubble suggest that the possibility that 1.5 turns of DNA are being
unwound. These experiments have established a working model to explain the effect of
CarD on mycobacterial transcription initiation kinetics, and will provide a foundation for
a comprehensive description of CarD’s mechanisms of transcription regulation.
I have also studied a second transcription factor RbpA, which was also known to increase
transcription from rrnAP3 and stabilize open-complexes at some mycobacterial
promoters. Using ensemble fluorescence, I found that RbpA stabilizes the rrnAP3
promoter using a kinetic mechanism distinct from that of CarD (8). These results are
consistent with a model in which RbpA utilizes conformational selection and induced fit
in series to stabilize RP o (Chapter 5). Experiments performed with both transcription
factors revealed positive linkage between RbpA and CarD with regard to mycobacterial
open complex stabilization, demonstrating that the two transcription factors work
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together at the rrnAP3 promoter. The cooperative stabilization of rrnAP3 open complexes
led to increased fluorescence and faster kinetics, and resembled time courses resulting
from EcoRNAP on the rrnAP3 promoter. Taken together, these data demonstrate that
RbpA and CarD dramatically increase the amount of open complex and accelerate the
approach to open complex equilibrium compared to either factor acting alone (8).

Figure 1. Summary of CarD and RbpA regulation of mycobacterial transcription
initiation in NaCl-based buffer. (Top) General kinetic mechanism in the absence of
factors includes an intermediate (RP i ) in between closed and open complexes.
Transcription factors (X) could potentially interact with any of these states (dashed box).
(Bottom) Free energy diagram. In the absence of factors (black), opening is rate-limiting.
In the presence of low concentrations of CarD (short blue dashed line), all promoterbound states are stabilizes, and RPo is further stabilizes relative to other states compared
to no factor. In the presence of high concentrations of CarD (long blue dashed line), the
activation barrier to opening is lowered leading to acceleration of open complex
equilibration. In the presence of RbpA (dashed red line), all states are stabilized relative
to no factor and the activation barrier to opening is lowered. In the presence of both
factors (green dashed line), all states are stabilized and all activation barriers are lowered.
In each case, the end of each curve qualitatively represents the amount of transcriptional
flux, where lower free energy represents more transcription.
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Recommendations for future work
Characterization of the basal mechanism of mycobacterial transcription initiation
Mechanistic studies of transcription factors in E.coli have been greatly facilitated by
knowledge of the kinetic mechanism of transcription initiation in the absence of factors
(9-12). Characterization of multiple closed and open intermediate states as well as the
rates of conversion between them has required decades of study, and new states continue
to be revealed (13). The basal mechanism of mycobacterial transcription initiation is
often assumed to take place through similar mechanisms, however the work presented
here demonstrates that there are fundamental and dramatic differences between how
EcoRNAP and MboRNAP initiate transcription from the same promoter. Therefore, the
assumption that the kinetic mechanism of mycobacterial transcription includes the same
intermediates as E.coli should be used with caution. Studies presented here suggest the
presence of at least one intermediate in between closed and open complexes. Detailing
the structural properties of such intermediates will allow mechanisms of transcription
factors to be studied with greater clarity.
Solution-based binding assays
I have studied binding interactions using EMSA and double-filter binding, but these
approaches provide measurements under non-equilibrium conditions and thus may not be
representative of true solution binding equilibria (14). Furthermore, they cannot be used
to measure the kinetics of binding, which is often diffusion limited and beyond the timeresolution of manual mixing approaches. The development of solution-based binding
assays would greatly aid this research because such assays allow for one to control for
189

solution conditions such as pH, salt and temperature. Given the dynamic solution
environment experienced by Mtb in vivo, the effects of chloride and glutamate should
specifically be tested so that the effects of anion concentration on transcription complex
assembly can be characterized (6). Furthermore, solution-based binding assays can be
used to measure kinetics of association and dissociation in a controlled manner. Direct
measurements of the rates of binding will provide additional constraints to kinetic
models.
Examples of especially valuable binding measurements to establish include sigmasaturation of core RNAP, holoenzyme saturation of promoter DNA, and affinities of
CarD and RbpA to all combinations of RNAP and DNA. Measurements of the oligomeric
states of the proteins should also be performed, so that analysis of data can take into
account the stoichiometry of interactions. This is important because studies of both CarD
and RbpA have been reported as dimeric structures (15, 2). Fluorescence anisotropy and
fluorescence correlation spectroscopy are particularly attractive approaches, since they
could potentially be used to probe the affinity of transcription factors to RP o using
holoenzyme-saturated bubble DNA templates.
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Fluorescence studies of transcription initiation
There are many useful controls that can be performed in order to aid interpretation of the
fluorescence time courses presented in this work. The use of the MboRNAP-FYWW
(Chapter 2) would enable measurements of fluorescence enhancement resulting from a
holoenzyme expected to be deficient in promoter opening. Measurement of any
fluorescence enhancement arising from closed complexes may enable global fitting of
time courses, which has thus far proven elusive (Chapter 5). 2-Aminopurine is an
alternative fluorophore that can also be used to measure promoter opening in real-time,
although the incorporation of multiple fluorophores is often necessary to obtain sufficient
signal-to-noise (16). Thus, these studies must be interpreted carefully because they
involve the perturbation of multiple bases in the promoter sequence. Additionally,
fluorophores could be conjugated to downstream regions of DNA templates to study the
arrival of RNAP during transcription (17). Dependence of these signals on NTP
concentration and distance to fluorophore will provide information on the kinetics of
nucleotide incorporation, promoter escape and elongation.
Quench flow studies for transcription initiation
Many techniques can elucidate intermediates on pathway to productive mycobacterial
transcription initiation, but of particular interest are those techniques that leverage a
quench flow apparatus. This rapid mixing technique is able to provide millisecond time
resolution for footprinting techniques that can measure binding and opening (DNAseI,
KMnO 4 , hydoxyl radical) as well as time-resolved production of RNA transcripts in the
presence of NTPs (18). The primary advantage of such an approach is that the signal
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provides a complementary measurement to fluorescence-based studies of transcription
initiation.
Computational approaches for global evaluation of kinetic schemes
Global exploration of rate space is essential for the development of mechanistic models
that can account for experimental data. Developing a global fitting program (i.e. through
the use of published Mathematica notebooks) will greatly facilitate exploration of many
kinetic models over a wide range of rate space (19). This will be useful not only for
examining the relationship between eigenvalues and observed rates (as described in
Chapter 5), but also for examining the relationship between eigenvectors and amplitudes,
which are thus far an unused and valuable constraint (14). Furthermore, programs such as
KinTek Explorer should be used to simulate time courses (20-22). In principle, a kinetic
model that sufficiently captures the mechanism can be used to reproduce experimental
time courses, observed rates, and amplitudes. This remains the goal of future
computational work for evaluation of kinetic schemes.
Promoter-dependence of transcription factor mechanisms
Studying rrnAP1 by itself as well as together with rrnAP3 will provide great insight to
how the rRNA operon works in Mtb. Preliminary data indicates that RNAP-promoter
complexes at rrnAP3 have a longer half-life in the presence of competitor when rrnAP1 is
present upstream (as in the genomic sequence of the Mtb rRNA operon), as opposed to
when rrnAP3 is present alone. These results indicate that there is a link between rrnAP1
and RNAP’s affinity for rrnAP3. Studies of lac repressor and T7 RNAP indicate that
DNA-binding proteins can affect RNAP-promoter affinity at a distance, suggesting the
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possibility that RNAP-AP1 interactions could be increasing RNAP-AP3 affinity through
the DNA. This effect could be dependent on the spacing of the two binding sites, which
could be tested by creating templates with varied spacing between the two promoter sites
(23).
Since CarD and RbpA are known to affect many promoters throughout the mycobacterial
genome, the development of an in vitro transcription assay that utilizes purified
mycobacterial genomic DNA offers a way to probe the effect of these transcription
factors when many promoters are present. To further bridge the gap between in vitro and
in vivo phenotypes, fractionated cell lysate could be used to test transcription factor
effects on genomic DNA. Such experiments offer the potential to elucidate pleiotropic
effects of these transcription factors that may involves molecules that are not as yet
known (1).
Single-molecule studies of mycobacterial transcription initiation
Single-molecule magnetic-tweezers can be used to measure promoter unwinding with
near-base-pair resolution, and therefore represent a powerful way to probe the potential
effects of transcription factors during transcription initiation. Of particular interest is the
possibility of “scrunching” during transcription initiation, which can take place in E.coli
(in the presence and absence of initiating nucleotides) but has not yet been demonstrated
in the mycobacterial transcription system (24, 13). The mechanistic implications of DNA
scrunching may be linked to efficiency of promoter escape, especially from ribosomal
promoters (13). However, some measurements suggest that the energy stored in
scrunched DNA is modest and would not have a major effect on promoter escape (17).
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Nevertheless, such measurements may be dependent on species and promoter and
therefore scrunching intermediates may play a major role in mycobacterial transcription
initiation in the presence of regulators.
Single molecule TIRF can be used with multiple fluorophores to probe the effects of
multiple factors acting simultaneously during transcription initiation (25). Such an
approach could be used with labeled DNA and proteins in order to study the energetics of
transcription initiation in the presence of many factors under a range of conditions.
Links between transcription factor mechanisms and treatments for TB
Weakening CarD’s interactions with RNAP led to increased efficacy of Rifampicin,
suggesting a direct link between transcription factor mechanism and treatment of
Tuberculosis (26). Many treatment strategies of Tuberculosis are aimed at preventing
growth, but these strategies are less effective at treating latent Tuberculosis. Thus, the
development of small molecules that target CarD and RbpA offers a way forward for
treating this disease. The development of the genome-editing technology of CRISPRCas9 has advanced to the point where it can be reliably used in the mycobacterial system
(27, 28). Furthermore, nanoparticle delivery systems can be developed to introduce the
CRISPR system to Mtb within a granuloma (29). Therefore, CRISPR targeted to the
genes of CarD and RbpA could soon be a new way to eliminate these essential genes in
vivo, and in doing so kill the bacterium.
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Conclusion
The work presented here represents the first thermodynamic and kinetic measurements of
two transcription factors essential in Mycobacterium tuberculosis. The working models,
recommendations, and hypotheses that have emerged from this dissertation will serve to
inform future studies of these factors not only at the Mtb rrnAP3 promoter but also
throughout the mycobacterial genome. These data are tangible steps towards
understanding the complex mechanisms of gene regulation in a deadly pathogenic
bacterium that continues to mystify and intrigue biomedical researchers around the world.
I trust that future researchers will look back on this work with a feeling of justified
superiority.
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Appendix A
Sample preparation of Cy3-labeled
promoter DNA
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This protocol was originally taught to me in March 2013 by Tomasz Heyduk and a
member of his laboratory, Agnieszka Lass-Napiorkowska. I adapted the protocol as
needed in order to account for differences in equipment between Saint Louis University
and the Department of Biochemistry and Molecular Biophysics at Washington University
in St. Louis. Any differences between the two protocols are minor and have been noted.

Oligo design
The nontemplate oligo is 85 nt long from -80 to +5, and the T at +2 is modified with an
amine attached to a C6 linker. In IDT, when typing the oligo into the field from 5' to 3',
the T is replaced by /iAmMC6T/ like this:
5'-...G/iAmMC6T/TTGC-3'
For the modification, you can either type it in manually, or insert an "Internal Mod" using
the tools on the website, under the category "Attachment Chemistry / Linkers". This is
code for "Int Amino Modifier C6 dT", which will be used to conjugate a Cy3-NHS Ester
(Lumiprobe Cat#21020) to the base. The modified base not be counted as a base, so the
length will be displayed as 84 bases even though it's really 84 + 1 modified base = 85.
The template oligo is also 85 nt long and overlaps the nontemplate oligo by 20bp, and
extends downstream. So, it is typically from -15 to +60. Remember to enter both oligos
5'-3'.
Using IDT's Oligo Analyzer Tool, each oligo should be checked for secondary structure
propensity (Hairpin) as well as self-assembly (Self-Dimer) and any structures with
(delta)G < -20 kcal/mol should be considered disruptive to the prep. Lastly, both oligos
should be checked together for their annealing stability (Hetero-Dimer) to make sure the
20 bp overlap is the lowest-energy hetero-dimer between the two primers.
Order both oligos on a scale of 100 nmol, which is enough for several preps of
fluorescent promoter. The default purification is PAGE, but manually select HPLC
instead because it is better.
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Promoter preparation
GENERAL TIMELINE FOR PREP
Day 1 – Label amine-modified oligo with Cy3-NHS-Ester overnight
Day 2 – Ethanol precipitate oligos, HPLC to purify labeled oligo from unlabeled oligo
Day 3 – Extension reaction and FPLC to purify double-stranded product
DAY 1: Label amine-modified non-template strand (NTS) oligo with Cy3-NHS
1. Measure concentration of oligo. Oligos typically arrive dry from IDT.
Resuspend amine-oligo in 50 ul freshly-prepared 0.1 M NaHCO3 (sodium bicarbonate)
on the same day that it will be labeled overnight. Measure Abs(260) by diluting 1 ul of
the sample ~100 fold. This material is not recovered for further use.
The template strand pellet can remain dry until Day 3, at which point it can be
resuspended in 50 ul MQ H2O (or Buffer EB) prior to its use in the extension reaction.

2. Calculate molar amount of amine-oligo.
A “100 nmol” order usually produces around 10 nmol of oligo at most. This is because
the scale of the order does not refer to the final product, it refers to the amount of
phosphoramidites that are used in the synthesis process.
3. Prepare a 10x molar excess of Cy3-NHS-ester for labeling.
Usually, Cy3-NHS-ester arrives dry, is resuspended in DMSO, aliquoted such that each
tube contains 100 nmoles of dye, and frozen at -80C. These aliquots are made assuming
that they will be combined with 10 nmoles of amine-oligo (10x molar excess dye over
oligo). It is fine to have greater than a 10-fold molar excess dye over oligo.
4. Add the DNA in 0.1 M NaHCO3 onto an aliquot of the dry Cy3.
Gently pipette up and down to mix. You may need to use the pipette tip to gently
dislodge the pellet of dye, but do not let the dye get stuck in the hole of the pipette tip
otherwise you will risk removing material from the reaction. Let the DNA/Cy3 mix
remain at room temperature overnight protected from light (covered in foil or in a drawer
is fine).
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DAY 2: Purification of Cy3-oligo
Ethanol precipitate Cy3-oligo
1. Add 2 M NaCl to DNA-Cy3 mix to a [NaCl] final = 0.25 M. Add 2.5x volume 100%
EtOH from -20C.
Example:
50 ul DNA + 7.15 ul of 2 M NaCl = 57.15 ul
57.15 ul x 2.5 = 142.9 ul EtOH
142.9 ul EtOH + 57.15 ul = 200.05 ul total
2. Balance the reaction tube with another tubes and spin at 15,000 rpm for 30 min at +4C.
3. Remove and save supernatant using a protein-loading tip without disturbing pellet.
This is a precautionary measure in case the pellet accidentally gets removed with the
supernatant.
4. Wash with 300 ul 70% EtOH (-20C), add gently to side of tube by the pellet. Remove
and save the 70% EtOH, leaving the pellet behind. Once again, saving the wash is a
precautionary measure in case the pellet gets removed with the wash.
5. A Vacufuge can be used to evaporate the residual ethanol, 5 min should be enough. Be
careful when removing tubes from the centrifuge, pellet may have dislodged from wall of
tube. Alternately, you can place the eppendorf tube with the cap open in heat block (set to
at least 60 C) and wait a few minutes for residual ethanol to evaporate.
6. Resuspend the Cy3-NTS pellet in 50 ul H2O, pipette up and down until you see a
uniform pink color. Alternately, the pellet can be resuspended in Buffer A as described
below.
Reverse-phase HPLC-purification of Cy3-labeled oligo from unlabeled oligo
Column: XTerra C18
Reference: Thang Ho, Lohman Lab
C18 Column storage conditions:
40% H2O
60% CH 3 CN
HPLC buffers:
Component
Buffer A (1 L)
TEAA (0.1 M stock) [final] = 0.098 M
CH 3 CN
5% (v/v)

Buffer B (1 L)
[final] = 0.01 M
50% (v/v)
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Waters HPLC Directions:
Install one of the C18 columns (either small or large will work) and equilibrate in Buffer
A.
In software program:
Click the top left button, and select “Make single injections”.
Increase flow for Buffer A to 1 ml/min. If the flow rate is very low or zero, ramp the rate
up over the course of 1 min. Turn the injection valve to “Inject” to make sure the loop is
rinsed and equilibrated with Buffer A. Turn the injection valve back to “Load”.
Select the program titled “Analytical 260 549 Cy3”.
Click the button to “Prepare”. Inject the sample into the loop (usually a 250 ul loop is
installed), be careful to not inject any air bubbles.
Turn the injection valve to “Inject”, and immediately after, click the button for “Inject” in
the software to start the program.
The program will go from 0 to 100% B linearly over the course of 10 min. At this flow
rate and time, it is useful to note that each minute represents a 10% increase in %B.
Collect fractions by hand. Elution will occur in the following order:
1. Non-labeled NTS oligo – fractions will look clear, will elute approximately halfway
through run (~50%B, corresponding to ~25% CH3CN v/v).
2. Cy3-labeled NTS-oligo – fractions will appear pink, will elute towards the end of the
run (~75%B, corresponding to ~37.5% CH3CN v/v).
Eluted volume will be at least 1 ml. Concentrate the Cy3-NTS products using a spinconcentration column. Alternately, centrifugation under vacuum or ethanol precipitation
can be used. Pall Microsep spin concentrators (10K or 3K MWCO) work well.
Concentrate down to <500 ul. Perform a buffer exchange by resuspending the
concentrated solution in 1-2 ml of Buffer EB, and concentrating down to <500 ul.
Perform 2-3 washes with Buffer EB, ending with as low a volume as possible (~100 ul).
Spec the final, concentrated, buffer-exchanged Cy3-labled oligo using an EB blank.
Typical concentrations are in the range of 10-100 uM.
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DAY 3: Anneal, extend and purify Cy3-labeled, double-stranded promoter
Extension reaction of oligos with Taq Polymerase
Objective: Anneal template strand (TS) and Nontemplate strand (NTS-Cy3) (in this case,
20 bp overlap) and extend in both directions to create a double-stranded promoter (in this
case, 150 bp total length).
Spec DNA using Tris buffer to calculate volumes of NTS and TS needed for reaction:
Final concentrations/volumes of NTS-Cy3 and TS for extension reaction:
[NTS-Cy3]final = 0.25 uM
[TS]final = 0.275 uM (use excess of TS to extend all of NTS-Cy3)
Example
Non-template strand
(0.25 uM / 54.07 uM) x (1000 ul / 1 ml total rxn vol) = 4.62 ul
Template strand:
(0.275 uM / 48.57 uM) x (1000 ul / 1 ml total rxn vol) = 5.66 ul

Component
Oligo 1 – labeled
Oligo 2
10X PCR Buffer
dNTP
Taq Polymerase
ddH2O (nuclease-free)
TOTAL

[final]
0.25 uM
0.275 uM
1X
0.2 mM
1:100

Vol (ul)
4.62
5.66
100
20
10
859.73
1000 ul

Add components to a 1 ml master mix, starting with ddH2O and ending with enzyme.
Mix well with pipette then aliquot into PCR tubes (20 tubes, 50 ul each).
(20 tubes) x (50 ul/tube) = 1000 ul.
Thermocycler Program:
*Choose Annealing Temperature to be 5C less than the lowest melting temperature (Tm)
of the two oligos.
95C for 4 min (initial melt)
Repeat 2X:
95C for 1 min (melt)
60C* for 2 min (anneal)
72C for 3 min (extend)
72C for 2 min (final extend)
4C hold
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FPLC purification of labeled duplex promoter DNA
Objective: Purify the extended, double-stranded Cy-3 labeled promoter.
FPLC Column: DNA Swift
Stored in 20% EtOH.
Set pressure limit for Pumps A and B to 1.5 MPa.
FPLC Buffers (2L each):
Component
Buffer A
NaCl
100 mM
Tris
20 mM
Acetonitrile
5%

Buffer B
1.5 M
20 mM
5%

Both buffers are vacuum-filtered and degassed before use.
Prepare finished extension reactions for FPLC:
Consolidate all 20 rxns into one 1.5 ul Epp tube.
Using Dionex HPLC, choose the “Primer_Extension” program and start a new batch.
1. Create sequence using “primer-extension-preparative” program.
2. Load sequence
3. Start Batch
Load sample loop and turn valve to inject to start program.
Watch elution. Initial peaks soon after the loading injections (~ 5 min) are simply
components of the extension reaction (dNTP’s, etc) that are eluting early.
Usually, the extended, labeled promoter DNA will elute between 10-12 minutes.
Concentrate elution fractions using an Amicon30 spin column, spinning max speed on
tabletop centrifuge for no more than 3 min at a time. Resuspend in TE (or Buffer EB
from Qiagen kit) 3 times to wash and ensure full buffer exchange. Last, elute by flipping
the column upside down and placing it into a fresh Eppendorf tube. Spin for 2 min to
elute.
Determine concentration using Nanodrop.
A typical yield for a 100 nmol scale order used for a 1 ml extension reaction is ~100 µl at
~1 µM.
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208
tbAP3 NTS no mod

tbAP3 TS

tbAP3 TS lessGC

4/23/2013

4/23/2013

tbAP3 NTS +2mod

4/23/2013

4/23/2013

tbAP3-TS-85

2/20/2013

tbAP3 TS biotin

tbAP3-aminoNTS-85

2/20/2013

4/23/2013

Oligo name

Order Date

Jayan Rammohan
Galburt Lab
IDT Oligo Library

85

85

85

85

85

85

GC content
reduced
downstream

Genomic from -40
to +4, random
flanking sequence

Genomic from -40
to +4, random
flanking sequence

Genomic from -40
to +4, random
flanking sequence

Genomic from -40
to +4, random
flanking sequence

Genomic from -40
to +4, random
flanking sequence

Length Notes
Genomic from -40
to +4, random
85
flanking sequence

5' - 3' sequence
AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGCAG
GG/iAmMC6T/TGA
CACTACCATCGGCGCTACGGCGTTTC
ACTTCTGAGTTCGGCATGACGTCAGG
TGGGACCCAAGCTTCAACCCTGCCAG
TCTAATA
AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGCAG
GG
/5BiosG/CACTACCATCGGCGCTACGG
CGTTTCACTTCTGAGTTCGGCATGACG
TCAGGTGGGACCCAAGCTTCAACCCT
GCCAGTCTAATA
AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGCAG
GGTTGA
CACTACCATCGGCGCTACGGCGTTTC
ACTTCTGAGTTCGGCATGACGTCAGG
TGGGACCCAAGCTTCAACCCTGCCAG
TCTAATA
CACTACCATCGGATATACGTAGTTTCA
CTTCTGAGTTCATCATGACGTCAGGTG
ATACATAAGCTTCAACCCTGCCAGTCT
AATA
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empty NTS +2mod

empty TS lessGC

empty TS less GC biotin

tbAP3 TS lessGC biotin

tbAP3-NT-amino-85

FullCon-NT-100

FullCon-T-100

BubbleCon-T-100

tbAP3-NT85_minus3mod-2AP

4/23/2013

4/23/2013

4/23/2013

4/23/2013

8/15/2013

8/15/2013

8/15/2013

8/15/2013

1/27/2014

85

100

100

100

85

85

85

85

85

Anneal with
FullCon NT 100 for
Bubble DNA
competitor
2-Aminopurine at 3 nontemplate

Anneal with
FullCon NT 100 for
dsDNA competitor

Anneal with either
FullCon-T-100 or
BubbleCon-T-100

Empty promoter,
GC content
reduced
downstream
GC content
reduced
downstream

Empty promoter

Empty promoter

AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCGGTCAGCC
ATTGCCGGATTTGTATGCTCAGGGCA
GGG
CACTACCATCGGATATACGTAGTTTCA
CTTCTGAGTTCATCATGACGTCAGGTG
ATACATAAGCTTCAACCCTGCCCTGAG
CATA
/5BiosG/CACTACCATCGGATATACGT
AGTTTCACTTCTGAGTTCATCATGACG
TCAGGTGATACATAAGCTTCAACCCTG
CCCTGAGCATA
/5BiosG/CACTACCATCGGATATACGT
AGTTTCACTTCTGAGTTCATCATGACG
TCAGGTGATACATAAGCTTCAACCCTG
CCAGTCTAATA
AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGCAG
GG
GTATCACGAGGCCCTTTCGTCTTCAAG
AATTCGTCTTGACACCATTGCCGGATT
TGTATTATACTGGCAGGGTTGAAGCTT
ATGTATCACCTGACGTCAT
ATGACGTCAGGTGATACATAAGCTTC
AACCCTGCCAGTATAATACAAATCCG
GCAATGGTGTCAAGACGAATTCTTGA
AGACGAAAGGGCCTCGTGATAC
ATGACGTCAGGTGATACATAAGCTTC
ATGGGACGGTCATTAATACAAATCCG
GCAATGGTGTCAAGACGAATTCTTGA
AGACGAAAGGGCCTCGTGATAC
AAAATAGGCGTATCACGAGGCCCTTT
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGC/iA
mMC6T/GGGTTGA
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t3_T85_plus2-2AP

FullCon-NT100_17sp

FullCon-T100_17sp

tbAP3-86t-nomod

3/20/2014

4/22/2014

4/22/2014

7/22/2014

86

100

100

85

85

t3_NT85_minus3-2AP

3/20/2014

85

100

tbAP3-T85_plus2mod-2AP

1/27/2014

85

1/27/2014 FullCon-NT100_plus2mod-amino

tbAP3-T85-unmodified

1/27/2014

FullCon 100
promoter with +2
label, use with
Full/BubbleCon-T100
2-Aminopurine at - AAAATAGGCGTATCACGAGGCCCTTT
3 nontemplate
CGTCTTCAAGAATTCGTCTTGACTCCA
TTGCCGGATTTGTATTAGACTGGC/i2A
mPr/GGGTTGA
2-Aminopurine at CACTACCATCGGATATACGTAGTTTCA
+2 template
CTTCTGAGTTCATCATGACGTCAGGTG
ATACATAAGCTTCA/i2AmPr/CCCTGC
CAGTCTAATA
FullCon with 17 bp GTATCACGAGGCCCTTTCGTCTTCAAG
spacer
AATTCGTCTTGACAAAAGTGTTAAATT
GTGCTATACTGGCAGGGTTGAAGCTT
ATGTATCACCTGACGTCATG
FullCon with 17 bp CATGACGTCAGGTGATACATAAGCTT
spacer
CAACCCTGCCAGTATAGCACAATTTAA
CACTTTTGTCAAGACGAATTCTTGAAG
ACGAAAGGGCCTCGTGATAC
GCTCTAGAGCCGGATATACGTAGTTT
CACTTCTGAGTTCATCATGACGTCAGG
TGATACATAAGCTTCAACCCTGCCAGT
CTAATA

2-Aminopurine at
+2 template

CACTACCATCGGATATACGTAGTTTCA
CTTCTGAGTTCATCATGACGTCAGGTG
ATACATAAGCTTCAACCCTGCCAGTCT
AATA
CACTACCATCGGATATACGTAGTTTCA
CTTCTGAGTTCATCATGACGTCAGGTG
ATACATAAGCTTCA/iAmMC6T/CCCTG
CCAGTCTAATA
GTATCACGAGGCCCTTTCGTCTTCAAG
AATTCGTCTTGACACCATTGCCGGATT
TGTATTATACTGGCAGGG/iAmMC6T/
TGAAGCTTATGTATCACCTGACGTCAT
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tbAP3-86t-5'amine

tbAP3-86nt-nomod

tbAP3-86nt-5'amine
770rev-nomod
770rev-5'amine
770fwd-nomod
770fwd-5'amine

Gen_tbAP3_NT85_5'bt_+2Am

Gen_tbAP3_T85

Gen_tbAP3_NT85_5'bt_+2Am

Gen_tbAP3_T85

7/22/2014

7/22/2014

7/22/2014

7/22/2014

7/22/2014

7/22/2014

7/22/2014

3/26/2015

3/26/2015

7/23/2015

7/23/2015

85

85

85

85

21

21

22

22

86

86

86

/5AmMC6/GCTCTAGAGCCGGATATA
CGTAGTTTCACTTCTGAGTTCATCATG
ACGTCAGGTGATACATAAGCTTCAAC
CCTGCCAGTCTAATA
CGGGATCCCGGTATCACGAGGCCCTT
TCGTCTTCAAGAATTCGTCTTGACTCC
ATTGCCGGATTTGTATTAGACTGGCA
GGGTTGA
End-label
/5AmMC6/CGGGATCCCGGTATCACG
AGGCCCTTTCGTCTTCAAGAATTCGTC
TTGACTCCATTGCCGGATTTGTATTAG
ACTGGCAGGGTTGA
Primer
CCCACACTACCATCGGCGCTAC
Primer for labeling /5AmMC6/CCCACACTACCATCGGCG
CTAC
Primer
AATAGGCGTATCACGAGGCCC
Primer for labeling /5AmMC6/AATAGGCGTATCACGAGG
CCC
Genomic flanking /5BiosG/GGCGACGGTCACCTATGGAT
sequence around
ATCTATGGATGACCGAACCTGGTCTT
Mtb rrnAP3
GACTCCATTGCCGGATTTGTATTAGAC
promoter
TGGCAGGG/iAmMC6T/TGC
Genomic flanking TGAAACCACCAAACACACTATTGAGTT
sequence around
CTCAAACAACACGCTTGCTTGTTTCCG
Mtb rrnAP3
CCCGCTTCGGGGCAACCCTGCCAGTC
promoter
TAATA
Genomic flanking /5BiosG/GGCGACGGTCACCTATGGAT
sequence around
ATCTATGGATGACCGAACCTGGTCTT
Mtb rrnAP3
GACTCCATTGCCGGATTTGTATTAGAC
promoter
TGGCAGGG/iAmMC6T/TGC
Genomic flanking TGAAACCACCAAACACACTATTGAGTT
sequence around
CTCAAACAACACGCTTGCTTGTTTCCG
Mtb rrnAP3
CCCGCTTCGGGGCAACCCTGCCAGTC
promoter
TAATA

End-label
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Genomic flanking
sequence around
Mtb rrnAP3
promoter
Genomic flanking
sequence around
Mtb rrnAP3
promoter

/5BiosG/GGCGACGGTCACCTATGGAT
ATCTATGGATGACCGAACCTGGTCTT
GACTCCATTGCCGGATTTGTATTAGAC
TGGCAGGG/iAmMC6T/TGC
TGAAACCACCAAACACACTATTGAGTT
CTCAAACAACACGCTTGCTTGTTTCCG
CCCGCTTCGGGGCAACCCTGCCAGTC
TAATA

Appendix B
Binding protocols and controls
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Introduction
I have studied binding interactions between CarD, RNAP, and DNA using double-filter
binding assays and electrophoretic mobility shift assays (EMSA) and as described in
Chapter 2.

The development of the double-filter binding assays required control experiments testing
the effects of the positions of the Cy3 dye (end versus internally labeled) as well as
different instruments (STORM vs. Typhoon) for maximizing signal for DNA-only on the
nylon over the nitrocellulose. The protocol was developed taking these factors into
consideration, and is presented here along with data control experiments.

The development of the EMSA assay was initially difficult due to the presence of a
nuclease contaminant in a preparation of Mtb CarD, which caused degradation of the
Cy3-DNA substrate. Identifying the cause of the Cy3-DNA degradation was confounded
by the use of competitor DNA (i.e. Poly dI-dC) in the assay, as recommended by
Hellman and Fried. The use of competitor DNA can not only affect measurements of
CarD-DNA binding (which is non-specific and therefore susceptible to competitor DNA),
but the presence of competitor DNA can also “soak up” nuclease in the reaction and
prevent a researcher from knowing about the contaminant. I have included EMSA results
from troubleshooting this issue in the hopes that they can inform future experiments.
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Protocol: Nitrocellulose and Nylon Filter-Binding for Quantitative ProteinDNA Binding Interactions
Jayan Rammohan
Galburt Lab

References:
1. Quantitative nonisotopic nitrocellulose filter binding assays. J.D. Czerwinski
et. al., Anal. Biochem. 336 (2005) 300-304.
2. A double-filter method for nitrocellulose-filter binding: Application to
protein-nucleic acid interactions. Wong and Lohman, PNAS. 90 (1993) 54285432.
Buffers
Reaction buffer:
60% MQ H2O
10% 10x Mycobacterial transcription buffer +DTT/+BSA (“MTB +/+”)
…also make MTB +/- (no BSA) for filter soaking and wash steps
20% RNAP Storage Buffer (10 mM Tris pH 8, 200 mM NaCl, 25% glycerol)
10% CarD Storage Buffer (20 mM Tris pH 8, 150 mM NaCl)
Final glycerol = 5% (v/v)
Reaction volume: 30 ul
Reaction mix:
6 ul RNAP Stg Buffer (up to 400 nM [RNAP]final )
3 ul CarD Stg Buffer (up to 11 uM [CarD]final )
3 ul 10x MTB +/+
18 ul MQ H2O/DNA for up to ~ 10nM [DNA]final, can use as low as 1nM
Nitrocellulose and nylon filters

Whatman Protran Nitrocellulose Transfer Membrane (pore size = 0.1 um)
Treatment:
10 min soak in 0.4 M KOH
3 x 5 min washes in distilled water (bring pH to neutral)
1 hour soak in Rxn Buffer (-BSA) at 4 deg C
Millipore Immobilon-Ny+ Transfer Membrane
Treatment:
1 hour soak in Rxn Buffer (-BSA)
Reaction procedure

Binding assays will be performed at minimal fixed [DNA].
Perform reactions in a sterile, low-protein-binding polystyrene 96-well assay plate,
or in PCR tubes.
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1. Mix each component of the reaction and incubate for 30 min at desired
temperature.
2. Disassemble filter-binding apparatus, place Nitrocellulose filter (notch-cut,
top right corner) on top of Nylon filter (diagonal cut, top-right corner),
reassemble apparatus.
3. Immediately before filtering each set of samples, wells of the vacuumfiltering apparatus are flushed with 200 ul of Rxn Buffer (-BSA) at desired
temperature using a multi-channel pipette, and vacuum-filtered (house
vacuum). Avoid overdrying membrane.
4. Load 30 ul reactions into the wells using a multi-channel pipette and vacuum
filter. Immediately after filtering each set of samples, the wells of the
vacuum-filtering apparatus are washed once with 200 ul of Rxn Buffer (-BSA)
at the desired temperature using a multi-channel pipette.
5. The filters are then removed from the apparatus and placed in a heated
vacuum dessicator for 20 min (up to 45 min) at 80 deg C under constant
vacuum. Overbaking (>1 hr) results in browning and fragmentation of the
membrane.
6. Detection of Cy3-DNA was performed using Typhoon with Cy3-fluorescence
settings, and “press-sample” was included to reduce warping or wrinkling of
the filters.

Note: inclusion of BSA in the soaking and washing buffers can potentially
“hyperblock” the nitrocellulose membrane leading to inverse data.

Chemiluminescent Detection (haven’t tried yet, notes from Mascotti et. al.)

1. Soak the nitrocellulose membrane in blocking buffer for 30 min. Blocking
Buffer: TBST (+BSA) (10 mM Tris-Cl, pH 8, 100 mM NaCl, 0.1 % Tween 20
containing 1% BSA)
2. Discard blocking buffer and replace with identical blocking buffer containing
40 ul of AvidX streptavidin (PE Biosystems), or 1 ul of streptavidin-alkaline
phosphatase conjugate (Ambion).
3. 3 x 5 min washes with blocking buffer.
4. 2 x 2 m in washes with reaction buffer (include 5% solution of Nitroblock
(Ambion Nitro-Block II, Cat. No. T2184, 20 ml, $127.00) in 1 x Ambion
Brightstar assay buffer)
5. Substrate: CPDSTAR (Ambion, T2146, 100 mL, $315.00) is reacted with the
alkaline phosphatase moiety of the membrane-bound AvidX for 5 min before
a digital picture was taken with a GDS-8000 cooled CCD camera (UVP, Palo
Alto, CA). Exposure times ranged from 4-10 min for quantitative data
collection, although band intensity was typically visible within 1-2 min. If no
cooled CCD camera is available, one could, alternatively, expose the
membrane to X-ray film and quantitate by densitometry.
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140612 notes:

Membranes were cut at top right corner – diagonally for nitro, notch for nylon.
Nitro: 0.4M KOH (10 min), 3 washes with MQ H2O, 2 hr 4C soak in Rxn Buff no BSA
Nylon: 1 min wash with 0.5 M NaOH, 3 washes with MQ H2O, 2 hr soak in MQ H2O
Assembled vacuum manifold as described in Wong and Lohman 1993.

Binding reactions were mixed in pcr tubes at room temp, held in metal block for
stability.
All additions were performed with a multichannel pipette (5-50ul volume).
96 half-well plate was pre-loaded with rxn buffer (no bsa) for easy loading of
multichannel pipette for wash steps.
For each 8-well row:
50 ul wash (rxn buff no BSA) – vacuum on 5-10s, off
30 ul load of rxn – vacuum on 5-10s, off
50 ul wash (rxn buff no BSA) – vacuum on 5-10s, off
Disassembled manifold and placed membranes in a large glass tray. Held down
edges and corners with small weights (sharpies and plastic pipette trays) so a gentle
stream of hot air could be applied by a hair drier. Moved glass tray to 60C oven
(Frieden Lab) containing dessicant. Allowed to dry for 30 min before imaging in
STORM.
STORM imaging – “Blue fluorescence/chemiluminescence” mode. Excites at 450
nm, detects ~520nm(?). Best images were collected when filter was face-down, no
saran wrap, and “press sample” option was chosen (***without pressing the sample,
there were large areas of the filter not visible due to poor contact with the imaging
surface***). PMT was set to 800V.
Stored filters in the dark (in a plastic tray in a drawer) over the weekend.
Repeated imaging on 140616 am/pm. Afternoon settings, changed PMT to 650V.
Less saturation and better image contrast.
Initial conclusions and next steps:
High background signal for RNAP with no DNA.
Need at least 10-100nM DNA for detection.
RNAP-dependent signal over background could be detected on Nitrocellulose (100
nM DNA), but not Nylon.

Typhoon Imaging – 1-10nM of Cy3 DNA can be easily detected, with far excess signal
on nylon compared to nitrocellulose. Use this for all future experiments.
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End-labeled Cy3-DNA substrates cannot be used in double-filter binding assays
I hypothesized that the location of the Cy3 label within the promoter fragment
would have no effect on the ability of free Cy3-DNA to pass through the

nitrocellulose filter and bind the nylon filter. To test this hypothesis, I constructed

promoter DNA fragments with Cy3 labels on the ends of the DNA. I tested these end-

labeled fragments against internally labeled DNA using a double-filter binding assay
(Figure 1). Ideal signal-over-background in this assay is achieved when DNA-only

samples have the least signal on nitrocellulose (which in theory specifically traps

protein-bound DNA samples), and the most signal on nylon (which in theory traps
free DNA). Interestingly, end-labeled DNA constructs stuck to the nitrocellulose,

while internally labeled DNA did not. In addition, I found that pre-treatment of the

nitrocellulose with 0.4 M KOH was required to observe higher signal on nylon than
nitrocellulose. For these reasons, analysis of double-filter binding assays for

estimates of binding affinities were limited to experiments performed with
internally-labeled DNA tested with nitrocellulose pre-treated with 0.4 M KOH.
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Appendix B, Figure 1: Effects of label position and pre-treatment of
nitrocellulose on binding signal. End-labeled DNA (first 6 columns) was
compared to internally labeled DNA (last 3 columns) to test whether it would
provide sufficient signal-to-noise for double-filter binding experiments. Also tested
was pre-treatment of the nitrocellulose filter with 0.4 M KOH. The only sample
which provided sufficient nylon signal over nitrocellulose (expected for free DNA)
was internally labeled DNA used with 0.4 M KOH-pre-treated nitrocellulose (green
boxes).
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Appendix B, Figure 2: Effect of DNA concentration on signal-to-noise in
double-filter binding experiments. Titrations of [MboRNAP] were performed
with DNA ranging from 0 to 100 nM to identify the minimum concentration of DNA
that could provide sufficient signal-to-noise for binding experiments. Based on these
results, 10 nM DNA was used for all subsequent binding experiments.
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Presence of a competing nucleic acid can affect measurements of binding affinity and
observation of degraded DNA
It is not uncommon for EMSA protocols to include a competing nucleic acid in order

to improve specific detection of protein-DNA interactions. From Hellman and Fried,
subsection titled “Competing nucleic acid”:

Often a protein sample will contain more than one
nucleic acid binding activity. When secondary binding
activities obscure the one of interest, the addition of
unlabeled competing nucleic acid to the reaction
mixture can reduce the binding of secondary proteins to
the labeled target (1). This strategy works when the
protein of interest binds the target nucleic acid with
greater affinity than it binds the competitor and when
the secondary binding activities do not discriminate
between competitor and target sequences. Since
competing nucleic acids also reduce the amount of
specific binding, even under favorable conditions, it is
best to test a range of competitor concentrations to
optimize discrimination of specific and nonspecific
binding. Commonly used competitors include genomic
DNAs, poly d(A–T) and poly d(I–C) (2).
I tested the effect of genomic DNA by measuring the binding of Msm CarD and Mtb

CarD to DNA in the presence and absence of Salmon Sperm (SaSp) at 100 ng/μl (75

nM) (Supplemental Figure 3). These experiments indicated that [CarD] > 1 μM could

shift DNA in the absence of SaSp DNA, but not in the presence of SaSp DNA,

demonstrating that the presence of competing nucleic acid at this concentration can
effect measurements of CarD-DNA interactions. Furthermore, the observation of
degraded DNA substrate was possible only in the presence of Mtb CarD and the

absence of SaSp DNA. This is important because degraded DNA can be symptomatic
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of nucleases in the reaction, which could have important consequences for future
experiments performed with the same reagents and buffers.

I tested the effect of including Poly(dI-dC) in the EMSA assay by performing

titrations of CarD over Cy3-DNA in the presence and absence of 83 ng/ml (63 nM)
Poly(dI-dC) (Supplemental Figures 4 and 5). I observed that 11.6 μM Msm CarD was
able to shift DNA in the absence but not presence of Poly(dI-dC). These results

demonstrate that the presence of Poly(dI-dC) at this concentration can affect the

measured binding affinity of CarD to DNA. I also found degraded DNA could be
observed in the absence but not presence of Poly(dI-dC). These results further

demonstrate that the observation of degraded DNA can be affected by the presence

a competing nucleic acid. Taken together with the results from the Salmon Sperm
experiments, they eliminate the possibility that these effects are unique to a specific
type of competing nucleic acid, or a particular batch or lot of reagent.

One possible reason for the effect of competing nucleic acids to prevent observation

of degraded DNA is that if a nuclease is present, excess competing nucleic acid could

potentially “soak up” the nuclease and prevent its activity on the labeled nucleic
acid. If nuclease presence is suspected, possible courses of action are (1) to treat
buffers with diethyl pyrocarbonate, or (2) re-prepare the buffers and reagents in

question (3). For these reasons, analysis of EMSA assays for estimating binding

affinities were limited to those reactions performed in the absence of competing
nucleic acid.
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Appendix B, Figure 3: EMSA of CarD-DNA binding in the presence and absence
of Salmon Sperm DNA. Shown is a 4-20% non-denaturing PAGE gel for probing
MsmCarD-DNA and MtbCarD-DNA binding interactions in the presence and absence
of competing genomic DNA. Lane 10 shows DNA-only. Lanes 1-5 show MsmCarDshifted DNA. A super-shift can be seen in lane 3, which is no longer visible when the
same [MsmCarD] is used in the presence of SaSp DNA (lanes 4). Lanes 6-9 show
MtbCarD-shifted DNA. Lanes 6 and 7 show degraded DNA, which are no longer
visible when the same [MtbCarD] is used in the presence of SaSp DNA (lanes 8 and
9).
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Appendix B, Figure 4: Poly(dI-dC) can affect measurements of CarD-DNA
binding affinity in an EMSA. Titrations of MsmCarD over 10 nM Cy3-labled
promoter DNA were performed in the presence (lanes 3-6) and absence (lanes 710) of Poly(dI-dC). The blue boxes demonstrate that MsmCarD at 11.6 μM shifts
DNA in the absence of Poly(dI-dC) (lane 10) but not in the presence of Poly(dI-dC).
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Appendix B, Figure 5: Poly(dI-dC) can mask observation of degraded DNA in
an EMSA. Titrations of MtbCarD were performed over 10 nM Cy3-labeled DNA in
the presence (lanes 3-6) and absence (lanes 7-10) of Poly(dI-dC). The red boxes
indicate that when [CarD] > 1 μM, no degraded DNA can be seen in the presence of
Poly(dI-dC) (lanes 5 and 6). However, in the absence of Poly(dI-dC), degraded DNA
can be seen (lanes 9 and 10). The degradation of DNA is partially-rescued by EDTA,
which chelates metal ions and in doing so helps to prevent nuclease activity (lane
11). In the absence of nuclease, Proteinase K would degrade CarD restore the DNAonly band, which is not observed in lane 12. This suggests the presence of a nuclease
contaminant in the Mtb CarD prep.
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Appendix C

Stopped-flow fluorescence protocol
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Experiment design and execution
This section will contain a protocol for experiment design and execution using an
Applied Photophysics SX-20 spectrophotometer.

1. Instrument initialization
Clean instrument with Nitric Acid and NaOH (if necessary)
Change emission filter to 570+ (if necessary)
Power off all local electronics
Ignite Lamp – allow ~1 hr for warmup and stabilization
Turn on lamp power supply
Adjust knob to 8 A for ignition
Press ignition button
Adjust knob to 150 W
Turn on water bath, adjust setpoint to desired temp (default = 25 C)
Add water to appropriate level if necessary
Open valve for gas, pressure should be ~120 psi
Power on CPU
Power on electronic control box for SX-20
Load and advance at least 10 ml MQ H2O through the

2. Prepare Buffers
Fill 50 ml conical with MQ H2O
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Make 10 ml of 10X MTB +/+
9450 ul 10X MTB -/500 ul stock NEB BSA (20 mg/ml), [10x BSA]i = 1 mg/ml
50 ul stock DTT (2M), [10x DTT]i = 10 mM
Make 25 ml Protein BLANK buffer:
5 ml RNAP Core storage buffer
5 ml SigA storage buffer
5 ml CarD storage buffer
2.5 ml 10x MTB +/+
7.5 ml MQ H2O
Make 25 ml DNA BLANK buffer:
2.5 ml 10x MTB +/+
2.5 ml glycerol
20 ml MQ H2O

3. Collect MQ H2O and Buffer Shots
Instrument settings
Fluorescence
Excitation wavelength: 515 nm

Load and advance at least 5 ml of Protein BLANK and DNA BLANK buffers
into the stopped-flow. Convention: Protein in Syringe F (on left), DNA in
Syringe C (on right).
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Set the Detector High Voltage such that the live reading from the PMT is
between 0.5-1 V. Typical DHV values range between 500-750 depending on
instrument variables (i.e. lamp intensity).

Collect “Buffer” traces.
Collect 3 x 10x/1000pt(log) shots, all 3 shots should overlay. If they do not,
collect 3 more. These will serve as the baseline which will be subtracted from
all traces.

4. Prepare DNA
Calculate total volume of DNA needed for entire day
#shots/condition = 3 prime + 2 data = 5 total
75 ul / shot
Volume / condition = 5 shots * 75 ul / shot = 425 ul (round up to 500 ul)
Total volume = # conditions * 500 ul

Example: 6 conditions (DNA initial, RNAP, RNAP-CarD1, RNAP-CarD2,
RNAPCarD3, DNA final) would require 6 x 500ul = 3000 ul total DNA at 20
nM.
For equal volume mixing, this results in [DNA]final = 10 nM in the reaction.

5. Collect DNA only traces
Load DNA into Syringe C (on the right). Reload more Protein BLANK into
Syringe F (left) if necessary.

Collect “DNA prime” traces.
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3 x 10s/1000pts(log).

Collect “DNA only” traces.
2 x 1200s/10,000pts(log).

6. Prepare protein
7. Collect protein traces
8. Shut down instrument

A.3 Data analysis
This
1. Create Fold Change Plots
Open the buffer traces collected at the same DHV as the rest of the experiment.
Using the trace-selection dropdown menu, average the traces
Fit the averaged trace from 0.1-10s using a linear fit.
Record the value. Copy the exact number from the fitting screen using
C.

CTRL-

Open the DNA and Protein traces (in order if possible) on a single plot by
drag/drop. Make sure that each of the traces shows up for a given condition,
if the initial file opened only has one trace, subsequent “dropped” files will
only display one trace even if multiple traces were collected:
DNA only
MbR225
MbR225-1
MbR225-2
…
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MbR225-N

Trace selection – dropdown menu:
Average the replicate traces for each condition (Shift+mouse click to select
multiple traces, then click “Average”). This will result in filenames
“Average0, Average1, Average2, … AverageN). Do each condition individually
if this is easier, in order to keep the trace numbering in register with sample
types.

Select all of the averaged traces, and click “Simple Maths” and then subtract
the buffer only value (CTRL-V) to buffer-correct all averaged traces.

Select the buffer-corrected and averaged DNA-only trace, and fit it with a line
from 0.1-1200s. Use the y-intercept (“c”) as the signal for the DNA. Again,
copying the exact number from the fitting screen using CTRL-C is useful. This
value is referred to as “F0”, or “F naught”.

For all of the data traces, calculate fold change as (F – F0) / F0. This can be
done by selecting all of the traces, and using Simple Maths to first subtract
the DNA-only value (CTRL-V), and then again using Simple Maths to divide by
the DNA-only value (CTRL-V again).

To clean up the oversampled noise at the beginning of the traces, Smooth the
data using a 20-pt window.

Save the finished Fold-Change plot!

2. Measure equilibrium fluorescence
Create a spreadsheet where each row represents each protein condition, and the
columns are as follows:
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EQBM c

a1

k1

a2

k2

a3

k3

MbR225
MbR225-1
MbR225-2
…
MbR225-N

Open the “Fold Change” plot.

Measure the final point of each trace and record this as the EQBM fluorescence
value.

3. Fit Protein data to a 3exp
Fit the DNA only (probably called “Smooth0”) to a line from 0.1-1200s, and after
fit make sure the “save residual on graph” box is checked and then click “OK”. This will
create 2 more traces, one for the fit and one for the residual error.

Fit each protein trace first by fitting to a 2exp from 1-1200s. Then expand the fit
to a 3exp and extend the start time earlier from 1s to 0.1s. Copy and past the [a1, k1, a2,
k2] to [a2, k2, a3, k3], respectively. Lock these numbers. Do not re-click Estimate.
Click Fit until the numbers converge. Record C, a1, k1, a2, k2, a3, and k3 in the table.
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Appendix D
Matlab code for eigenvalue calculation
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Introduction
Shown here is Matlab code written for evaluating eigenvalues calculated from a 5-state
model for factor-dependent stabilization of open-complexes.

function SSE_k3_eig2()
%UNTITLED Summary of this function goes here
%
Detailed explanation goes here

%
% DNA + R + X
%
%
%
%
%

k1
k3
<----> RPc <-----> RPo
k2
^
k4
^
k5 | k6
k7 | k8
v
k9
v
XRPc <----> XRPo
k10

%% FIRST, plot the raw data of k(obs)3 vs. [CarD].
%
This section uses C to represent [CarD].
C = [0 5 11 16 25 32 55 105.5 250 527.5 1027.5 1800 2000];
kobs3 = [0.00381 0.00418 0.00186 0.00235 0.00278 0.00212 0.00148
0.00201 0.00457 0.00389 0.00632 0.00812 0.00837];
sem=[
0.000257292
0.000987779
0.000987779
0.000987779
0.000987779
0.000987779
0.000987779
0.000442219
0.000987779
0.00149522
0.001210826
0.000987779
0.000987779];
figure(30);hold on;
errorbar(C,kobs3,sem,'k');

%% SECOND, calculate and plot the eigenvalues vs. [CarD] in a semicontinuous fashion
%
This section uses "scale" to titrate a rate constant as an outer
loop.
%
This section uses X to titrate [CarD] as an inner loop, from 010,000nM.
%
%
This section uses k#a to designate the original rate value, and
k#(i) is
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%
%
to
%

defined as a vector that titrates the original value across a
range of values defined by "scale". k8(i) is calculated accordingly
maintain detailed balance within the thermodynamic cycle.

k1 = 0.3;
% RNAP on rate
k2 = 75;
% RNAP off rate
%k3 calculated below
% intrinsic opening rate
k4 = 0.004;
% intrinsic closing rate
k5 = 0.3;
% CarD on rate to RPc
k6 = 400;
% CarD off rate from RPc
k7 = 0.3;
% CarD on rate to RPo
k8 = 2.0;
% CarD off rate from RPo
k9 = 0.0125;
% CarD opening rate
k10a = 0.0005;
% CarD closing rate
k3a = (k5*k9*k8*k4)/(k7*k10a*k6) % intrinsic opening rate calculated
from detailed balance.
%R = [125:50:525];
R=225;
scale=[0.001 0.01 0.05 0.1 0.5 1 1.5 2 2.5 3 4 5 10 100];
%scale
is a scaling factor which is used to titrate a rate constant
X = [0:0.5:10000]; %X represents a semi-continuous vector of CarD
concentrations
for i = 1:length(scale)
k10(i) = k10a*scale(i);
containing titration
k3(i) = (k5*k9*k8*k4)/(k7*k10(i)*k6);
for all scaled values for detailed balance
end

%create a vector for k#
%calculate a vector for k3

%% PLOT Eigenvalue vs. [CarD] across the range of rate constants
defined by "scale"
for i = 1:length(scale)
for j = 1:length(X)
%R=2^r;
%X=[1:10000];
rates =
[
-k1*R
0;
k1*R
0;
0
k8;
0
(k6+k9)
k10(i);
0
-(k8+k10(i)); ];

k2

0

0

-(k2+k3(i)+k5*X(j)) k4
k3(i)

k6

-(k4+k7*X(j))

k5*X(j)

0

-

0

k7*X(j)

k9

0

E(:,j) = eigs(rates);
end
%

for(j=1:5)

%plots a fig for each eig
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%
%

for(j=2)
%figure(19+j);hold on;
figure(30);hold on;
using same fig# as above

%plots a fig for each eig
%overlay on top of raw data

%

set(gca,'ColorOrder',parula);
plot(X,-E(2,:));
eigenvalue
%
lstring{n} = num2str(R(n));
end

%just plot second

%% THIRD, calculate SSE using eigenvalues for each of the experimental
values of [CarD]
%
This section uses the same vector R for [RNAP] as the outer loop.
%
This section now uses C to represent [CarD] in the inner loop,
where C
%
is the concentrations of CarD tested experimentally.

for i = 1:length(scale)
for k = 1:length(C)
rates =

[

-k1*R

k2

0

0

k1*R

-(k2+k3(i)+k5*C(k)) k4

0;
k6

0;
0

k3(i)

-(k4+k7*C(k))

0

k8;
0
k10(i);
0
-(k8+k10(i)); ];

k5*C(k)

0

-

0

k7*C(k)

k9

(k6+k9)

E2(:,k) = eigs(rates);
% E2 represents a vector of eigenvalues
corresponding to each experimental CarD concentration
end
% calculate squared error (SE) for each value of experimental CarD
(C)
for a=1:length(C)
SE(a)= (kobs3(a) - (-E2(2,a)))^2;
% squared error (SE) of
prediction taking into account every experimental concentration
end
figure(31);hold on;
plot(k10(i),sum(SE),'o')
error (SSE) of prediction

% plot titration of rates vs. sum squared

figure(32);hold on;
plot(k3(i),sum(SE),'o')
figure(33);hold on;
plot(k10(i)/k3(i),sum(SE),'o')
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end
figure(30);hold on;
same fig# as above
title('k10 and k3 titration');
xlabel('[CarD](nM)');
ylabel('eig2');
savefig('k10_w_k3_ttrn.fig');

%overlay on top of raw data using

figure(31);hold on;
title('k10, based on k10 and k3 titration');
xlabel('k10');
ylabel('SSE');
savefig('k10_w_k3_SSE.fig');
figure(32);hold on;
title('k3, based on k10 and k3 titration');
xlabel('k3');
ylabel('SSE');
savefig('k3_SSE.fig')
figure(33);hold on;
title('k10/k3, based on k10 and k3 titration');
xlabel('k10/k3');
ylabel('SSE');
savefig('k10_w_k3_ratio.fig')
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